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Summary
A variety of methods for preparing human immunoglobulin G (IgG) 
specific immunoadsorbents have been compared. All preparations have 
been based on cellulose and its derivatives, and the suitability of 
this polysaccharide as a carrier has been investigated.
The relative efficiencies of different protein immobilisation 
procedures have been assessed with particular reference to the success 
and practicalities of the carrier activation procedure and the capacity 
to couple antibody protein. Once immobilised the activities of the 
antibodies were measured in terms of the capacity for antigen using 
radioimmunoassay procedures and comparisons were made with free antibody.
A number of different eluting agents were used to recover antigen, and
 ^ •'
the relative effectiveness of these agents was determined. The most 
efficient immobilisation procedures were those involving coupling of 
the antibody to diazotised N-(3-aminobenzyloxymethyl) cellulose, 
glutaraldehyde activated aminoalkyl cellulose or bromoacetamidoalkyl 
cellulose. These methods were used to make immunoadsorbents for use on 
a preparative scale and in solid-phase radioimmunoassay.
Immunoadsorbents were used as the basis of sensitive and specific 
radioimmunoassays for IgG, IgD, insulin and human placental lactogen.
Immunoadsorbents specific for human IgG were used in various 
purification protocols involving different combinations of batch and column 
immunoadsorption, washing and elution. The findings were then applied 
to the purification of IgD from both myeloma and normal sera. The IgD 
was characterised both physically and immunochemically.
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CHAPTER ONE 
Introduction
Introduction
Some of the most exciting immunological techniques to evolve in 
recent years are those involving immunoadsorbents. These are 
insolubilised preparations of antibodies or antigens used for the 
specific adsorption of antigens or antibodies respectively. The concept 
was first put into practice by Campbell, Luescher and Lerman (1) who 
prepared an immunoadsorbent by linking the antigen bovine serum albumin 
(BSA) to a carrier, p-aminobenzylcellulose. This particular immuno­
adsorbent was employed to remove the specific antibody to BSA from 
rabbit antiserum. Subsequently, the potential of immunoadsorption for 
both antibody and antigen purification has come to be realised.
Specific antibodies can be removed from whole anti'sera with the 
appropriate insolubilised antigen, and conversely antigens can be 
purified from mixtures using insolubilised forms of specific antisera.
Other applications include the simple agglutination reactions used for 
the detection of human chorionic gonadotrophin in urine as being indicative 
of pregnancy; removal of cross-reacting antibodies from antisera to render 
them mono-specific; and the estimation of antibody and antigen levels 
either by adsorption and subsequent elution or by solid-phase radio­
immunoassay.
The preparation of immunoadsorbents by immobilising antibodies or 
antigens allows for the conservation of valuable materials which can be 
used repeatedly, as well as imparting increased stability to the molecular 
structure.
The number of published methods of immunoadsorbent preparation 
continues to grow and would seem to indicate that no one technique has
asserted itself as a good all round method.
There are four basic approaches to the problem of making a soluble 
antigen or antibody insoluble:- covalent coupling to a support; physical 
adsorption on to a support; trapping within a lattice; or cross-linking 
the material with itself or a similar ’'sacrificial*1 substance. The 
introduction of the glutaraldehyde polymerisation method by Avrameas and 
Temynck (2) was considered by many to be potentially the most satisfactory 
method of immunoadsorbent preparation. Similarly, some methods using 
covalent coupling to polysaccharides have found wide acceptance, 
particularly the cyanogen bromide method of Axen, Porath and Emback (3). 
However, the relative merits of various immunoadsorbent preparations are 
rarely considered for particular applications, and it is this that has 
been attempted in the work for this dissertation.
Antibodies to human immunoglobulin G (IgG) have been used as a model 
in the preparation of immunoadsorbents to study the relative efficiencies 
of these adsorbents for immunoglobulin purification. Conclusions drawn 
from this study have been applied to the purification of immunoglobulin 
D (IgD) from myeloma and 'normal' human sera. Furthemore, solid-phase 
indirect radioimmunoassays have been developed for immunoglobulins, 
insulin and human placental lactogen.
a) Immunoadsorbents
The word 'immunoadsorbent' was originally coined to define an 
insolubilised antigen preparation, but in recent years it has come to 
describe both antigen and antibody preparations. Campbell, Luescher and 
Lerman (1) pioneered the technique with insoluble protein antigens which 
would combine specifically with the antibody, and referred to them as 
immunologic adsorbents.
Immunoadsorption requires either an antiserum showing specificity 
for the particular antigen to be purified or, if antibody purification 
is to be attempted, pure antigen. The protein is first immobilised by 
linking it to a suitable matrix or trapping it in a lattice, then any 
protein which has not reacted is washed off. Unreacted sites on the 
matrix are blocked by reaction with suitable compounds . For the purpose 
of protein purification the immunoadsorbent is either suspended in the 
biological fluid containing the protein of interest, or else the fluid 
is passed through a column packed with the adsorbent. Specific antibody- 
antigen binding then occurs while all non-specific proteins remain free 
to be washed from the adsorbent by a suitable buffer. The immuno- 
chemically linked protein is then eluted using a solution of suitable 
pH and/or ionic strength (Fig. 1.2)
Three different approaches may be made to radioimmunoassay using 
immunoadsorbents. The more generally used method employs insolubiLised 
antibodies, and the assay depends upon the ability of the antibody to bind 
radio-actively labelled antigen, and the competitive inhibition of this 
reaction by unlabelled antigen. The antibody-bound antigen is then 
separated from the unbound by centrifugation. The more specialised 
iramunoradiometric assay developed by Miles and Hales (4) involves the 
use of radioactively labelled antibodies. Antibodies are isolated on 
an immunoadsorbent composed of antigen bound to cellulose, labelled with 
radioactive iodine and then eluted from the adsorbent. An excess of this 
antibody is incubated with antigen standards and unknowns, and the amount 
of antibody-antigen complex formed, is proportional to the antigen 
concentration. An antigen immunoadsorbent is then added to remove excess 
antibody. After centrifugation the supernatant is sampled for measurement 
of radioactivity.
Fig. 1.1.
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Sandwich techniques employing antibody and antigen immunoadsorbents 
are used to assay antibody and antigen respectively. The antigen to be 
assayed is incubated with the appropriate antibody immunoadsorbent, and 
this is then washed. Radioactively labelled antibodies are then added 
and these react with the antigen bound to the antibody on the solid 
matrix. The antigen must be able to bind to two antibodies simultaneously. 
The uptake of labelled antibody is directly proportional to the amount of 
antigen present. A similar rationale applies to the assay of antibodies.
A more detailed discussion of these assays is included in Chapter 3.
b) Antisera
Although apparently a powerful technique, immunoadsorption presents 
many problems. The first of these is in obtaining a suitable specific 
antiserum, or a very pure sample of the antigen. The antiserum of choice 
must be mono-specific and cause the formation of antibody-antigen complexes 
that are readily dissociable. Proteins of molecular weight greater than 
5000.are usually good immunogens, but smaller molecules may have to be 
linked to a carrier protein such as bovine serum albumin. A single 
inj ection of a particular immunogen will initiate a primary response 
made manifest by the appearance of antibodies after a lag period. The 
antibody concentration rises to a maximum and then slowly declines. A 
booster injection of immunogen at this time will be followed by a 
transient negative phase due to mopping up of circulating antibodies and 
then an anamnestic response leading to a higher peak of antibody 
concentration. Repeated injections at suitable time intervals will 
lead to the production of a maximum level of antibody which will vary 
from one individual to another. The primary response to an immunogen 
initially results in the synthesis of 19 S immunoglobulin M (IgM).
Since IgM is less stable than IgG it is not as suitable for immuno­
adsorbent preparation. IgG is synthesised in preference to IgM as the 
primary response progresses (5). Najjar (6) has suggested that this 
change over from IgM to IgG synthesis may be because the body responds 
differently to antigen-antibody complex than to antigen alone. Although 
the insolubilisation will probably confer greater stability upon the 
IgM antibodies, antibodies from the IgG class are generally used due to 
their inherent stability and the fact that they are more easily obtained.
A protein as large as human IgG, which has a molecular -weight of- 
160,000, will possess several antigenic determinants,of different immuno- 
genicity. Consequently an antiserum raised to such a protein will contain 
several antibodies showing specificity for different antigenic determinants 
Further, the free binding energies of the different antibody molecules for 
any one determinant are distributed according to the Gauss error function 
(7). The most weakly reacting antibodies probably do not reflect the true 
structure of the antigenic determinants and are often referred to as being 
the least avid, whilst the most strongly reacting antibodies have the 
greatest avidity for the antigen. When using immunoadsorbents for 
preparative purposes the avidity of the antibodies should ideally fall 
between the two extremes. Avidity can be measured by means of a Scatchard 
plot (8) derived from a radioimmunoassay standard curve. A plot of the 
ratio of antibody-bound to free antigen against bound antigen (moles litre 
gives a linear response, the slope of which represents the avidity of the 
antibody. Immunoadsorbents prepared with weakly reacting antibodies are 
liable to suffer from non-specific adsorption problems, whilst with highly 
avid antibodies it will be very difficult to effect dissociation of the 
antigen once it has reacted with the specific antibody. Another point
to be borne in mind is that of early and late antibodies (9). Late 
antibodies from hyperimmune sera may show reactivity with antigen 
determinants not exhibited by sera taken from the same animal on a 
previous occasion. The antisera often become less specific as an 
immunisation course progresses (10). The antiserum obtained from 
an animal very often shows cross-reactions to other proteins, therefore 
before using the antiserum to prepare an immunoadsorbent the cross­
reactions must be removed. This is achieved by either liquid adsorption* 
or by use of an immunoadsorbent prepared from the cross-reacting 
proteins (11).
c) Types of Immunoadsorbents and Support Materials
The methods available for either coupling proteins to insoluble 
supports, or trapping or polymerising them are numerous and diverse, 
reflecting the fact that no one technique is generally applicable to 
all systems. One can only ascertain which system is best suited to a 
particular application by testing each one in turn and assessing it 
according to a set of established criteria.
There are basically four approaches to the problem of protein 
insolubilisation: physical adsorption on to a carrier, covalent bonding 
to a carrier, trapping within a lattice structure and polymerisation.
■t
Immunoadsorbents prepared by physical adsorption of antibody to a 
carrier are unsuitable for preparative work because conditions of pH 
and ionic strength which will dissociate the protein from the carrier 
are almost certain to be encountered. However, such preparations do 
find applications in the field of immunological tests and assays. 
Polystyrene latex particles have been used in a passive agglutination 
test for the rheumatoid factor (12), and more recently in a number of
* The cross-reacting protein is added to the antiserum, and the 
immunoprecipitate formed on incubation is removed.
pregnancy diagnostics. In the latter case, latex particles are 
sensitised with human chorionic gonadotrophin (HCG). Addition of 
antiserum to HCG will cause agglutination. If urine containing 
a significant level of HCG is added to the antiserum it will 
neutralise the antibodies and so prevent agglutination. Hagiwara (13) 
used latex particles coated with antigen to bind specific antibody, 
and after centrifuging and washing the particles he dissociated the 
latex-antigen-antibody complex. Other carriers used for physical 
adsorption include tanned (14) or formalised (15) red blood cells, 
glass beads (16), and bentonite, which has been used for solid-phase 
radioimmunoassay (17).
Preparations involving trapping of the antibody molecules within 
a lattice structure, such as that formed by polyacrylamide, also have 
their shortcomings. Provided that the antibody molecules cannot escape 
through the pores of the lattice-work and that the antigen is small 
enough to enter, the immunoadsorbents should perform satisfactorily.
These problems were overcome by Carrel and Barandun (18) who used a 
macroporous gel to prepare a number of immunoadsorbents of high capacity, 
and by Carrel et al (19) in isolating normal immunoglobulin E. It is 
possibile that the protein is covalently coupled to the polyacrylamide 
geli
Protein polymers are easily made by reaction of protein with cross- 
linking reagents such as ethylchloroformate (20), glutaraldehyde (2), 
and bis-diazotised benzidine (21). Disulphide-linked antibodies have 
been prepared successfully by thiolating the protein with N-acetyl 
homocysteine thiolactone and then cross-linking with a potassium 
ferricyanide reagent (22, 23). Bifunctional organomercurial compounds 
may also be used to cross-link through thiol groups (74).
Methods of coupling proteins to insoluble carriers through covalent 
bonds account for the majority of immunoadsorbent preparations. Several 
of these methods were originally developed for the preparation of 
insolubiised enzymes, but have proved to be equally useful for immuno­
adsorbent preparation. Linking of antigens or antibodies to a suitable 
carrier by covalent binding eliminates the danger of desorption during 
elution. The most commonly used insoluble carriers are cellulose and 
its derivatives, beaded agarose, Sephadex, beaded polyacrylamide, 
ethylenelmaleic anhydride copolymer, polystyrene, nylon and glass. The 
applications of these carriers will be discussed in subsequent sections.
d) The choice of support
Immunoadsorbents may be used either in columns or in a 'batchwise* 
procedure (2) which involves stirring the adsorbent in suspension and 
recovery by centrifugation. Ideally, adsorbents used in columns should 
have a loose, porous network which permits uni-form and unimpaired entry 
and exit of macromolecules. The adsorbent particles should be of 
uniform size, spherical and rigid (25), so imparting good flow properties 
to the column. Cellulose is not ideal in these respects, but it does 
form columns with acceptable flow rates. Weliky and Weetail (26) prepared 
immunoadsorbent columns based on carboxymethylcellulose for the study of 
antigen-antibody interactions. Boegman and Crumpton (27) concluded that 
myoglobin immunoadsorbents prepared from aminoethylcellulose and carboxy­
methylcellulose were suitable for column applications. The very small 
particle size of many cellulose derivatives causes clogging of columns, but 
this problem has been overcome by mixing the immunoadsorbent with swollen 
Sephadex G-25 (28,29). The Sephadex serves not only as a solid diluent 
but also as a molecular sieve, a property which has contributed to its 
success as an immunoadsorbent support in its own right (30). Beaded
agarose (Sepharose) comes even nearer to the ideal because of its loose 
network (30),. & b ead ed  polyacrylamide (Biogel) also shows promise (31).
Glass beads were used by Baum, Ward.and Weetall to couple acetylcholinesterase 
(32) , and are now used as the  basis o f antibody-im m unoadsorbents in certain  radioim m uno­
assay k i ts .  Polyaminostyrene was used by Williams and Kunkel (33) for 
the insolubilisation of rabbit and human IgG, and has also been used to 
prepare insolubilised enzymes, but references to its use are few and 
far between.
As pointed out by Porath (30), and Hornby, Lilly and Crook (34), 
it is very important to make allowance for fixed charge groups on the 
support material. Hydrophobic carriers such as polystyrene may tend to 
denature the covalently linked protein, while hydrophilic carriers may 
stabilise its configuration. The hydrophilic nature of hydroxyl- 
containing carriers such as agarose may be enhanced by reaction with 
polyhydric phenols or alcohols and epichlorohydrin (35). Strongly anionic 
or cationic carriers will produce electrostatic interactions with the 
insolubilised protein and so influence its stability and activity. Further, 
such carrier properties can be expected to- affect the optimum pH of the 
antibody-antigen reaction and its sensitivity to temperature and ionic 
strength. Hornby, Lilly and Crook (36) studied insolubilised ficin 
preparations with oppositely charged supports, and concluded that charge- 
charge interactions between substrate and support strongly influenced the 
enzyme’s activity. Since a charged support has the ability to adsorb 
proteins with an opposite charge, such physical adsorption may occur 
during either the coupling reaction or immunoadsorption (37). The 
chemical nature of the support may also affect its affinity for a given 
protein and hence its ability to covalently bind that protein. Weliky 
and Weetall (26) studied the influence of carboxymethylcellulose as a
support material on some antigen-antibody reactions. The adsorbent 
contributed strongly to the interaction of ionisable haptens with 
antibody, with a pH dependency typical of acid-catalysed reactions. 
Dissociation of antibody from haptenic and protein immunoadsorbents 
showed no significant discontinuities in the acid range. Antibodies 
to haptens which did not ionise in acid did not dissociate from the 
immunoadsorbent at low pH, but did so at high pH. Unmodified and 
hapten-substituted carboxymethylcellulose exhibited non-specific 
adsorption of gammaglobulin and albumin between pH 3.0 and 4.0.
Hydrogen bonding to hydroxy groups in the cellulose was considered to 
be an important factor, and this could only be prevented by. using 
highly ethylated or acetylated carboxymethylcellulose. After such 
modification, non-specific gammaglobulin was not retained by the 
adsorbent column between pH 2.0 and 7.0.
The surface area of the support plays a major role in determining 
the amount of protein which may be covalently bound, and its subsequent 
stability. By dissolving m-aminobenzyloxymethylcellulose in a 
cuprammonium solution and then reprecipitating it by the addition of 
water followed by rapid cooling and addition of 101 sulphuric acid to 
discharge the blue colour, Gurvich et al (38) obtained a finely divided 
cellulose derivative. After diazotisation the reprecipitated cellulose 
bound in excess of 500mg of protein per gram as compared with 50mg per 
gram for the untreated cellulose. Jagendorf et al (39) chose cellulose 
as a solid phase because of its enormous surface area and its hydrophilic 
nature which serves to minimise the degree of non-specific adsorption 
one would expect from a hydrophobic support.
Silman and Katchalski (37) predicted that functional groups closely 
attached to the backbone of a polymeric carrier should display lower
reactivity than similar groups situated on the ends of long, flexible, 
hydrophilic side chains. Therefore by employing spacer side-chains it 
should be easier to couple protein to the carrier, and in greater 
amounts. Cuatrecasas (25) pointed out that attaching proteins to a 
carrier in this manner should help in overcoming steric difficulties 
when interactions with macromolecules are studied. This is more likely 
to be the case when low molecular weight antigens are insolubilised for 
immunoadsorption of their respective antibodies than when the roles are 
reversed.
Following the covalent coupling of an antigen or antibody to an 
insoluble support it is often necessary to block any unreacted groups 
on the carrier. Unreacted diazo-groups are commonly blocked by 
3-naphthol. Weetall and Weliky (40) followed such a procedure after 
coupling BSA to diazotised p-aminobenzylcellulose and arylaminocellulose 
derivatives with different levels of free amino groups. The retention 
and subsequent release of non-specific protein by these immunoadsorbents 
appeared to be dependent upon the number of 3-naphthol groups present.
One gram of the p-aminobenzylcellulose derivative retained 0.10 mg of 
non-specific protein per ml of serum passed over the adsorbent, whereas 
the arylaminocellulose derivative which has twice the number of 3-naphthol 
groups retained twice the quantity of non-specific protein. The possible 
influence of unmodified amino groups was not considered. An immuno- 
adsorbent prepared by direct coupling of BSA through an amido link to a 
carboxymethylcellulose in the presence of dicyclohexylcarbodiimide required 
no blocking agent, and retained only 0.011 mg of non-specific protein per 
ml of serum passed over one gram of the adsorbent. Following diazotisation 
of polyaminostyrene and subsequent reaction of the diazo groups with 
3-naphthol, Yagi et al (41) found that antigen was bound to the carrier
by physical adsorption. By decreasing the number of amino groups in 
the polyaminostyrene-based immunoadsorbent the affinity of the 
antigen for its antibody was increased. This suggested that any charge 
on the carrier attributable to the amino groups influenced antibody- 
antigen binding. Appreciable amounts of non-specific protein were 
released with the antibody on elution (42).
Ethanolamine and propanolamine have been employed to block any 
excess of reactive groups occurring in cyanogen bromide activated 
polysaccharides and bromoacetyl derivatives. In this way hydroxyl 
groups are restored to the carrier.
Amino acids are employed as blocking agents for groups exhibiting 
specificity for amino or carboxyl functions. However, it must be borne 
in mind that their use will introduce ionisable groups to the carrier 
which may have the disadvantage of causing non-specific protein 
adsorption. In a few cases serum albumin has been used to quench 
unreacted groups on the carrier, as for example, after coupling immuno­
globulins to cellulose carbonate (43).
e) Methods for Coupling Proteins to Insoluble Carriers by Covalent Bonds
The chemistry and use of cellulose derivatives is largely covered in 
a comprehensive paper by Weliky and Weetall (44). Reviews of methods • 
available for covalent bonding of proteins to insoluble supports include 
those by Silman and Katchalski (37), Sehon (42), Campbell and Weliky (45), 
Goldman et al (46), Cuatrecasas (25), Cuatrecasas and Anfinsen (47) and 
Cuatrecasas (48).
The functional groups available in proteins for covalent bond 
formation are the N-terminal and e-amino groups, C-terminal, 3“ and y- 
carboxyl groups, the hydroxy groups of serine and threonine, the phenolic
ring of tyrosine, the thiol group of cysteine, the imidazole group of 
histidine, the indole group of tryptophan and the guanidino group of 
arginine.
Hie first reference to the preparation of an immunoadsorbent by 
covalent binding of an antigen to a support was that employing bis- 
diazobenzidine to couple ovalbumin to sheep erythrocytes (83) • The 
coupling of protein to cellulose was also effected through a diazo bond 
by Campbell et al (1) and subsequently by Gurvich et al (38) . ’ / They 
prepared p-aminobenzylcellulose and m-aminobenzyloxymethylcellulose 
respectively by etherification reactions of cellulose and diazotised 
tliese derivatives by reaction with hydrochloric acid and sodium nitrite 
at G°C. Mildly alkaline pH favours reaction with the phenolic ring of 
tyrosine and amino groups, while at pH 6.0 tyrosine reacts more slowly 
and the imidazole groups of histidine may also react. An advantage 
gained with diazonium salts is that they are able to react with proteins 
under a range of conditions. Comparable coupling levels are obtained 
between pH 6.0 and 9.0, and between CPand 37°C (49). An aminoarylcellulose, 
derived by coupling benzidine to carboxymethylcellulose in the presence 
of N,N^-dicyclohexylcarbodiimide (40), was diazotised and coupled with 
rabbit anti-human IgG (50). Diazo coupling was employed in the linking
j
of a-amylase to 3-(p-aminophenoxy)-2-hydroxypropyl ethers of cellulose 
with different degrees of substitution (51). The lower the substitution 
level the higher was the retention of a-amylase activity. This effective 
loss of activity at higher substitution levels was more marked when 
coupling at pH 6.3-6.4 than at 7.6-7.7. It was considered probable that 
at pH > 7.0 coupling took place via tyrosine residues, whereas at pH < 7.0 
coupling via histidine and tryptophan residues was of importance.
Sehon (52) bound albumin and human IgG to polyaminostyrene by a 
diazo bond, and the method has been used in numerous other applications.
Marked variations in the physical and chemical properties of poly- 
aminostyrene result in immunoadsorbents with considerably different / 
properties. Bovine serum albumin was covalently coupled to a diazonium 
salt derivative of polyacrylamide to the extent of 300 mg per gram of 
acrylamide (31). Diazonium-Sepharose derivatives (25) were prepared 
by treating amino-Sepharose with p-nitrobenzoyl azide in 501 dimethyl- 
formamide, followed by reduction with dithionite and diazotisation 
with nitrous acid. Coupling of the diazo-group to the protein occurred 
through imidazole and phenolic groups of the protein. Blocking of 
unreacted diazo-groups, following the coupling of the protein,\\ras 
achieved by reaction with 3-naphthol forming a red azo dye.
Enzymes have been coupled to carboxymethylcellulose by modifications 
of the method of Micheel and Ewers (53) , which involves the synthesis 
of carboxymethylcellulose hydrazide and its conversions to the azide 
for reaction with the protein. The technique has been applied to the 
insolubilisation of chymotrypsin (54), alkaline phosphatase (55) and 
ficin (34). Bovine serum albumin was coupled to an acyl azide derivative 
of beaded polyacrylamide, and the product contained 78 mg protein per gram 
(31). Unreacted azide groups were reconverted to the amide by the 
addition of either ammonium hydroxide or hydrazine and ammonium chloride, 
to the reaction mixture. The acyl azide group can react with amino, 
hydroxyl and thiol groups of the protein by nucleophilic substitution 
producing amide, ester and thioester bonds respectively.
Esterification of cellulose by bromoacetic acid and bromoacetyl
bromide yields bromoacetylcellulose (39, 56). Proteins are coupled by
*
an alkylation reaction via their amino groups at pH 8.5-8.9. Coupling 
also occurs via the phenolic and imidazole substituents. The weakness
* See Fig. 1.3, p.21.
of the method lies in the labile ester linkage produced in the first 
reaction. Jagendorf et al (39) employed an initial physical adsorption 
step at pH 4.6 to immobilised rabbit IgG. Covalent bonding was effected 
by adjusting the pH to 8.5. Approximately 981 of the protein was linked 
to the cellulose support, equivalent to 400 mg of protein per gram of 
bromoacetylcellulose. Blocking of the free bromoacetyl groups was 
achieved by reaction with ethanolamine.
Kay and Lilly (57) favoured the use of coupling agents which react 
with hydroxyl groups on the support. It was then possible to choose the 
net electrostatic charge on the insoluble support by using such materials 
as DEAE- or CM-cellulose. Cyanuric chloride (2,4,6-trichloro-s-triazine)' 
and various of its derivatives were employed in the preparation of ■ 
insolubilised enzymes. It was concluded that 2-amino-4,6-dichloro-s- 
triazine* was the most convenient and produced the best results. One of 
the chlorines reacts with an hydroxyl on the cellulose giving a monochloro- 
s-triazinyl cellulose. The second chlorine reacts with stronger nucleo­
philes such as amino groups of proteins. Chymotrypsin was coupled to 
various support materials at pH 8.75.
Activation of hydroxylated polymers can readily be achieved by
*
reaction with divinylsulphone which simultaneously introduces a side 
chain on to the support. The active vinyl groups are some considerable 
distance from the base polymer and will react with protein amino groups 
in the pH range 8-10 (35). Pretreatment of the polymer with polynydric 
phenols or alcohols and epichlorohydrin was advocated in order to increase 
the number of available hydroxyl groups, some of which are in sterically 
more favourable positions and possess higher reactivities.
* See F i g .  1 . 3 ,  p . 22.
Studies of the cyanogen halide activation of polysaccharides (58), 
cellulose, Sephadex and Sepharose in particular, have shown cyanogen 
bromide to be the most satisfactory activator. Procedures based on this 
method are now widely 4sed for both immunoadsorption and affinity 
chromatography. Activation results in the substitution of imidocarbonate 
esters and carbamate groups into cellulose and Sephadex. However,
Sepharose has no vicinal hydroxyl groups and therefore imidocarbonate 
groups are not formed. The degree of activation can be controlled by 
varying the reaction pH, activation being maximal at pH 11 or above.
The method of protein coupling is gentle and therefore particularly useful 
for immunoadsorbent preparation. A slightly alkaline pH is preferable.
Cyanogen bromide has been used as the first step in the preparation
of various polysaccharide derivatives (25, 59). Aliphatic amines of various
chain lengths were substituted directly into the activated polysaccharide
giving rise to w-aminoalkyl derivatives. Proteins were linked to these
through their carboxyl groups in the presence of carbodiimide. Trypsin
was coupled to aminoethylcellulose with the bifunctional reagent
glutaraldehyde at pH 7.0 (60). Carboxylic acid derivatives, prepared
by reacting w-aminoalkyl derivatives with succinic anhydride at pH 6.0,
coupled through the amino functions of proteins in the presence of 
*
carbodiimide. This procedure has been used extensively for coupling 
proteins to carboxymethyl cellulose (26, 40, 51, 61, 62), and to an 
aminocellulose derived by reacting carboxymethylcellulose with a diamine 
in the presence of a carbodiimide (61). Bromoacetyl polysaccharides were 
prepared by the action of O-bromoacetyl-N-hydroxy succinimide on the 
w-aminoalkyl derivatives (25), and the sulphydryl derivatives by reaction 
with N-acetylhomocysteinethiolactone. Proteins couple to thiol groups, in
the presence of carbodiimide, through thiol ester bonds.
See F i g .  1 . 3 , p . 22.
The method of activation of aminoethylcellulose mentioned above, 
was also employed to activate polyacrylamide beads for the preparation 
of immunoadsorbents (63). Various proteins, including rabbit, sheep 
and human IgG and BSA, were immobilised by coupling them to the activated 
polyacrylamide at pH 7.4. The quantity of protein coupled was of the 
order of 1 to 2 mg per 1 ml of beads. Unreacted aldehyde groups were 
subsequently blocked by reaction with lysine.
Cellulose carbonate has several characteristics in common with the 
cyclic imidocarbonate of cellulose prepared by activation with cyanogen 
bromide. Immunoadsorbents are relatively simple to prepare, covalent 
coupling occurring by nucleophilic substitution under relatively mild 
reaction conditions via terminal- or £-amino groups in the protein.
The preparation of cellulose carbonate was described by Barker et al (64), 
and covalent coupling of 3-D-glucosidase was effected at pH 7.8 (65).
Catty et al (44) have since employed the cellulose carbonate to prepare 
immunoadsorbents by coupling rabbit and human immunoglobulins. The 
effect of charged groups on the carrier has been demonstrated by Gray ahdYeo 
(66) with DEAE-cellulose carbonate coupled enzymes. At the coupling pH 
the protein, 3-D-glucosidase, was adsorbed on to the DEAE groups and then 
covalently linked by reaction between amino groups on the protein and the 
cyclic carbonate groups.
Barker et al (67) reported the formation of titanium-cellulose 
chelates by reaction with titanous or titanic chloride. The ions bind 
six molecules of water which are easily replaced by other ligands such 
as proteins. The titanium chelates were considered to be particularly 
suitable for the insolubilisation of enzymes, especially those with 
poly(n-acryloyl-:4 and -5-aminoalicyclic acid) which have the advantage 
of being non-biodegradable (68).
Another insolubilisation procedure which has application to immuno- 
adsorbent preparation, is the oxirane method (69). Sepharose was 
activated with 10% epichlorohydrin in 1 M sodium hydroxide at 60-Cfor 
2 hours, and after exhaustive washing the protein was coupled in 0.5 M 
bicarbonate buffer. Unreacted groups were subsequently blocked with 
ethanolamine.
A simple method for activation of polysaccharides was described by 
Sanderson and Wilson (70). Cellulose, Sephadex and Sepharose were 
oxidised with sodium periodate, and the aldehyde groups thus generated 
reacted with the amino functions of BSA. Cellulose bound 25 mg of 
protein per gram following treatment with 0.1 M periodate for 25 hours. 
Sephadex G-75 (fine)was degraded by 0.1 M periodate. Treatment for 
1 hour with a 0.1 M solution of periodate had no visible effect, and 
1 gram of the product coupled approximately 190 mg of protein. Unreacted 
groups were reduced with a 1% solution of sodium borohydride.
Reaction of the p-aminophenoxyhydroxypropyl ether of Sephadex with . 
thiophosgene produces the corresponding isothiocyanate (71). Oxytocin, 
insulin, glucagon and IgG were coupled to this derivative, IgG to the 
extent of 34 mg per gram.
Organic isocyanides have been used to couple a-chymotrypsin to 
CM-Sephadex and periodate-oxidised Sepharose (72). 3-Dime thylamino- 
propylisocyanide, acetaldehyde (not in the case of oxidised Sepharose) and 
chymotrypsin were mixed with the insoluble carrier and the reaction 
maintained at pH 6.5. The CM-Sephadex preparation contained 345 mg of 
the enzyme per gram, but only 8% of the original activity was retained.
The Sepharose derivative, whilst containing only 20 mg of protein per gram, 
possessed 50-60% of the original activity.
Hydrophilic copolymers based on polyacrylamide are marketed under 
the trade name Enzacryl. Aromatic amino residues of Enzacryl AA may be 
activated either by diazotisation or by conversion to isothiocyanate 
groups by thiophosgene. Coupling to the protein is achieved through 
tyrosine and imidazole groups in the first instance and through amino 
groups by formation of a thiourea in the second instance. An Enzacryl 
acid hydrazide may be converted to the azide, by the method of Michael and 
Ewers (53), which then reacts with protein amino groups’.with formation of 
amide bonds. The syntheses and some of the applications of such poly­
acrylamide derivatives have been reported by Inman and Dintzis (31).
An alkylaminosilane derivative of porous glass, obtained by reacting 
the glass with aminoalkyltriethoxysilane in toluene (73), has been used 
to immobilise protein. This was achieved after activation of the aromatic 
groups either by diazotisation or by conversion to the isothiocyanate with 
thiophosgene. The porous glass was found to lend itself well to column 
chromatography giving very good flow rates.
Centeno and Sehon (74) prepared Versatile and high capacity’ immuno­
adsorbents by coupling antibodies or antigens to ethylene maleic 
anhydride copolymers. The anhydride reacts with amino groups forming an 
amide linkage and a carboxyl group. Goldstein (75, 76) converted the 
copolymer to a polyamine by reacting if with 1,6-diaminohexane in the 
presence of N,N’-dicyclohexylcarbodiimide. Proteins were then coupled 
through either their carboxyl groups in the presence of a water soluble 
carbodiimide or their amino groups after activation of the carrier with 
glutaraldehyde.
The use of glutaraldehyde as a protein cross-linking reagent (2,77) 
has given rise to another widely used type of immunoadsorbent. These can
be made either by direct polymerisation of the protein in solution or 
by linking the protein to a carrier polymer prepared by cross-linking 
BSA with glutaraldehyde. Different proteins exhibit different pH 
optima for polymerisation by glutaraldehyde and ethylchloroformate (20), 
a property associated with the ionisation state of the amino groups.
An alternative method of protein polymerisation was reported by Stephen, 
Gallop and Smith (22) involving disulphide linkages. Antibodies were 
thiolated by reaction with N-acetylhomocysteine thiolactone at pH 10.6. 
Cross-linking was achieved with a mixture of potassium ferricyanide,
ammonia and ammonium chloride. Alternatively organo-mercurial compounds 
may be used to effect the cross-linking.
This section has out of necessity included only the briefest details 
of the methods of protein immobilisation involving covalent bond formation. 
However, it is felt that the list of methods presented is comprehensive, 
omitting only those which involve minor modifications to those already 
described.
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f) Tlie Efficiency of Protein Immobilisation and Retention of 'Immunological 
Activity
Tne degree and efficiency of covalent bonding of proteins to cellulose 
and other insoluble carriers is dependent upon the concentration of the 
protein and the physical and chemical properties of both the protein and 
the carrier. The amount of protein coupled is restricted by the number 
of active groups on the carrier until the surface area of the latter 
becomes a limiting factor. By reprecipitation of aminocellulose from an 
ammoniacal copper solution, Gurvich et al (38) obtained a cellulose 
preparation with a much reduced particle size and consequently greater 
surface area. This treatment greatly increased the capacity of the amino­
cellulose for protein. For some applications, such as the ’batchwise'
extraction of protein from a small volume or the processing of large 
volumes through columns, it may be desirable to have a high protein: 
carrier ratio, provided that the protein retains a high percentage 
of its original capacity for antigen or antibody.
Most proteins, provided that they are of sufficiently high
t
molecular weight, have more than one antigenic site. Glucagon,for 
-example, with a molecular weight of 3485 and 29 amino acid residues, 
has been shown to have two antigenic sites (78). Some antigenic 
sites may be masked by the process of immobilisation, but there is a 
good chance that others will still be available to react with antibody. 
An antiserum' raised to such an antigen will contain a heterogeneous 
antibody population with antibodies specific for all the antigenic 
determinants.
The antigen binding sites of an antibody are localised at the 
N-terminal ends of the heavy and light chains. If immobilisation 
involves covalent linking with amino acid residues in this region of 
the molecule the antigen binding sites may be masked with a complete 
loss of the ability to bind antigen.
The ease with which protein can be coupled to a carrier may be an 
important consideration. The conditions should be kept as mild as 
possible as regards pH, ionic strength and the use of organic solvents 
so as to minimise the chances of denaturation. Typical carriers which 
enable these conditions to be fulfilled are bromoacetylcellulose and 
cellulose carbonate, both of which'have the added advantage that they 
can be stored and used without the need for further activation. Such 
properties would prove attractive if immunoadsorbents had to be 
prepared quickly.
The reactivities of various functional groups at different pHs1 has 
been considered in the previous section. The importance of the choice of 
coupling pH has been demonstrated for insulin and insulin antibodies. 
Cuatrecasas (79) found that reaction of insulin with cyanogen bromide- 
activated Sepharose at pH 6.5 favoured coupling via the terminal amino group 
of the B chain (phenylalanine), while reaction at pH 9.0 lead to coupling 
via the e-amino group of the B29 lysine residue. Both preparations adsorbed 
antibodies. Sheep antiporcine insulin antibodies coupled to Sepharose at 
pH 6.5 bound 80% of their theoretical capacity for insulin. However, when 
the coupling reaction was carried out at pH 9.5 only 7% of this capacity was 
available (25). This last figure is in good agreement with the findings of 
Bolton and Hunter (80) who recovered 6.2% of the original antigen binding 
capacity as measured with iodinated insulin. At pH 9.5 covalent coupling 
is likely to occur through the lysine residues. The considerable loss in 
activity would seem to indicate that either the lysine residues concerned 
are located in or near the active site, or that the extent of covalent 
coupling to the carrier is such that it introduces unfavourable steric effects. 
At the lower pH the reaction with lysine is not favoured.
Cellulose carbonate-IgG immunoadsorbents prepared under weakly acid 
or neutral conditions contained greater amounts of protein than those 
prepared at alkaline pH (43). An immunoadsorbent prepared at pH 6.0 
retained 38% of the binding capacity of the antigen in free solution as 
opposed to 45% for an immunoadsorbent prepared at pH 9.0. The immobilisation 
of IgM on cellulose carbonate did not show a pH optimum between 6 and 10.
The products obtained between pH 6 and 8 retained all their capacity for 
antibody, but this was reduced by more than half for the antigen immobilised 
at pH 10. These results again point to the dangers to be encountered if one 
generalises when considering immunoadsorbents. It is important to allow for the
specificities imposed on a system by the antisera, the antigen and 
the conditions of immobilisation.
Hill (81) found that on repeated re-use, a human serum albumin (HSA) 
immunoadsorbent bound less antibody, but that a higher percentage of 
this antibody was recovered on elution. The following hypothesis was 
put forward to explain these results. If an immunoadsorbent has a high 
antigen density then antibodies will bond through all their available 
antigen binding sites. At low antigen densities only a small proportion 
of these sites will be involved and consequently the antibody is eluted 
more readily. In the case of the HSA-immunoadsorbent only 53.3% of 
the antibody was eluted, whilst the remaining 46.7% blocked antigenic 
sites on the immunoadsorbent, so effectively reducing the antigen density. 
Subsequent re-use of the immunoadsorbent revealed a decreased capacity 
for antibody, but increasing amounts of this were recovered on elution.
In the fifth adsorption 13.6% of the added antibody was bound of which 
79.3% was recovered on elution. These figures compare with 19.5% and 
53.3% respectively on the first cycle. A gradual diminution in the 
capacity of rabbit IgG coupled to cellulose carbonate was observed by 
Catty et al (43) on re-use of the immunoadsorbent.
An interesting study reported by Nicklin and Smith (82) concerned 
the recovery of protein antigens from disulphide linked immunoadsorbents 
derived from non-avid sera. They concluded from a study of human serum 
albumin, ovalbumin and lysozyme systems that the non-avid sera adsorbed 
and released antigen 3 to 4 times more efficiently than avid sera.
A non-avid serum contained a higher proportion of antibody with a low 
binding affinity for antigen than did an avid one. The elution conditions 
necessary to recover antigen from non-avid antibody immunoadsorbents
were less severe than those required with avid antibody immunoadsorbents. 
Re-use of the non-avid antibody preparations produced recoveries of the 
order of 80 to 100% of the freshly adsorbed antigen. This was in keeping 
with the theory that antibodies with high binding affinities were blocked 
by antigen when the immunoadsorbent was used for the first time. These 
antibodies could then no longer influence the adsorption and subsequent 
elution of antigen.
The most widely used method of estimating the amount of protein 
coupled to an insoluble carrier involves measuring the difference between 
the initial amount of protein added and that found in the washings. This 
has its disadvantages in that it involves large volumes of solution which 
have to be concentrated in order to make accurate determinations of 
their protein content. More accurate results should be achieved by making 
direct measurements of the protein in the immunoadsorbent. Kjeldhal (28, 
61) and Dumas (56) nitrogen determinations, isotopically labelled proteins 
(62) and amino acid analysis have been used in this approach. Methods 
employing specific properties of a protein may be applicable, as for 
example the estimation of iron as a measurement of the coupling of 
myoglobin (27). The activities of immobilised antigens and antibodies 
are measured by their respective capacities for antibody and antigen 
relative to those in solution, and also in terms of the percentage of 
adsorbed protein recovered by elution.
Immunoadsorbents are usually stored in suspension at 4°C in a 
suitable buffer containing a bacteriostat such as sodium azide.
Aims
T h e  p r o je c t  has been  u n d e rta k e n  w i t h  th e  o b je c t  o f  co m p a rin g  
a n t i-h u m a n  im m u n o g lo b u lin  G ( Ig G )  im m unoadsorbents  p re p a re d  fro m  
a  w id e  ra n g e  o f  c e l lu lo s e  d e r i v a t i v e s .  T he  v a r io u s  a n t ib o d y  
im m o b il is a t io n  p ro c e d u re s  w i l l  be com pared so as to  f i n d  w h ic h  
i s  th e  m ost e c o n o m ic a l i n  r e s p e c t  o f  th e  am ount o f  a n t ib o d y  
im m o b il is e d  and th e  p e rc e n ta g e  o f  t o t a l  a n t ib o d y  a c t i v i t y  r e t a in e d .  
P a r t i c u l a r  m ethods o f  a n t ib o d y  im m o b il is a t io n  w i l l  be  in v e s t ig a t e d  
to  e s t a b l is h  th e  e f f e c t s  o f  v a r y in g  th e  e x t e n t  o f  c o v a le n t -b o n d in g  
b etw e en  th e  p r o t e in  and th e  c e l l u lo s e  and o f  in t r o d u c in g  s p a c e r  
arms b e tw e en  th e  tw o . T h e  ease  w i t h  w h ic h  th e  a n t ig e n  c an  be  
d is s o c ia t e d  fro m  th e  im m unoadsorbent w i l l  a ls o  be c o n s id e r e d .
A f t e r  a s c e r t a in in g  w h ic h  m ethods o f  im m o b i l is a t io n . a r e  th e  m ost 
s a t i s f a c t o r y ,  a n t i-h u m a n  Ig G  im m unoadsorbents  w i l l  be p re p a re d  i n  
o r d e r  to  s tu d y  v a r io u s  p r o to c o ls  f o r  IgG  p u r i f i c a t i o n .  T h e  m ost 
s a t i s f a c t o r y  p r o to c o ls  w i l l  th e n  be a p p l ie d  to  th e  p u r i f i c a t i o n  
o f  Ig D  fro m  b o th  m yelom a and 'n o r m a l ’ human s e r a .  S o lid -p h a s e  
rad io im m u n o assays  w i l l  be d e v e lo p e d  f o r  th e  r o u t in e  m easurem ent 
o f  th e  im m u n o g lo b u lin s .
CHAPTER TWO
The Preparation, Characterisation 
and Comparison of Cellulose-Based 
Antibody-Immunoadsorbents
(a) Introduction
Sheep IgG, containing antibodies specific for the Fc region of 
human IgG, has been linked covalently to cellulose by a variety of 
methods. This variety has been achieved by employing several cellulose 
derivatives, different types and numbers of covalent bonds9 and spacer 
arms between the support and the protein.
The amounts of sheep IgG coupled to the cellulose were measured with 
the aid of 1^5I-labelled IgG and compared for the different methods of 
preparation. The capacities of the antibody-immunoadsorbent for human 
IgG were measured in a radioimmunoassay system employing 125I-labelled 
human IgG and compared with the values for free antibody. The assay 
curves were used to deduce the properties of the immunoadsorbents. 
Subsequently, a study was made to ascertain the ease with which antigen 
could be recovered from the different immunoadsorbents by elution.
A less extensive study was made of antibody-immunoadsorbents to 
insulin.
The ideal immunoadsorbent was expected to meet the following criteria:
i) Linkage of the antibody to cellulose should be via covalent bonds.
ii) The immunoadsorbent should be highly insoluble.
iii) The specific antigen should bind to the antibody-immunoadsorbent 
under conditions in which no other protein is retained.
iv) A high percentage of the adsorbed protein should be recoverable 
by elution.
v) The immunoa'dsorbent should be stable with respect to time and eluant.
vi) The physical properties of the immunoadsorbent should lend itself
to either column or batchwise purification procedures or radioimmuno­
assay.
vii) The preparation should be economical, a large proportion of the 
antibody being incorporated in the immunoadsorbent, and the immuno­
logical properties of the antibody should not be affected by 
immobilization.
(b) Materials and Methods 
1. Materials
The chemicals used were Analar grade wherever possible and were 
purchased from B.D.H. Chemicals, Poole, Dorset-,with the 
following exceptions. Ethylene diamine, 1,5-diaminopentane,
3,3’-diaminodipropylamine, N-hydroxysuccinimide and 1-cyclohexyl 
-3-(2-morpholonoethyl) carbodiimide metho-p-toluene sulphonate were 
purchased from Ralph Emmanuel, Wembley, Middlesex. l-Ethyl-3- 
(3-dimethylaminopropyl) carbodiimide hydrochloride, papain and ■ 
bovine serum albumin were purchased from Sigma Ltd., Kingston- 
Upon-Thames, Surrey. Agarose was obtained from L' indust rie 
Biologique Francaise SA, 35 a49, Quai du Moulin de Cage,
Gennevilliers, Seine, France, and Ionagar No. 2 from Oxoid Ltd.,
London, S.E.l. Cotton wool was a product of Boots Ltd., Nottingham. 
Whatman CF11 and CC31 celluloses were purchased from W.R. Balston, 
Maidstone, Kent, as were DEAE-cellulose and CM cellulose. CM-cellulose 
hydrazide was obtained from Miles Seravac (Pty) Ltd., Maidenhead,
Berks. Sephadex, Sepharose and Dextran blue were supplied by 
Pharmacia Fine Chemicals Ltd., Ealing, London.
Antisera were prepared at The Wellcome Research Laboratories, 
Beckenham, Kent.
Polystyrene tubes with caps (GL3) were obtained from Greyward 
Laboratory Disposables, Bedford.
Buffers
B1 Na H2P04.2H20 2.34 g
Na2HP04.2H20 • 10.68 g
NaCl 8.5 g
E.D.T.A. 3.72 g
NaN3 1 g
B.S.A. 5 g
to 1 litre with distilled water pH 7.4
B2 ^3^3 acid) 5.5. g
■^a2^4^7 (sodium tetraborate) 4.5 g
NaCl 8.5 g
E.D.T.A. 3.72 g
NaN^ . 1 g
B.S.A. . 5 g
to 1 litre with distilled water pH 8.4
Phosphate Buffered Saline (PBS) pH 7.66
Na2HP04 1.56 g
NaH2P04 ■. 12.80 g
NaCl 85.00 g
to 10 litres with distilled water .
Borate Buffer pH 8.75, 0.25M
H3B03 - 12.37 g
Na2B4Oy 10.20 g
to 1 litre with distilled water.
Phosphate/Citrate pH 5.5 
Na2HP04.2H20
Citric acid (C^ngOy^ 0)
20.11 g
9.14 g
Washing of Immunoadsorbents
Following the protein coupling reaction, remaining uncoupled 
protein was removed by washing with various buffers. The washing 
procedure was performed on a glass sinter fitted to a Buchner vacuum 
flask. Aliquots (100 ml) of the buffers were used in the following 
sequence:- phosphate-buffered saline. (PBS) pH 7.66 three times; 
glycine 50mM - hydrochloric acid pH 2.8; PBS; phosphate buffered 
sodium thiocyanate 3M pH 6.0; and PBS three times.
Freeze Drying
Samples of selected immunoadsorbents were freeze-dried in order 
to ascertain the effect of this process on the stability of the antibody. 
Before freezing the immunoadsorbents were suspended in 0.05 M borate 
buffer pH 8.4 containing 0.51 BSA, 0.91 sodium chloride and 5% sucrose.
Synthesis of 3-nitrobenzyl alcohol
Sodium borohydride (3.8 g) was dissolved in 40 ml of 0.2 N sodium 
hydroxide and was added to a continuously stirred suspension of m-nitro- 
benzaldehyde (31 g) in 200 ml of methanol. The temperature was maintained 
between 20 and 25°C by occasional cooling in ice water. The methanol was 
evaporated under reduced pressure followed by the addition of 200 ml of 
distilled water to the residual gum. The upper oil fraction was extracted 
four times with diethyl ether and the combined extracts dried over 
anhydrous sodium sulphate. The solution was filtered and evaporated under 
reduced pressure, and the residual oil distilled in vacuo.
b.p. 112-115°C| 0.05inm Hg. yield 28.1 g.
Synthesis of 3-nitrobenzylchloromethyl ether (84, 85) •
Dry hydrogen chloride was passed into a vigorously stirred mixture 
of m-nitrobenzyl alcohol (16 g) and 361 formaldehyde (13.3 g) in benzene 
(200 ml) for four hours. The mixture was kept at room temperature over­
night, and the benzene layer separated and washed with water. After 
drying over sodium sulphate the benzene was evaporated under reduced 
pressure and the residue distilled in vacuo. A residue of a higher b.p. 
remained.
b.p. 112°C | 0.07 mm Hg. yield 14.7 g.
Synthesis of N- (3-nitrobenzyloxymethyl) pyridinium chloride monohydrate 
3-nitrobenzylchloromethyl ether (14.7 g) was added dropwise to 
stirred dry pyridine (37 ml) over 30 minutes. A white crystalline solid 
began to precipitate. After a further 20. minutes the mixture was cooled 
in ice, and the solid filtered-and washed with petroleum ether' (80-100°C).
The product was dried over phosphorous pentoxide in vacuo.
m.p. 98-100°C yield 19.2 g
Preparation of N-(3-aminobenzyloxymethyl) cellulose
N-(3-aminobenzyloxymethyl) cellulose was prepared either from cotton 
wool, as described by Gurvich et al (38) writh minor modifications (28, 86) 
or from microcrystalline cellulose. When using the microcrystalline 
cellulose the initial step of treatment with ethanol was omitted, as was 
the reprecipitation of the final product from a cuprammonium solution.
Various quantities of 3-nitrobenzyloxymethyl-pyridinium chloride monohydrate, 
between 0.25 and 7.0 g per 100 g of cellulose,were used to treat the 
cellulose in order to obtain different degrees of substitution. The
degree of substitution was estimated by measuring the nitrogen content 
of the dried product.
Coupling of antibody to N- (3-aminobenzyloxymethyl) cellulose
The aminocellulose was diazotised using the method described by 
Gurvich et al. (38) and Miles and Hales (86). The aminocellulose (2 g) 
was suspended in 20 ml of I N hydrochloric acid and stirred at 0°C.
A ten-fold excess, (relative to the amino groups) of sodium nitrite was 
added, and stirring continued for 30 minutes. Solid urea was added until 
the starch-iodide paper test was negative, indicating that excess nitrous 
acid had been neutralised. The diazocellulose was washed three times 
in ice cold distilled water and twice in 0.1 M borate buffer pH 8.75.
After the final wash the diazocellulose was resuspended in 6 ml of the 
borate buffer containing the immunoglobulin. The reaction mixture was 
stirred gently for 36 hours at 4°C. The suspension was centrifuged and 
the resulting pellet resuspended in fresh borate buffer. Remaining 
diazo groups were inactivated by the addition of $-napthol or tyrosine 
and stirred for a further 18 hours at 4°C. The resulting immunoadsorbent 
was washed thoroughly and stored- either freeze-dried or in phosphate buffered 
saline (PBS) at 4°C.
Coupling of antibody to p-aminobenzyl cellulose
p-aminobenzyl cellulose (BDH) was washed with 50% ethanol and 
distilled water until the washings were colourless. Nitrogen estimation 
then showed that the product contained 0.08 mequiv. NH^ per gram of 
aminocellulose compared with 0.11 mequiv. claimed by the manufacturer. 
Diazotisation, coupling of the antibody and blocking of unreacted 
diazo-groups were achieved by the same procedures as, ' with N-(3-amino- 
benzyloxymethyl) cellulose.
Coupling of immunoglobulins to carboxymethyl cellulose hydrazide
Carboxymethyl cellulose hydrazide (CMC-hydradide) contained 600 yequiv. 
of hydrazide groups per gram. Immunoglobulin was coupled to CMC-hydrazide 
by the Curtis azide method as described by Mitz and Summaria (54) , but 
with minor modifications.
One gram of CMC-hydrazide was suspended in 20 ml of 1 N hydrochloric 
acid and stirred at 0°C. After the cellulose derivative had swollen, 0.7 g 
of solid sodium nitrite was added and stirring continued for a further 
20 minutes. The resulting CMC azide was washed twice with 30 ml of ice 
cold 1 M sodium chloride and twice with 30 ml of ice cold distilled water.
The pellet was resuspended in 10 ml of 0.1 M borate buffer pH 8.75 at 0°C, 
containing the immunoglobulin. The suspension was stirred at 0°C for 
six hours followed by the addition of 0.2 g of glycine which reacted with 
any remaining azide groups. The suspension was then stirred overnight 
at 0°C. The preparation was washed as described previously, and the 
resulting immunoadsorbent was stored in PBS at 4°C. '
Preparation of 2-amino-4,6-dichloro-s-triazine
The method was that of Thurston et al. (87) with some modifications.
Cyanuric chloride (18.4 g) was dissolved in a mixture of dioxan 
(100 ml) and dimethoxyethane (15 ml) in a 250 ml beaker equipped with 
stirrer, thermometer and gas inlet tube. * The beaker was then cooled 
in ice on a balance pan. The solution was maintained at 4°C while a 
stream of ammonia was -passed into it. 3.4 g of ammonia was absorbed in 
75 minutes, during which time a solid was precipitated. Excess ammonia 
was flushed from the mixture by the passage of nitrogen for five minutes.
The mixture was heated to 95°C in order to dissolve the 2-amino-4,6-dichloro- 
s-triazine while the ammonium chloride remainedinsoluble and could therefore
• q
be filtered from the hot solution. The filtrate was cooled to 3 C, and
the product crystallised as fine colourless needles. The solution 
was filtered, the crystals collected and dried in vacuo.
m.p. 235-236°C yield 8.5 g.
Coupling of immunoglobulin to aminochloro-s-triazinyl cellulose
Minochloro-s-triazinyl cellulose was prepared as described by 
Kay and Lilly (57). Different degrees of substitution were .achieved 
by varying the quantity of 2-amino-4,6-dichloro-s-triazine between 
20 and 300 mg per gram of cellulose. The degree of substitution was 
estimated by measuring the nitrogen content of the products. The 
cellulose derivative was suspended in a solution of immunoglobulin 
in 0.2 M borate buffer pH 8.75. The coupling reaction was allowed 
to proceed at room temperature for six hours, and for a further 16 
hours at 4°C. The reaction mixture was centrifuged at 2,500 £ for 
five minutes. Hie resulting pellet was suspended in 0.2 M glycine 
and stirred at room temperature for six hours in order to block any 
unreacted triazinyl groups. The immunoadsorbent was then washed using 
the procedure previously described in order to remove any non-covalently 
bound protein.
Coupling of immunoglobulin to carboxymethyl cellulose in the presence 
of carbodiimides (50, 61, 62).
Carboxymethyl cellulose (CM2) was suspended in 2N hydrochloric 
acid and stirred at room temperature for 30 minutes to ensure complete 
conversion to the acid form. The CMC was then washed on a Buchner 
funnel with distilled water until the washings were of neutral pH.
Two grains of the treated CMC was added to a stirred solution of immuno­
globulin in 8 ml of 0.15 M phosphate/citrate buffer pH 5.5 to give a 
thick slurry. NjN'-dicychohexy 1 -• carbodiimide (600 mg) was dissolved in
1 ml of tetrahydrofuran and 1 ml of water was added forming an emulsion. 
This emulsion was then added to the CMC/protein mixture, and the slurry 
stirred at 4°C for three days. Alternatively, l-ethyl-3-(3-dimethyl- 
aminopropyl) carbodiimide hydrochloride or l-cyclohexyl-3-(2-morpholino- 
ethyl) carbodiimide metho-p-toluene sulphonate dissolved in 2 ml of 
distilled water were used. The immunoadsorbent was washed following 
the procedure described previously.
Cyanogen bromide activation of cellulose (3, 88 , 89)
The entire procedure was conducted in a.well ventilated fume- 
cupboard. A 101' w/v solution of cyanogen bromide in distilled water 
was prepared, 4 ml of this ■ was added to a stirred suspension of 
cellulose (2 g of cellulose in 20 ml of distilled water). The pH 
of this mixture was immediately adjusted to 11.0 by the addition of
2 N sodium hydroxide, and the pH maintained by ‘further additions of 
alkali until it remained constant after eight to ten minutes. The 
activated cellulose was transferred to a Buchner funnel and quickly 
washed with 250 ml of ice-cold distilled water followed, by 50 ml of 
ice-cold 0.5 M bicarbonate buffer pH 9.0. The activated cellulose 
was suspended in the minimum volume of 0.5 M bicarbonate buffer'pH 9.0, 
containing the immunoglobulin, and the mixture was stirred at 4°C for
’ 16 hours. The resulting immunoadsorbent was collected by centrifugation 
and resuspended, in either 100 mM 3-aminopropan«l-6l in 0.25 M sodium 
bicarbonate buffer pH 9.0 or 100 mM glycine pH 9.0 and allowed to stand 
for 16 hours at 4°C. Remaining unreacted groups on the activated cellulose
were blocked by the 3-aminopropan-lbl or glycine.
Preparation of to-aminoalkyl cellulose.
Cellulose was activated with cyanogen bromide as previously 
described.. The cellulose:cyanogen bromide ratio was varied from 
.20:1 to 3:1. The activated cellulose was washed with ice cold water.
2 g of this cellulose was then added to 10 ml of a solution containing 
6 m moles of the appropriate diamine previously titrated to pH 10.0 
with 5 N hydrochloric acid. The mixture was stirred for 16 hr. at 
4°C prior to washing with distilled water. The diamines used in 
these experiments were ethylene diamine, 1,5-diaminopentane, and 
3,3’ -diamino-bis -propylamine.
Coupling of immunoglobulin to aminocellulose
a) ■ Carbodiimide method (25, 61)
The method employed was that previously described for coupling 
immunoglobulin to CM-cellulose.
b) Glutaraldehyde method (60, 63)
Two grams of aminocellulose were suspended in 8.0 ml of 0.2 M  
phosphate buffer pH 7.0. To this suspension was added 8.0 ml of 2*51 
glutaraldehyde adjusted to pH 7.0. The mixture was incubated at room 
temperature for 18 hr and then filtered using a Buchner funnel. Still 
using the Buchner funnel the cellulose was washed with 21 of 50 mM 
phosphate buffered 1 M saline, pH 7.0,and 3 litres of distilled water, 
in order to remove the excess glutaraldehyde. The activated'cellulose 
was suspended in 6.0 ml of 0.2 M phosphate buffer pH 7.0 containing 
the protein for coupling. The suspension was stirred at room 
temperature for 4 hr and then for a further 44 hr at 4°C. The resulting 
immunoadsorbent was collected by centrifugation and resuspended in 
either 100 mM glycine,pH 7.0,or 100 mM 3-amino-propan-l-ol,pH7.0, arid 
stirred for a further 16 hr. The preparation was washed and stored 
at 4°C in PBS. '
Preparation of and Coupling to Sulphydrylcellulose
Cellulose was activated by the cyanogen bromide method, and 
2g of this was reacted with 600 mg N-acetylhomocysteinethiolactone 
in 10 ml 1M sodium bicarbonate buffer pH 9.5. After stirring for 
24hr at 4°C the suspension was filtered on a BUchner funnel and 
washed with 2 1 of PBS. Immunoglobulin was coupled by the carbodiimide 
method previously described for coupling to CM-cellulose. .
Preparation of Bromoacetylcelluloses
a) Bromoacetamidoalkylcellulose
O-Bromoacetyl-N-hydroxysuccinimide was prepared as described by 
Cuatrecasas (25) and Cuatrecasas et al.(90). One mmole 'each of 
bromoacetic acid and N-hydroxysuccindmide was dissolved in 10 ml dioxan. 
One mmole of NjN'-dicyclohexylcarbodiimide was added and the mixture 
stirred for Ihr, during which time a heavy precipitate of dicyclohexylurea 
was formed. The precipitate was removed by filtration and the filtrate 
added to 2 ’g of w-aminocellulose in 8 ml of 100 mM phosphate buffer 
pH 7.5 at 4°C. The mixture was stirred for 16hr and the cellulose 
washed with 1 litre of distilled water. A small sample was dried over 
phosphorus pentoxide for bromine estimation by the method of Schoniger
(91). . .
b) Bromoacetylcellulose (39, 56)
A solution of 33.3 g of bromoacetic acid in 20 ml of dioxan was 
added to 10 g of dry powdered cellulose (CC31) in a 250 ml round 
bottomed flask. The flask was stoppered and the mixture stirred at 
room temperature for 24 hr. A sodium hydroxide trap was connected to the 
flask following the addition of 25 ml of bromoacetylbromidc, and after 
6hr the mixture was poured into 2 litres of vigorously stirred
deionised water. A sample was dried for bromine analysis.
Different degrees of substitution were achieved by varying the 
quantities and relative proportions of bromoacetylbromide and bromo­
acetic acid.
Protein coupling was effected in 0.2M borate buffer pH 8.75.
In some experiments coupling was preceded by physical adsorption of 
the protein to the carrier in 0.15M phosphate-citrate buffer pH 5.4.
The preparation was stirred in 50mM 2-aminoethanol pH 8.75 for 6 hr 
in order to react any remaining bromoacetyl groups prior to washing.
Periodate Oxidation of Cellulose and Coupling of Immunoglobulin (70)
Powdered cellulose (CC31) was stirred in suspension in 10 or lOOmM 
solutions of sodium periodate at room temperature for 24 hr. The 
oxidised cellulose was washed exhaustively with distilled water 
followed by the coupling buffer, and then reacted with immunoglobulin 
at 4°C for 48 hr. Remaining aldehyde groups were blocked by reaction 
with 50mM 3-aminopropan-l-ol pH 7.0 for 6 hr prior to washing of the 
immunoadsorbent.
Coupling of Immunoglobulin to Cellulose by- the Oxirane Method (69)
. A  suspension of 2g of powdered cellulose (CC31) in 10ml of 
distilled water was mixed with an equal volume of 1M sodium hydroxide.
The mixture was made 10% with respect to 1-chloro-2,3-epoxypropane and 
stirred in a round bottomed flask for 2 hr at 60°C. The product was 
washed exhaustively with distilled water and then 0.5M sodium bicarbonate 
pH 9.0. Immunoglobulin was added in the minimum volume of the same . 
buffer necessary to give a stirrable suspension. The coupling reaction 
was allowed to proceed for 48 hr at 4°C. The product was stirred in 
5QnM 2-aminoethanol buffered with lOOmM tris-HCl pH 7.8 for 16 hr, and 
then washed.
N-Hydroxysuccinimide Ester of Cellulose (92)
Carboxyl cellulose, prepared by reacting 6-aminohexanoic acid 
with the imidocarbonate of cellulose was treated with lOOmM 
N,N’-dicyclohexylcarbodiimide and lOOmM N-hydroxysuccinimide in 
dioxan. After 70 min at room temperature the derivative was washed 
with dioxan and methanol to remove dicyclohexylurea. Immunoglobulin 
was coupled to the cellulose ester in 0'.2M sodium bicarbonate buffer 
pH 9.0, the reaction being left for 16 hr at 4°C.. Remaining succinimide 
groups were reacted with 3-aminopropan-l-ol at the same pH before 
washing the immunoadsorbent.
Mixed Anhydride Derivative of CM-Cellulose
Two g of CM-cellulose were stirred in 2N HC1 for 30 min and then 
washed with distilled water until the washings were neutral. The 
CM-cellulose was dried and mixed with 1.4 ml triethylamine and 0.5 ml 
ethyl chloroformate in 12 ml dioxan at room temperature. After 1 hr 
the product was filtered and washed with dioxan and distilled water 
before adding it to a solution of the immunoglobulin*in lOOmM sodium 
phosphate buffer pH 7.0 at 4°C. After 48 hr the product was transferred 
to either lOOmM glycine or lOOmM 3-aminopropan-l-ol pH 7.0 arid stirred 
for 16 hr. The resulting immunoadsorbent was washed and stored at 4°C.
Carboxycellulose
Powdered cellulose (7.5 g) was reacted with cyanogen bromide 
(500 mg/g cellulose). After washing the resulting imidocarbonate 
derivative with 2 1 of distilled water it was suspended in 50 ml of water 
containing 9.83 g 6-aminohexanoic acid (75 mmoles) at pH 9*0. The 
mixture, was stirred at room temperature for 18 hr and the derivative 
washed with distilled water.
Alternatively, aminoalkyl cellulose was reacted with succinic 
anhydride (25) and washed with 0.1 N sodium hydroxide for 30 min
(92) and then distilled water.
Cross-linking Proteins with Glutaraldehyde .
Protein polymers were prepared with glutaraldehyde as described 
by Avrameas and Temynck (2). Serum was dialysed against 150 mM 
sodium chloride at 4°C for 16 hr, and then adjusted to pH 4.4 by the 
addition of IN HC1. One-tenth of the volume of 1M acetate buffer 
pH 4.4 was then added. Solutions of immunoglobulins or immunoglobulin 
. fragments were adjusted to pH 7.0 and buffered with 1M sodium phosphate 
buffer. The protein solution was stirred vigorously while three-tenths 
the volume of 2.51 glutaraldehyde was added dropwise. The mixture 
began to gel after 8 to 10 min and was kept at room temperature over­
night. The gel was dispersed by repeatedly forcing it through a 
syringe and then washed as were the cellulose immunoadsorbents.
Protein Estimations
The concentration of purified human IgG was estimated from the
I 0'extinction at 280 nm, assuming the specific extinction coefficient ^so^ 
to be 13.8. Otherwise, protein concentrations were determined by a 
‘■modified Biuret-method (93). •
The amount of protein covalently coupled to cellulose was determined 
by one of two methods:-
(i) Samples of the immunoadsorbent were allowed to stand at. room 
temperature for 16 hr in 0.5M sodium hydroxide. The mixture 
was centrifuged at 2000g for 15 min, and the supernatant assayed 
by an automated Folin-Lowry procedure (94, 95) (Fig. 2.1). The 
reagents used:were as follows:- 0.5 N sodium hydroxide, copper
f i g  2.1
WASH (blue 1.6 ml/min)
0.5M NaOH (red 0.8ml/min)
Sample (red Q.8ml/min)
Air (blue 1.6ml/min)
HO
Buffer (Blue 1.6ml/min)
Folin (yellow 1.2ml/min)
W aste  (green 2.0 m l/m in)
Debubble
-/////— /////— /////—
105/0089 105/0089 105/0089
colorimeter 720nm
105/0088
D1
Copper tartrate (white 0.6^ D1
ml/min) r
105/0088
105/0088
D1
(Technicon nomenclature)
Technicon auto analyser manifold for the measurement 
of protein by the Folin-Lowry technique.
tartrate (0.1% cupric sulphate plus 0.2% sodium potassium tartrate), 
Folin-Ciocalteau reagent diluted 1 in 3 with distilled water and 
bicarbonate buffer (84 g sodium bicarbonate plus 25 g sodium hydroxide 
in 1 litre).
(ii) Trace labelling. The immunoglobulin-cellulose coupling reaction was 
carried out in the presence of immunoglobulin trace-labelled with 
125I. The amount of labelled protein added was compared with the 
amount in the product by counting samples of equal volume taken from 
the initial reaction mixture and a suspension of the washed immuno­
adsorbent. The results were corrected for t1.
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Analysis of Serum Proteins and Anitsera;-
(i) Measurement of Serum IgG by Radial Immunodiffusion (96)
A 2% solution of agarose was prepared by dissolving 2 g of agarose 
in 0.05M sodium veronal buffer pH 8.6 at 100°C. The solution was cooled 
to 54°C, and 10 ml was added to 9.8 ml 0.05M sodium-veronal buffer, pH 8.6 ^ and 
0.2ml of the antiserum at the same temperature. After mixing, 12 ml of 
the solution was pipetted on to a 3J in square glass slide and left to 
solidify at room temperature in a moist box. A 2mm stainless steel 
tube connected to a vacuum line was used to cut wells in the gel. The 
wells were filled to the brim with dilutions of a standard containing 
from 10 to 100 mg IgG per 100 ml, or dilutions of unknowns. Drawn-out 
capillary tubes fitted with rubber bulbs were used for this purpose. 
Precipitin rings were allowed to develop for 30 hr, and their diameters 
were then measured. The square of the diameters were plotted as a 
function of the log^Q of the concentration of standard antigen.
6-J Quantitative Precipitin Test
Various known amounts.of antigen dissolved in 0.9 ml PBS were added 
to 0.1 ml of the antibody preparation. Control tubes contained either
PBS instead of the antigen solution or non-immune serum instead of 
the antiserum. All deteiminations were made in triplicate. The 
tubes were incubated for 72 hr at 4°C, and the precipitates collected 
by centrifugation at 2000 g for 20 min. They were washed twice by 
resuspension in PBS at 4°C, and then dissolved in 0.2 N sodium 
hydroxide. The extinctions were measured at 280 nm.
Immunoelectrophores is . -
Immunoelectrophoresis was carried out after the method of Grabar 
and Williams (97, 98) in barbitone-buffered 1% agar. Plates were 
prepared by pouring 12 ml molten agar, on to 3£ in square glass slides. 
The electrophoresis was performed in Shandon tanks using a constant 
current of 25mA per plate.
Double Diffusion Test
This was performed as described by Ouchterlony (99). Plates were 
prepared in 9 cm plastic petri dishes with a 1% solution of Ionagar 
in PBS containing 0.1% sodium azide as preservative.
Purification of Human IgG
Human IgG was purified from 25 ml of a human serum pool. Serum
was made 45% saturated with respect to ammonium sulphate by the dropwise
addition of saturated ammonium sulphate to the stirred serum. The
mixture was allowed to stand overnight at 4°C. The precipitate was
collected by centrifugation at 2000g for 20 min and washed twice by 
€
resuspension in 45% ammonium sulphate. The precipitate was dissolved 
in the minimum volume of PBS and dialysed for 30 hr against three 
changes of 1 litre of sodium phosphate buffer lQmM, pH 7.66. The 
dialysate was applied to a column of DEAE-cellulose (DE32) 30 x 2 cm 
equilibrated with the same buffer. IgG was eluted from the column and 
dialysed overnight against sodium phosphate buffer lOOmM- sodium
chloride 15QmM, pH 7.66. The solution was concentrated to approximately 
30 mg per ml by pressure dialysis using a PM-30 membrane. The IgG 
was further purified by gel filtration on a Sephadex G-200 column,
120 x 2.5 cm.
Preparation of Fab Fragment (100, 101, 102, 103)
Human IgG (200 mg in 10 ml) was dialysed overnight at 4°C against 
0.1 M acetate buffer pH 6.0. The solution was then made 10 mM with 
respect to cysteine and 20 mM with respect to ethylenediaminetetracetic 
acid EDTA) before the addition of 2 mg of papain. The mixture was 
incubated for 16 hr at 37°C, and then dialysed against three changes 
of 10 mM acetate buffer pH 7.0 over 24 hr. The dialysate was applied 
to a 2 x 30 cm column of DEAE-cellulose (DE32) and eluted with a linear 
gradient of acetate buffer pH 7.0 from 10 to 350 mM. The digest was 
resolved into two major peaks, the first of which represented the 
Fab fragment.
Antibody for Immunoadsorbent Preparations
Sheep anti-human IgG (Fc) was rendered specific for the Fc region 
by immunoadsorption with protein polymers prepared from the Fab fragment 
of IgG with glutaraldehyde. The adsorptions were performed at room 
temperature for 1 hr and the antisera recovered by filtration. The 
immunoadsorbents were regenerated by treatment with 3M sodium thiocyanate 
pH 6.0. Antisera were judged to be mono-specific by immunodiffusion and 
immunoelectrophoresis.
The antiserum was dialysed against PBS pH 7.66 overnight. Three 
and a half volumes of 0.4% Rivanol (2-ethoxy-6,9-di-aminoacridine lactate) 
were added dropwise to the antiserum with vigorous stirring. The resulting
precipitate was removed by filtration, and excess Rivanol was removed 
from the filtrate by dialysis against repeated changes of PBS. The 
immunoglobulins were precipitated by the addition of an equal volume 
of saturated ammonium sulphate. After standing at 4°C overnight the 
precipitate was collected by centrifugation, washed twice by resuspension 
in 50% ammonium sulphate and dissolved in PBS. The solution was dialysed 
against three changes of PBS over 36 hr, passed through an 0.22 y 
Millipore filter and stored at 4°C.
Iodination Methods
Human IgG and sheep and rabbit immunoglobulins were iodinated by 
the chloramine T method (104) using modifications of the procedure 
described by Sonoda and Schlamowitz (105).
Method (i): A small magnetic stirring bar was placed in a 2 ml
glass bottle to which was added 25 yl 0.5M phosphate buffer pH 7.0, 
lmCi Na125I (476 pmoles) and 25 yl of a 4 mg per ml solution of the 
protein (100 yg) in 0.05M phosphate buffer pH 7.0. The mixture was 
stirred in an ice bath and 50 yl of a 0.5 mg per ml solution of chloramine 
T (88 nmoles) was added. After 60 sec excess chloramine T was neutralised 
by the addition of 50 yl of 0.25M sodium metabisulphite. Two min later 
50 ^ 1 1.0M potassium iodide and 100 yl 15% BSA were added. The contents 
of the reaction vessel were transferrred to the top of a Sephadex G15 
column, and labelled immunoglobulin was eluted with PBS containing 1%
BSA. The labelled fraction was diluted to 20 ml with the same buffer, 
and dialysed against three changes of PBS (1 litre) at 4°C. The ’label' 
was divided into aliquots and stored at -20°CV
Method (ii): The reaction was conducted in a 25 ml glass bottle 
equipped with a magnetic stirring bar. One ml 0.5M sodium phosphate 
buffer pH 7.0, 500 y C i of Na125I and 50 y l  of a 4 mg per ml solution
of human IgG (200 yg) were added. The mixture was stirred vigorously, 
and 5 ml of freshly prepared chloramine T (690 nmoles) were added 
dropwise over 5 min. The reaction was allowed to proceed for 30 min 
before excess chloramine T was neutralised by the addition of 1.2 ml 
of sodium metabisulphite (667yM). After a further 2 min 0.5 ml of 
potassium iodide solution (l.CM) and 1 ml 15% BSA were added. The 
contents of the reaction vessel were transferred to a column of 
Amberlite IRA-400 (Cl) with a bed volume of 8 ml. The iodinated 
IgG was eluted with PBS containing 1% BSA.
Measurement of Immunoadsorbent Activity
(i) Immunoadsorbent Titration
Immunoadsorbent suspensions were diluted to the same protein 
concentration per ml. Serial dilutions of the suspensions were incubated 
at room temperature with fixed quantities of 125I-IgG and IgG standard 
in a borate buffer containing 0.5% BSA in polystyrene tubes. The tubes 
were tumbled throughout the incubation period, and then centrifuged 
at 2000 g for 10 min. The supernatants were decanted or aspirated and 
the immunoadsorbent samples washed by resuspension in the borate-BSA 
buffer. After centrifugation the supernatants were discarded and the 
tubes counted in an automatic y-counter (LKB-Wallac or Tracerlab).
Typical assay: 200 yl 0.05M borate buffer pH 8.4
- 0.5% with respect to BSA.
100 yl dilution of the immunoadsorbent
100 yl IgG standard or human serum 
dilution or buffer.
50 yl 125I-IgG
450 yl
Incubation time 16 hr.
(ii) Immunoadsorbent suspensions were diluted to the same protein 
concentration per ml. Equal aliquots of the suspensions were incubated 
at room temperature with fixed quantities of 125I-IgG and various 
dilutions of either human serum or an IgG standard in borate buffered 
BSA in polystyrene tubes. The assay was continued as in (i) above. 
Controls were run for both assays as follows:
(a) Omitting the immunoadsorbent.
(b) Employing a labelled preparation other than 
125I-human IgG, e.g. sheep Or rabbit 125I-IgG.
Elution of IgG (antigen)
The recovery of adsorbed human IgG from anti-IgG immunoadsorbents 
was measured with trace labelled IgG. Aliquots of immunoadsorbent 
suspensions were incubated at room temperature with fixed amounts of 
125I trace-labelled IgG in borate buffer BSA in polystyrene tubes.
The tubes were tumbled throughout the incubation period and then
centrifuged at 2000 g for 10 min. The supernatants were aspirated 
and the immunoadsorbents washed by resuspension in assay buffer. The 
tubes were again centrifuged and aspirated. The eluting fluids were 
added and the tubes tumbled for a fixed time before centrifugation at 
2000 g for 10 min. The supernatants were aspirated and the tubes counted 
in a y-counter. The efficiency of elution was measured as the difference 
between the total amount of IgG adsorbed and that remaining after elution. 
The eluting fluids employed were:- 
glycine 50mM - hydrochloric acid pH 2.8
glycine 50mM - hydrochloric acid pH 2.0
acetic acid l.CM pH 2.3 
propionic acid l.CM pH 2.5 
propionic acid 0.1M pH 3.0
citric acid lOOnM - sodium chloride 154mM - glycine 133mM pH 2.8.
sodium thiocyanate 3.CM - 50mM sodium phosphate pH 6.0 
sodium thiocyanate 3.CM - 5QmM tris-HCl pH 9.0 
magnesium chloride 2.5M
urea 8.0M - sodium chloride 154mM - phosphate lQmM pH 7.6 
manganese sulphate 3.CM
(£) Results 
Antisera
Antisera raised to the Fc fragment of human IgG were found 
to contain some antibody activity towards the other immunoglobulins 
and the Fab fragment. The antisera were rendered specific for the 
Fc fragment of IgG by immunoadsorption with the appropriate 
glutaraldehyde polymerised proteins. Immunoglobulin fractions 
were purified from each of the sheep anti human IgG (Fc) sera 
designated 51, 55 and 57. The protein and antibody concentrations 
of these preparations are given in Table 2.1. The precipitin curve 
obtained for antibody from sheep 57 is shown in Fig. 2.2, and an 
immunoelectrophoresis pattern in Fig. 2.3.
Table 2.1
Sheep Immunoglobulin Antibody
preparation concentration
mg protein/ml mg/ml
51 57.0 7.07
55 68.0 7.52
57 72.0 14.40
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Fig. 2.2 Precipitin curve for antibody from sheep 57 (AS 57).
Upper curve represents total protein in the precipitate and the
lower curve the antibody protein in the precipitate.
Fig. 2.5 Immunoelectrophoresis patterns of whole human serum against 
(in the troughs from top to bottom) sheep anti whole human serum, sheep 
anti whole human serum, sheep anti human IgG (Fc) (AS 51) and sheep 
anti-human IgG (Fc) (AS 57).
Iodine-Labelled Immunoglobulins
In method (i) described previously, IgG and Na125I were employed 
in a molar ratio of approximately 4:3. Two experiments with sheep IgG 
gave substitution levels of 0.23 and 0.25 I atom per mole of IgG. In 
method (ii) the molar ratio was approximately 5-25 :1, and with sheep IgG 
this gave substitution levels of about 0.02 atom I per mole of IgG.
These results represent incorporation of 25-331 of the label by method 
(i) and 60-75% by method (ii).
Human IgG iodinated according to method (ii) was mixed with an 
aliquot of unlabelled IgG and the mixture subjected to chromatography 
on a Sephadex G-25 column (20 x 0.5 cm). Fractions were collected and 
the radioactivity measured in a y-counter (Fig. 2.4). An equal volume 
of 15% trichloracetic acid (TCA) was added to each fraction and after 
10 min the precipitated protein was collected by centrifugation at 
2000 g for 10 min. The supernatants were aspirated and the precipitates 
washed twice by resuspension in 7.5% TCA before measurement of radio­
activity. The first peak emerging from the column in the void volume 
represented IgG. The second peak was accounted for by free 125I 
(Fig. 2.5). The Amberlite resin had removed . m o s t . of the free 
label, and that which remained was removed by dialysis. A small amount 
of iodine was presumed to have passed through the column physically 
adsorbed to the immunoglobulin. The iodinated IgG co-chromatographed 
with unlabelled IgG on a Sephadex G-150 column (90 x 2.5 cm), indicating 
that the molecule remained intact.
Samples of iodinated human IgG prepared by each method were incubated 
with aliquots of sheep anti human IgG as described for the quantitative 
precipitin test. Radioactivity in the precipitates and supernatants was 
measured. At least 97% of the radioactivity was associated with the
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Fig. 2.4. Gel filtration of a sample taken from the iodination mixture 
after the addition of sodium metabisulphite and potassium iodide. Solid 
line represents radioactivity emerging from the column and the broken line 
the radioactivity precipitated by TCA. Column:- Sephadex G-25, 20.0 x 
0.5 cm, equilibrated in phosphate buffered saline.
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Fig. 2.5. Gel filtration of a sample taken from the iodination mixture 
(solid line) and a sample after passage down a column of Amberlite IRA 400 
(Cl"). The small amount of free iodine remaining was removed by dialysis.
specific precipitate in the equivalence zone (i.e. at concentrations 
of the antiserum giving a maximum precipitation of the antigen).
Preparation of hnmunoadsorbents
Pilot experiments were conducted to test the conditions chosen for 
each immunoadsorbent preparation using 200 mg of the cellulose derivative 
and 10 mg of sheep immunoglobulin. Wherever necessary, published 
procedures were modified as set down in section 2.b. In several cases 
techniques which had hitherto been employed only for the immobilisation 
of enzymes were used successfully in the preparation of immunoadsorbents.
The amount of immunoglobulin linked to cellulose was measured by 
both an automated Folin-Lowry technique and a trace labelling technique.
A typical autoanalyser trace for the Folin-Lowry assay is shown in 
Fig. 2.6. The 150 yg/ml standards were duplicated to demonstrate the 
lack of cross-contamination between samples. The appropriate cellulose 
derivatives were run as blanks, and in a few cases, notably with
t
preparations involving N-acetylhomocysteine thiolactone, there was 
marked interference with the assay. Two experiments were conducted to 
compare measurement of protein content by the two techniques, and the 
results are combined in Table 2.2. Subsequent experiments were ' 
standardised on results obtained with the trace labelling technique 
because of its practical advantages. The interference with the Folin- 
Lowry assay by certain cellulose derivatives increased the possibility 
of error.
The validity of the trace labelling technique was tested with two 
bromoacetylcellulose preparations containing 1.29 and 0.89 meq bromide 
per g. Four different preparations of 125I-sheep IgG were used, and 
experiments were duplicated and run in parallel (Table 2.3).
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Table 2.2
A comparison of the amounts of protein coupled to cellulose carriers 
as measured by an automated Folin-Lowry procedure and a trace labelling 
technique.
Cellulose derivative Protein incorporated (mg) per g cellulose 
derivative 
Trace labelling Folin-Lowry 
method method
Triazinyl 13.2 13.2
6.9 7.4
20.5 20.4
Diazotized m-amino- 18.6 17.6
benzyloxymethyl 1.9 3.4
52.5 45.9
60.0 57.0
Diazotized p-aminobenzyl 23.5 21.4
12.1 14.8
Bromoacetyl 44.3 45.6
96.8 90.4
89.4 94.4
Imidocarbonate 23.0 20.6
21.5 29.0
Aminoethyl 14.6 13.3
27.9 24.3
Aminopentyl 36.3 34.6
26.0 23.9
Aminodipropyl amine 26.6 '23.9
18.7 16.7
Sulphydryl ' 30.4 33.7
(N-ace ty lhomo cy s t e ine thio lactone) 177.2**
* *
Uncorrected value..
55
Table 2.5
Experiment to test the validity of the trace labelling technique
Label % Counts Coupled
BAC 1.29 BAC 0.89
meq Br/g meq Br/g
A* 66.6 59.7
B* 64.7 55.0
c+ 69.2 56.5
D+ 66.3 58.0
Mean 66.7 + 1.61 57.3 + 2.07
*
Iodinated by Method (i)
+Iodinated by Method (ii.)
Wherever possible the degree of substitution of active groups on 
the carrier was varied, and, by using cyanogen bromide-activated 
cellulose, aliphatic diamines of various chain lengths were attached 
to the carrier in order to investigate the effects of these variations on 
antibody activity (Table 2.4). Other variation's investigated were 
the coupling pH and the choice of coupling reagent. For example, 
antibodies were coupled to amino-celluloses either by using water 
-soluble or-insoluble carbodiimides or by first activating the carrier 
with glutaraldehyde. Results of some of the immunoadsorbent preparations 
are shown in Table 2.5.
. Samples of 3-aminobenzyloxymethylcellulose containing 67 yeq 
NH^ per g were activated by diazotisation and reacted with sheep 
immunoglobulin. When 110 mg of protein was used the capacities of 1 g 
quantities of the reprecipitated and untreated preparations were similar 
- 52. 5 and 60 mg respectively. In a second experiment the effective 
protein concentration was doubled. This increased the amount of 
protein coupled to the untreated diazotised cellulose from 52.5 to 
61 mg/g. On the other hand the amount bound by the reprecipitated 
derivative was more than doubled from 60 to 129.8 mg/g. Therefore the 
amount of protein coupled was limited by the amount of protein added and 
the surface area of the cellulose as previously shorn by Gurvich et al 
(38). Further, by increasing the number of 3-aminobenzyloxymethyl 
groups the capacity of the derivative was also increased.
Immunoglobulin was coupled via a diazo bond to 4-aminobenzylcellulose.
. The capacity of this derivative was less than half that of the corresponding 
3-aminobenzyloxymethylcellulose. Again reprecipitation increased the 
capacity of the derivative for protein.
Table 2.4 Variation of the degree of substitution of active 
groups in cellulose derivatives
N- (3-aminobenzy.loxymethyl) 
pyridinium chloride monohydrate 
(mg per 10 g)
yeq M-Lj groups 
per g product
1) 50 18
2) 250 67
3) 500 121
4) 700 160
2-amino-4,6-dichloro-s- 
triazine (mg per g) % N in product
5) 8 0.05
6) 80 0.16
7) 400 0.42
Bromoacetylcellulose Preparations
Cellulose
(g)
Bromoacetic Bromoacetyl 
acid (g) bromide (ml)
Br in product 
meq per g.
8) 10 33.3 215 1.67
9) 3 1.33 1 1.00
10) 3 0.67 0.5 0.83
11) 3 0.53 0.4 0.73
12) 3 0.44 0.33 0.49
Employing the quantities as in 8), substitution levels ranged
from 10.3 to 13.41 or 1.29 to 1.67 meq Br per gram of bromoacetyl-
cellulose in nine replicate e;xperiments.
Bromoacetamidoalhylcellulose
CNBr per g. cellulose
(mg)
Diamine Br in product 
meq per g
13) 20 ED 0.090
14) 20 DP 0.075
15) 20 DADP 0.036
16) 80 ED 0.17
17) 80 DP ' 0.18
18) 80 DADP 0.18
19) 200 ED 0.27
20) 200 DP 0.23
21) 200 DADP 0.25
Table 2.5
Cellulose Designation Reaction- Sheep Immunoglobulin
Derivative in Table 2.4 Conditions Added(mg) % Bound Bound (mg)
Diazotised N- (3-aminobenzyl-
oxymcthyl 1 pH 8.75 73 15.6 11.4
1 pH 8.75 73 16.4 12.0
2 pH 8.75 73 32.1 23.5
2 pH 8.75 73 46.4 33.9
1 pH 8.75 20 19.8 4.0
- 2 pH 8.75 20 46.1 9.2
3 pH 8.75 20 55.3 11.1
4 pH 8.75 ’ 20 68.6 13.7
2 pH' 6.0 ■ 20 ’ 59.8 12.0
2 pH 8.75 20 47.3 9.5
2 pH 8.75 110 47.7 52.5
2 (reprecipitated) 110 54.5 60.0
2 pH 220 27.7 61.0
2 (reprecipitated) 220 59.0 129.8
4-aminobcnzyl - pH 6.0 20 21.5 4.3
- pH 8.75 20 11.3 2.3
- pH 8.75 73 11.6 8.5
- pH 8.75 110 21.4 23.5
- (reprecipitated) 110 53.6 59.0
Q4C-azide - pH 8-75 20 2.8 0.55
- pH 8-75 20 8.6 1.7
_ pH W S 20 16.3 3.3
■- pH 8-7? 73 40.9 29.9
Imidocarbonate 200 mg CNBr - pH 8.9 20 11.2 2.3
per g cellulose - pH 8.9 28 14.7 4.1
- pH 8.9 73 15.2 11.1
- pH 8.9 110 19.5 21.4
- pH 6.0 20 31.5 6.3
- pH 6.0 28 23.3 6.5
■ - pH 6.0 73 17.9 13.1
Carboxymethyl - DCC pH 6.5 12.5 73.2 9.1
DCC pH 6.5 27 81.6 22.0
- EDC pH 6.5 110 45.1 49.6
- CMCM pH 6.5 28 20.3 5.7
- O-iCM pH 6.5 110 23.6 26.0
Aminoethyl - DCC 28 74.6 20.9
- EDC 110 32.0 35.2
- EDC 27 73.8 19.8
- Glutaraldehyde 27 87.2 23.3
Aminopcntyl - DCC 27 87.2 23.3
- EEC 27 75.7 20.3
- Glutaraldehyde 27 58.2 15.6
Am i nod i p ropyl am.inc - DCC 27 80.5 21.6
_ Glutaraldehyde 27 65.8 17.7
Sulphydiyl - DCC 1-10 27.6 30.4
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Table 2,5 continued
Bromoacetyl -
L?*JCO 20 60.7 12.1
- pH 8.75 25 74.7 18.7
- pli 8.75 25 100 25.0
- pH 8.75 73 54.5 39.8
- pH 8.75 no 88 96.8
- pH 6.0 20 79.3 15.9
pH 6.0 25 82.1 20.6
- pH 6.0 , no 82.3 89.4
9 pH 8.75 20 46.1 9.2
10 pH 8.75 20 11.6 2.3
11 pH 8.75 20 8.1 1.6
Bromoacetamidoethyl 13 pH 8.75 28 3.8 1.1
16 pH 8.75 28 6.7 1.9
19 pH 8.75 28 8.8 2.5
Bromoacetamidopentyl 14 pH 8.75 28 18.9 5.3
17 pH 8.75 28 37.7 . 10.6
20 pH 8.75 28 47.2 13.2
Bromoacetamidodipropyl amine 15 pH 8.75 28 5.2 1.5
18 pH 8.75 28 7.3 2.0
21 pH 8.75 28 13.2 3.7
Aminochloro-s-triazinyl 5 pH S'-Ts" 20 33.4 6.7
6 pH 20 60.4 12.1
7 pH 20 90.2 18.1
7 pH 27 100 27
6 pH 110 18.6 20.5
6 pH 20 77.7 15.5
'mixed anhydride - ' 15 14.2 2.1
- - 110 21.5 23.6
Qxirane - - 36.5 4.4 1.60
N-hydroxysuccinimide ester - ethyl pH 9-o 73 25.2 18.4
diprojoylamine pH 9-o 73 18.0 13.1
Oxidised (Periodate) - 0.1M NalO^  coupling pH 5.8 28 9.0 2.5
- pH 7.0 28 13.3 3.7
- pH 9.0 28 14.3 4.0
0.01M NalO^ coupling pH 7.0 28 6.2 1.7
Carboxyethyl . - pH 6.5 EDC 73 60.1 43.9
- pH 8.75 EDC 73 75.5 55.1
Key:- CC - carboxymethyl cellulose
DCC - N,N'-dicycloliexylcarbodiimide
EDC - l-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride
CMCM - l-cyclohexyl-3-(2-morpholinoethyl)carbodiimide mctho-p-toluene sulphonatc.
T a b le  2,5 The am ounts o f  im m u n o g lo b u lin  im m o b ilis e d  b y  c o v a le n t  
b o n d in g  i n  v a r io u s  p r e p a r a t io n s  o f  sheep  a n ti-h u m a n  Ig G  im m uno- 
a d s o rb e n ts , I n  a l l  cases  i  g q u a n t i t i e s  o f  th e  c e l lu lo s e  
d e r i v a t i v e  w ere  u s e d . R e s u lts  r e p r e s e n t  th e  means o f  t r i p l i c a t e s .  
In f o r m a t io n  l i s t e d  u n d e r ' r e a c t io n  c o n d i t io n s ' q u a l i f i e s  t h a t  
g iv e n  i n  th e  M a t e r ia ls  and M ethods s e c t io n ,  p .28 a t  s e q , ,
CM-cellulose hydrazide was converted to the azide by reaction with 
nitrous acid according to the Curtis rearrangement reaction. The method 
had the disadvantage that it 'was not reproducible. . .
The physical adsorption of immunoglobulin by bromoacetylcellulose 
at pH 4.6 prior to covalent coupling at pH 8.75 (39) was found to be 
unnecessary with bromoacetylcellulose preparations containing in excess 
of 1 meq Br per g. However, with bromoacetyl and bromoacetamidoalkyl 
celluloses containing lower levels of bromine the inclusion of a 
physical adsorption step improved the level of protein coupling. 
Phosphate-citrate buffer between pH 3.8 and 5.2 caused precipitation 
of the sheep immunoglobulin. Mien the protein solution was dialysed 
against pH 5.0 buffer before addition of bromoacetylcellulose the 
physical adsorption step was not as successful as that achieved by 
adding the protein to the cellulose derivative buffered at pH 5.0 
(Table 2.6,p.63).
Bromoacetyl and bromoacetamidoalkyl cellulose derivatives showed 
an increased capacity for protein with greater degrees of bromoacetylation. 
Furtheimore, the capacity of pentyl derivatives was greater than that of 
ethyl derivatives, a factor which may be attributable to the longer 
aliphatic chain. However, the bromoacetylated aminodipropylamine 
cellulose, which has an even longer side chain than the pentyl derivative, 
had a capacity only marginally greater than that of the ethyl derivative.
The preparation of bromoacetylcellulose involved a reprecipitation 
step resulting in a preparation with a very small particle size. This 
property makes the derivative unsuitable for some applications such as 
use in columns. The preparation of bromoacetamidoalkyl cellulose 
derivatives does not involve a reprecipitation and consequently the 
physical properties of the starting material may be retained.
The method of synthesis of bromoacetamidoalkyl cellulose described 
by Cuatrecasas (25) involves reaction of the O-brompacetyl-N- 
hydroxysuccinimide ester with aminoalkyl cellulose at pH 7.5. A 
possible side reaction not mentioned by Cuatrecasas involves reaction of 
the bromoacetyl groups with the amino groups on the carrier, resulting 
in an N-hydroxysuccinimide cellulose. This may warrant investigation.
The degree of substitution of aminochloro-s-triazine in cellulose 
influenced the capacity of the derivative for protein, increased 
substitution leading to increased capacity. A 5.5 fold increase in the 
amount of protein added led to the incorporation of 20.5 mg of protein 
as opposed to-15.5 mg, a difference of only 32%. This again points to 
the carrier as the limiting factor and not the protein.
In view of its popularity the cyanogen bromide technique proved 
to be somewhat disappointing as regards the capacity of the imidocarbonate 
derivative to couple protein. Cellulose activated with 200 mg CNBr 
per gram bound only 11.1 and 21.5 mg or 15.2 .and' 195 % of the .added., protem 
per g r a m  61 cellulose _(l expts.).' The activated cellulose was more 
efficient in coupling sheep immunoglobulin at pH 6.0 than at pH 8.9.
N,Nf-Dicyclohexylcarbodiimide was the most satisfactory diimide for 
coupling immunoglobulin to CM-cellulose in terms of the amount of protein 
coupled, but the product was invariably granular and intractable. This 
may have resulted from cross-linking of the protein since the reaction 
involves a condensation between amino and carboxyl groups. l-Ethyl-3- 
(3-dimethylaminopropyl) carbodiimide. hydrochloride, a water-soluble 
diimide, was used to prepare an immunoadsorbent which retained the physical 
properties of the starting material. The same reagent was used to couple 
immunoglobulin to carboxycellulose prepared either by reacting 6-amino-
hexanoic acid with cyanogen bromide activated cellulose or by reaction of 
aminoalkylcellulose with succinic anhydride, and to aminoalkylcelluloses.
Aldehyde groups were introduced on to aminoalkylcellulose by 
reacting the amino groups with glutaraldehyde, a bifunctional aldehyde. 
Proteins were successfully coupled to this derivative through their 
amino groups. The same reaction was also used to couple immunoglobulin 
to periodate-oxidised cellulose, but the amount of protein that could 
be coupled was far less than that achieved with the glutaraldehyde - 
activated aminocellulose.
The mixed anhydride technique with CM-cellulose and ethylchloroformate 
produced a very granular immunoadsorbent. This almost certainly resulted 
from the ability of the ethylchloroformate to cross-link the protein.
Table 2.7 lists various guinea pig anti insulin immunoadsorbents.
The percentages of available antibody covalently bound to the carrier 
were of the same order as was achieved for sheep anti-human IgG.
Table 2.6 Coupling of Immunoglobulin to Bromoacetylcellulose
pH After dialysis Physically adsorbed ($)
3.8 turbid 72
4.2 precipitate 88
4.6 precipitate 92
5.0 precipitate 91
5.4 clear 100
5.8 clear 96
6.6 clear 98
Cellulose Derivative Coupling conditions Counts Bound %
Bromoacetyl (1.0 meq Br/g) pH 6.0 36.7
" " pH 9.0 47.2
" (1.33 meq Br/g) pH 9.0 85.1
chloro-s-triazine (0.211 N) - 69.4
" (0.50$ N) - 80.3
chloro-s-triazine CM-cellulose(0.21$N) - 11,4
Aminoethyl EDC 26.6
Carboxymethyl EDC 52.7
Bromoacetamidoethyl(0.27 meq Br/g) - 24.0
Bromoacetamidopentyl(0.23 meq Br/g) - 46.5
Bromoacetamidodipropylamine
(0.25 meq Br/g) - 30.0
Table 2.7 Guinea pig anti-insulin immunoadsorbents prepared
by reaction of cellulose derivatives with 0.5ml guinea pig
125
anti-bovine insulin and * ^1 trace labelled guinea pig 
immunoglobulin. Counts bound represent the means of triplicates.
Time Dependence of Immunoadsorption
The time dependence of immunoadsorption was investigated for 
immunoadsorbents prepared with antibodies to the Fc region of human 
IgG, porcine insulin and human placental lactogen (HPL).
Immunoadsorbents prepared from bromoacetylcellulose and diazotised 
N(3-aminobenzyloxymethy|cellulose and two different antisera to human 
IgG were incubated with aliquots of labelled IgG and a dilution of 
human serum equivalent to that necessary to inhibit 50$ binding of the 
labelled material. Incubations were carried out for different periods 
of time, and terminated by centrifuging the assay tubes and washing the 
immunoadsorbent with borate buffered saline. The extent of binding of the 
IgG was determined by measuring the bound radioactivity in a y-counter 
(Fig. 2.7). Binding of the antigen by immunoadsorbents prepared with 
antibodies from sheep 57 was essentially complete within 3 hr, whereas 
the preparations with antibody from sheep 51 bound only 80$ of their 
total capacity for antigen in the first 5 hr. Controls were run from 
which the immunoadsorbents were omitted, and it was found that a constant 
background count was achieved within the first 30 min. representing 
< 2.5$ of the total counts bound. The time required to achieve maximum 
binding of antigen is dependent upon the avidities of the antibodies and 
any influence different carriers may have on the reaction can only be 
assessed when antibodies from the same animal are considered. A comparison 
of several different antibody immunoadsorbents prepared with AS 57 
revealed no significant difference in the time required to bind equivalent 
amounts of antigen. However, the method of immobilisation did appear to 
influence the avidity of AS 51 as demonstrated by the difference between 
binding curves obtained with bromoacetyl- and diazotised N (3-aminobenzyl- 
oxymethy^cellulose based immunoadsorbents (Fig. 2.7). Time curves for the
binding of HPL and porcine insulin by their appropriate immunoadsorbents 
are shown in Fig. 2.8. Both immunoadsorbents were prepared with bromo­
acetylcellulose.
Fig. 2.7 Time dependence of the binding of IgG by anti-IgG 
immunoadsorbents. Solid symbols - AS51 and open symbols - AS57.
' ;o and© - immunoadsorbents prepared from diazotised N-3-amino- 
benzyloxymethyl cellulose. □ and® - immunoadsorbents prepared 
from bromoacetyl cellulose.
Fig 2.8 Time dependence of the binding of insulin ° and human 
placental lactogen 0 by appropriate immunoadsorbents. (Insulin 
antiserum - AS243/1).
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pH Optimum for Immunoadsorption
The immunoadsorbent B^q values were determined at pH 8.4 in 
0.05 M borate-phosphate buffer containing 0.51 BSA. Aliquots 
of the immunoadsorbents were incubated at room temperature for 16 hr 
with 125I-IgG and dilutions of IgG in a range of borate-phosphate 
buffers of different pH. Over the pH range 6.0 to 9.0 the antigen 
binding capacities of the preparations were constant within the limits of 
experimental error. Ionic groups on the carrier did not appear to 
affect the pH optima of the reactions, but the possible significance 
of such groups is discussed later in relation to non-specific adsorption 
and overall capacity.
Non-specific Binding of Antigen
In the assessment of immunoadsorbents non-specific binding of 
protein was routinely monitored with iodinated sheep IgG and porcine insulin.
a) Buffers for Immunoadsorption
Early experiments were conducted using a 0.05M phosphate buffer pH 7.4 
containing 0.5% BSA, 0.15M sodium chloride and 0.01M EDTA. Triplicate 
measurements frequently showed a variation greater than 5% of their mean 
values, and as such were considered unsatisfactory. Experiments were 
conducted to compare the relative merits of borate and phosphate buffers.
BSA was used routinely to minimise non-specific binding to the polystyrene 
tubes used for the assays.
Borate and borate-phosphate buffers gave consistently lower values for 
the binding of labelled IgG than were obtained with phosphate buffer 
(Table 2.8).
The interaction of borate ions with the 2’ and 3’ hydroxyl groups in 
the hexose ring may contribute to this result. However, in blocking the 
hydroxyl groups on the cellulose the borate ion introduces two hydroxyl
groups of its own.
T a b le  2 „ 8 The e f f e c t ,  o f  b u f f e r  io n s  on th e  a n t ig e n  b in d in g  
c a p a c ity  o f  a n t i - Ig G  im m unoadsorbents
Cellulose
Derivative
Counts bound (cpm) + SEM 
Phosphate Borate 
buffer buffer
N- 3- aminobenzy loxymethyl 
cellulose 2446 + 167 2075 + 69
4-aminobenzyl cellulose 1049 + 52 901 1 34
Bromoacetylcellulose 
(pH 6.0) 1907 + 70 1707 + 68 -
Bromoacetyl cellulose 
(pH 8.9) 1 7 6 8 + 8 1 1609 + 89
Chlorotriazinyl cellulose 1817 + 104 1406 + 53
Aminoethyl cellulose
(glutaraidehyde-coupled) 2393 + 142 2299 + 88
Figures represent the mean values (n = 6) of the counts bound by 
equal aliquots of the immunoadsorbents in the presence of a 1 in 10^ 
dilution of a standard human serum sample. '
The buffers used are designated . 3 1  and . B 2 in Materials and 
Methods section of this chapter.
(SEM - standard error of the mean)
b) Blocking of Unreacted Groups on the Carrier
Blocking of unreacted groups was effected in most cases by reaction 
with glycine, BSA, 2- amino ethano1 or 3-aminopropan-l-ol as detailed in 
Methods. Exceptions included reagents such as 3-naphthol and tyrosine, 
sodium borohydride and ammonium ions employed for reaction with diazonium 
groups, aldehydes and chloro-s-triazinyl derivatives respectively.
Sheep IgG, containing antibodies specific for the Fc region of 
human IgG, was coupled to diazotised N-(3-aminobenzyloxymethyl) cellulose. 
The preparation was divided, and unreacted diazo groups were blocked by 
reaction with 3-naphthol or tyrosine. Similar experiments were undertaken 
with immunoadsorbents prepared by the oxirane method and with cyanogen 
bromide activated cellulose. Glycine, BSA and 3-aminopropan-l-ol were 
used as blocking agents.
From Fig. 2.9 (a) it can be seen that the immunoadsorbents prepared 
from the diazotised derivative gave rise to similar assay curves except 
at lower concentrations of unlabelled antigen. Similar curves were 
obtained with two preparations employing the cellulose derivative 
containing 121 yEq NH2 groups per gram. Because of the instability of 
diazonium groups it might have been reasonable to suppose that any 
unreacted groups would have decomposed making blocking unnecessary.
However, on the addition of 3-naphthol the derivative changed from a pale 
yellow colour to orange, indicating a reaction with an azo dye as the 
product.
The assay curves obtained with immunoadsorbents prepared by the oxirane 
method (Fig. 2.9 (b)) and treated with 3-aminopropan-l-ol or glycine are 
compatible with a failure on the part of the amino acid to block unreacted 
oxirane residues on the carrier. This conclusion was supported by the
finding that the glycine treated immunoadsorbent bound 331 more iodinated 
sheep IgG than the one treated with the amino alcohol. Differences in the 
amounts of labelled antigen bound were most marked at low concentrations 
of unlabelled antigen. Consequently erroneously high results would have 
been obtained at low antigen concentrations had the curve been used as a 
standard in a radioimmunoassay. This finding would explain the results 
of Polmar et al (121) who obtained apparently high values when measuring 
low levels of IgE, as compared with those obtained from a double antibody 
assay. . . .
The results with cyanogen bromide activated cellulose were similar 
to those for the previous experiment: 3-aminopropan-l-ol proved to be more 
satisfactory than BSA or glycine (Fig. 2.10(a)).
The use of the reducing agent sodium borohydride for the blocking of 
aldehyde groups proved satisfactory. A comparison of the antigen binding 
capacities of blocked and unblocked immunoadsorbents prepared from 
glutaraldehyde activated aminoethyl and aminopentyl celluloses is made 
in Fig. 2.10(b).. Again failure to block unreacted groups on the carrier 
leads to the incorporation of high levels of iodinated antigen at low 
concentrations of unlabelled antigen. Although no direct evidence was 
obtained against the use of sodium borohydride it was felt that its strong 
reducing properties could be detrimental to the protein, and for this 
reason it was not used routinely.
The introduction of ionisable groups on to the surface of the 
carrier during the blocking process may influence the antibody configuration 
and hence its capacity for antigen. Consequently aminoalcohols should be 
used in preference to amino acids.
Fig. 2.9
A comparison of the effectiveness of various blocking agents.
(a) Immunoadsorbent:- sheep anti-human IgG(Fc)/diazotised 
N- (3-aminobenzyloxymethyl) cellulose.
Blocking agents:- p-naphthol (o) and tyrosine (©).
(b) Immunoadsorbent:- sheep anti-human IgG (Fc)/epichlorohydrin 
activated cellulose (oxirane).
Blocking agents:- glycine (e) and 3-aminopropan-l-ol (a).
Fig. 2.10
A comparison of the effectiveness of various blocking agents.
(a) Immunoadsorbent:- sheep anti-human IgG (Fc)/cyanogen 
bromide activated cellulose.
Blocking agents:- BSA (■), 3-aminopropan-l-ol (a) and glycine (•).
(b) Immunoadsorbent:- sheep anti-human IgG(Fc)/(i) aminoethyl cellulose 
( □ and b ) and (ii) aminopentyl cellulose ( o and @ ) . Both 
derivatives activated by glutaraldehyde.
Blocking agent: - sodium borohydride ( □ and o ).
No blocking agent - ( b and © ).
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The Influence of the Degree of Substitution of Active Groups on the Carrier
Cellulose derivatives which could easily be prepared with different 
degrees of substitution included N-(3-aminobenzyloxymethyl) cellulose, 
bromoacetyl cellulose, 3-amino-5-chlorotriazinyl cellulose and aminoalkyl 
cellulose (Table 2.4p.57).In all cases a reduction in the number of active 
groups lead to a reduction in the amount of antibody which could be 
covalently coupled (Table 2,5(p.58) Figs. 2.11, 13, 14, 15 and 16/p.80 et se_q.)).
A set of titration curves for three immunoadsorbents based on 
N-(3-aminobenzyloxymethyl) celluloses indicated that titres* were similar 
with the higher levels of substitution and increased slightly when the 
number of covalent linkages was reduced (Table 2.9 p.79).The titre of the 
immunoadsorbent prepared with 4-aminobenzyl cellulose was less than the 
other three. Standard dose response curves obtained with these preparations 
are shown in Fig. 2.11. In order to assist interpretation of these curves 
theoretical curves were constructed (see Appendix to this chapter).
. The smaller number of covalent bonds involved in immunoadsorbent
3 resulted in less damage to the antibody population, and consequently
the titre of this preparation was slightly higher than those of the other
two which employ a larger number of covalent linkages. The B/g vs.. : *
o
dose response curve for 3 is more sensitive than the other two at low 
antigen dose (Fig. 2.11(b)) and this may be explained in terms of a 
heterogeneous antibody population. If high avidity antibody were more 
susceptible to damage by immobilisation than low avidity material, then 
the chances of damage may be made greater by increasing the number of
* (Titre -the dilution of immunoadsorbent required to bind 50% of 
the labelled antigen at zero dose of unlabelled material).
covalent bonds involved in coupling to the carrier. If this were the 
case then immunoadsorbent 3 would contain more undamaged high avidity • 
antibody than 2 and 1. Assuming that the low avidity antibody is not 
saturated at low dose, then the dose response curve obtained for 
preparation 3 would be the most sensitive at low dose. Such is the 
case in Fig. 2.11(b). The packing density of the antibody is very unlikely 
to influence the activity of these preparations because of the small 
quantities of protein involved. The results of elution experiments 
suggest that 3 has a lower overall avidity than 2 (Fig. 2.12), a finding 
not in keeping with conclusions drawn from the dose response curve.
Fig. 2.13 shows the B/g vs. log dose response curves obtained for two
■ o ' . '
adsorbents with higher protein contents. Also, AS 57 was employed as 
opposed to AS 55 in the previous experiments. The higher .degree of 
activation of the carrier resulted in immobilisation of a larger amount 
of protein, but this was paralleled by a considerable loss of antibody 
activity and a resultant drop in titre.
It was difficult to make a direct comparison with the preparation 
based on 4-aminobenzyl cellulose because of differences in chemical 
structure and the fact that this derivative had a comparatively large 
particle size. However, immobilisation resulted in considerably more 
antibody damage than was experienced with the other preparations as reflected 
in the titres.
Meaningful inteipretation of Scatchard plots (Fig. 2.11(c)) was 
difficult because of the heterogenous nature of the antisera employed.
At pH 8.75, the pH used in the.preparations of the immunoadsorbents 
discussed here, the weakly electrophilic diazonium ions react with the 
phenoxide ion of tyrosine. The other immunoadsorbents to be discussed in 
this section, ones based on bromoacetyl celluloses & aminochlorotriazinyl 
celluloses, all involve immobilisation of the protein via its amino groups.
Dose response curves for a series of bromoacetyl and 3-amino-5-
\
chlorotriazinyl derivatives are shown in Figs. 2.14 and 2.15 respectively. 
The titres of the immunoadsorbents decreased with an'increase in the 
number of potential covalent linkages between the carrier and protein.
Higher levels of substitution of bromoacetyl or triazinyl groups on 
the carrier resulted in the immobilisation of larger amounts of protein and 
an increased antibody packing density. Hie dose response curves indicated 
that the immunoadsorbents with the highest protein contents were the 
least active. The results of elution experiments (Fig. 2.12) suggest 
that the most effectively immobilised antibodies have a higher overall 
avidity because smaller percentages of adsorbed antigen were recoverable 
by elution. There are several possible explanations for this.
High packing densities may result in more than one antibody 
reacting with different antigenic determinants on a single antigen 
molecule. The possibility of such reactions introduces a new phenomenon - 
’immunoadsorbent avidity’ (as opposed to antibody avidity).
Increasing the degree of substitution of active groups on the carrier 
increases the number of potential covalent linkages and also leads to larger 
amounts of protein being coupled. Consequently the three dimensional 
structure of the molecule will be more restricted and the conformational 
changes necessary for antigen binding become more difficult to achieve.
High avidity antibody, where a tight lock-key fit is involved, is most 
likely to be affected. A relatively poor fit, which is in keeping with 
a low avidity antibody, is likely to require less conformational juggling 
on the part of the antibody. Restrictions may however destroy any small 
measure of recognition a low avidity antibody shows for an antigen.
By increasing the packing density of the antibody the amount of 
’solid’ required to introduce the same amount of antibody into an assay
system is reduced. The effective antibody concentration is therefore 
greater while the distribution of antigen in the liquid phase is unaltered.
This will tend to push the antibody-antigen reaction to the right in 
the equation
Ab + Ag _  Ab.Ag. "1 ■ ■ ■ ■ ■
and so apparently increase the equilibrium constant.
The recoveries achieved on elution from anti-IgG triazinyl cellulose
preparations were on the whole lower (Fig. 2.12) than for the other
immunoadsorbents compared here. However, this was not consistent for
all preparations of this type, a finding presumably attributable to
variability of the cellulose derivative (e.g. Table 2.13 - equivalent
recoveries of antigen were made from immunoadsorbents prepared from
bromoacetyl cellulose and aminochlorotriazinyl cellulose when treated with 
glycine-HC1 buffers).
Hie degree of substitution of active groups also influenced
antibody activity when the protein was coupled to aminoalkyl celluloses
prepared from cellulose activated with 50 and 300 mg quantities of cyanogen
bromide per gram of cellulose. In the case of each of the three aminoalkyl
celluloses tested, i.e. aminoethyl, aminopentyl and 3-aminodipropylamine,
the antibody capacity or titre was less when coupled to the more highly
substituted derivative (Fig. 2-16 & 2.17q>-S3).Dose response curves plotted as the
ratio B/g vs. log dose showed that immunoadsorbents prepared from ethyl and 
o
pentyl derivatives were more sensitive at low antigen dose when the potential 
number of covalent linkages between the carrier and protein was greater. 
Comparable dose response curves were obtained with the different 3-amino­
dipropylamine derivatives. These results were substantiated by the findings 
of elution experiments (Fig.2.16, p 88')}. where the difference in percentage 
recoveries between the two 3-aminodipropylamine derivatives was less than 
those between the other pairs of immunoadsorbents. This suggested that
immunoadsorbents containing a higher potential number of covalent bonds 
between the carrier and protein had a higher avidity. This cannot be 
explained in terns of antibody packing density because the protein contents 
of the different immunoadsorbents were not of the right order. The more 
effective immobilisation involving a greater number of covalent bonds . 
is perhaps more damaging to low avidity antibody^ destroying any small 
degree of recognition it showed for the antigen.
The three diamines employed in this study may have shown different 
reactivities towards the cellulose imidocarbonate resulting in different 
degrees of substitution. However, analysis revealed that the degrees 
of substitution of the three derivatives were comparable,being of the order 
of 50-65 yeq. NH2 groups per gram. Had there been wide variation then 
the antibody activity could also have been influenced by the extent of 
covalent coupling as discussed previously.
One might reasonably expect longer spacer arms to make any active 
groups they carried more readily available for reaction with the pro tern, 
and as a result the protein would be more effectively immobilised with 
a greater chance <jf antigen binding sites being sterically hindered.
Both pentyl and dipropylamine chains are flexible, the latter more so 
because it is longer and also contains a secondary amino group which is 
capable of spontaneous inversion, so imparting even greater flexibility 
to the chain. Furthermore, under the mild alkaline conditions employed 
for coupling the protein there is a possibility of hydrogen bonding involving 
the long electron pair of the secondary amine and hydroxyl groups on the 
carrier. If such bonding were to occur the effective length of the 
dipropylamine chain would be considerably reduced. Finally, the buffering 
action of this secondary amino group may affect the imicro-environment of 
the spacer arm and so influence the reaction with the protein. It is this
last point which may account for the fact that the bromoacetamidodipropyl- 
amine derivative coupled considerably less protein than the pentyl 
derivative (Fig. 2.19,p.95). The affect is not observed when glutaraldehyde 
is used as a coupling reagent because this effectively increases the 
length of the spacer arm by a further four carbon units. Protein cross- 
linking conceals any such affect when carbodiimide is used as a coupling 
agent.
*
The combination of longer spacer arm and high density results in 
veiy effective immobilisation of the protein and loss of activity due- 
to steric hinderance and restriction on possible conformational changes.
In the case of shorter arms the active groups they carry find amino groups ' 
in the protein less accessible with the result that the protein retains 
more freedom. A similar result is achieved by using a smaller number of 
spacer arms. Such a hypothesis explains the observations for glutaraldehyde­
coupled protein (Fig. 2.16 & 2 . 1^3). Spacer arms, are therefore only of 
benefit when they are employed in relatively low numbers. Then, the arm 
holds the antibody away from the surface of the carrier and so reduces the 
steric effects the carrier may have upon the protein and the number of 
covalent linkages is not sufficient to have too significant an effect upon 
the antibody activity.
Whereas a high antibody:carrier ratio may be considered desirable from 
the point of view of adsorption, the results presented here suggest that this 
is not the case as far as elution is concerned. The packing density of 
the antibody should be as high as can be achieved without introducing the 
phenomenon of ’immunoadsorbent avidity’. Furthermore, the degree of 
activation of the carrier should be as low as is practicable so as 
to minimise the number of covalent linkages between the carrier and the
protein and cause as little damage to the antibody as is possible in 
the way of three dimensional flexibility and blocking of active sites.
Not only are the immobilisation conditions critical to the 
retention of biological activity, but so also is the choice of antiserum.
T a b le  2 .9  The r e la t io n s h i p  b e tw e en  t i t r e  and th e  e x t e n t  o f  
c o v a le n t  b o n d in g  b e tw e en  a n t ib o d y  and c a r r ie r . ( D e t e r m in e d  by  
th e  d e g re e  o f  s u b s t i t u t io n  o f  a c t iv e  g ro u p s  -  am ino gro u p s  -  
i n  th e  c a r r i e r ) .
yeq. NH2 
groups/g
mg protein 
per g.
Titre*
1. 121 11.1 1 / 3950
2. 67 9.2 1 / 4050
3. 18 4.0 1 / 4300
4. 80 4.3 1 / 2800
1, 2 and 3 - N-(3-aminobenzyloxymethyl) cellulose.
4 - 4-aminobenzyl cellulose.
* - the dilution of immunoadsorbent required to bind 501 of the
labelled antigen at zero dose of unlabelled material; Expressed 
as an equivalent dilution of antiserum immunoglobulin preparation.
(a) Dose response curves, B vs. log dose. 1, 2 and 3, N-(3-amino 
benzyloxymethyl) cellulose; 4, 4-aminobenzyl cellulose.
1.- 121 yeq NH2 groups/g, 11.1'mg protein/g.
2 - 67 yeq NH2 groups/g, 9.2 mg protein/g.
3.- 18 yeq NH2 groups/g, 4.0 mg protein/g.
4 - 80 yeq NH2 groups/g, 4.3 mg protein/g.
(b) Dose response curve B/^ vs. dose. Data as in (a).
o
(c) Scatchard plot. Immunoadsorbents as in (a).
Immunoadsorbents have been diluted so as to have the same concentration 
of antibody protein per ml.
Prepared with immunoglobulin from AS 55.
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Fig. 2.12
Percentage recoveries of antigen (IgG) with seven different 
eluting fluids. (Means of triplicates).
(a) glycine 50mMpH 2.5
(b) sodium thiocyanate 3M phosphate buffered pH 6.0
(c) sodium thiocyanate 3M tris buffered pH 9.0.
(d) acetic acid 1M.
(e) propionic acid 1M.
(f) urea 8M tris buffered pH 7.0.
(g) magnesium chloride 2.5M.
(i) Immunoadsorbents 2, 3 and 4 (Fig. 2.11).
(ii) Immunoadsorbents prepared from bromoacetylcellulose.
1. 1.67 meq.Br/g cellulose - 39.8 mg protein/g.
2. 0.49 meq.Br/g cellulose - 12.1 mg protein/g.
(iii) Immunoadsorbents prepared from 3-amino-5-chlorotriazinyl' 
cellulose.
1. 0.42VN - 18.1 mg protein/g.
2. 0.051 N - 6.7 mg protein/g.
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Fig, 2.13
Dose response curves, B/g vs. IgG dose , for two immunoadsorbents
o
prepared from diazotised N- (3-aminobenzyloxymethyl) cellulose and 
immunoglobulin from AS 57.
yeq. NH2 groups mg protein Titre* 
per g cellulose per g.
5 121 33.9 ' 1 / 2230
6 • 18. 11.4 1 '/ 396.0*:
* These figures are not comparable with those in Fig. 2.11 or 
Table 2.9.-
Fig. 2.14
(a) Dose response curves, B vs. IgG dose , for immune adsorbents 
dervied from bromoacetyl cellulose.
meq. Br per g. mg protein per g.
1 0.49 . 12.1
2 0.73 25.0
3 1.67 39.8
(b) Dose response curves, B/g vs. IgG dose .. Immunoadsorbents
o
as in (a).
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Fig. 2.15
(a) Dose response curves, B vs. IgQ dose, for immunoadsorbents 
prepared with 3-amino-5-chlorotriazinyl celluloses.
IN in derivative
1 0.05
2 0.16
3 0.42
(b) Dose response curves, B/^ vs., TgG dose. Data as in (a).
o
Fig. 2.16
(a) Dose response curves for immunoadsorbents prepared from amino-
alkyl cellulose derivatives with different chain lengths (glutaral^ eliyle
-activated)*
Cellulose activated with 50 mg cyanogen bromide per g:
(i) o - aminoethyl cellulose 12.4 mg protein per g.
' (ii) □ - aminopentyl cellulose 30.9 mg protein per g.
(iii) A - amino dipropyl amine cellulose 22.4 mg protein per g. 
Cellulose activated with 300 mg cyanogen bromide per g:
(iv) © - aminoethyl 23.7 mg protein per g.
(v) ©• - aminopentyl. 22.1 mg protein per g.
(vi) a  - amino dipropyl amine cellulose 15.9 mg protein per g. 
Immunoadsorbents were diluted to the same protein concentration per ml.
(b) The percentages of adsorbed antigen (IgG) recovered by treatment 
of the immune adsorbent with eluting agents. Other data as for 
Fig. 2.16(a).
mg protein per g. 
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The Use of Spacer Arms between the Carrier and Protein
Spacer arms were introduced on to the carrier by first reacting 
it with cyanogen bromide and then reacting the resulting imidocarbonate 
with 1,2-diaminoethane, 1,5-diaminopentane or 3,3’-diaminodipropylamine.
The effects of different chain lengths at two different levels of 
substitution of the carrier are shown in Figs. 2.16fp.ss) and 2.17, 
protein having been coupled with glutaraldehyde , As mentioned previously, 
immunoadsorbent titre was less at the higher level of aminoalkyl substitution 
on the carrier, and decreased in the order ethyl > dipropyl amine > pentyl 
at the higher level of substitution and dipropylamine > ethyl > pentyl at 
the lower levels.
In order to confirm that differences were attributable to variation in 
chain length as opposed to the method of coupling, experiments were conducted 
in which the protein was coupled to the carrier either by the carbodiimide 
method or after ’activating’ the aminocellulose with either glutaradehyde 
or O-bromoacetyl-N-hydroxysuccinimide. The carbodiimide method resulted in 
immobilisation of a high percentage of the added protein, but the titre 
or capacity of the antibody was very low. The immunoadsorbent, although 
particulate, had a somewhat gelatinous appearance, and it was concluded _ 
that protein cross-linking had occurred as well as coupling to the carrier.
This resulted in the blocking of a high proportion of the antigen binding 
sites on the antibody. Titres of those immunoadsorbents prepared by the 
’glutaraldehyde method’ were of the order dipropylamine > ethyl > pentyl 
(Fig. 2.18) and this order was also found to apply to the three bromoacetamido- 
alkyl derivatives (Fig. 2.19). In the latter case immunoadsorbents prepared 
from bromoacetyl cellulose were included for comparison and were found to 
have titres less than the ethyl derivative but greater than the pentyl 
derivative. Equilibrium constants were confirmed as being in the order
dipropylamine > ethyl > acetyl > pentyl by Steward-Petty plots (Appendix 1).
A decrease in antibody activity associated with the different spacer 
arm lengths in the order dipropylamine > ethyl > acetyl may be explained 
in terms of the reduced steric effects of the carrier on the antibody. 
However, why the pentyl derivative consistently had less activity than 
the ethyl derivative, and even the acetyl derivative in the case of bromo- 
acetyl cellulose, was not immediately obvious.
N ’ -Hydroxysuccinimide esters of cellulose were prepared from amino­
ethyl and aminodipropylamine cellulose. The shorter chain derivative 
coupled larger quantities of protein than did the longer chain preparation 
(Table 2.5,pi5^ but the antibody coupled to the latter had a 
higher titre (Table 2. li;p,io^ .The lower level of protein coupling may be 
due to a competitive aminolysis reaction on the part of the secondary amine 
or the buffering influence of this group on the microenvironment of the 
spacer arm, thus influencing activity and specificity of the N-hydroxy- 
succinimide towards amino groups on the protein. As mentioned earlier (p.. 61) 
it is possible that the method of synthesis of bromoacetamidoalkyl cellulose 
results in incorporation of some N-hydroxy succinimide groups through 
reaction of the bromine function with the amino groups on the carrier. 
These groups would be available to react with the protein along with the 
bromoacetamido groups.
Table 2.10 Titres of the immunoadsorbents described in Fig. 2.17
Glutaraldehyde Carbodiimide
aminoethyl ~1/730 1/180
aminopentyl 1/575 ,
aminodipropylamine 1/955 1/70
Fig. 2.17
Titration curves for immunoadsorbents to human IgG. Amino alkyl
derivatives of different chain length and degree of substitution activate? 
glixtajrckldehy<3e
Cellulose activated with 50 mg cyanogen bromide per gram.
o - aminoethyl
e - aminopentyl
A - aminodipropylamine
i
Cellulose activated with 300 mg cyanogen bromide per gram.
© - aminoethyl
0 - aminopentyl
A - aminodipropylamine
Fig. 2.18
Titration curves for immunoadsorbents to human IgG. A comparison of 
activities retained after coupling the antibody to aminoalkyl celluloses 
(i) with glutaraldehyde and (ii) in the presence of carbodiimide. 
Immunoadsorbents were standardised to the same protein concentration per 
ml before dilutions were .prepared.
Coupling method'"
Glutaraldehyde Carbodiimide
aminoethyl 23.3 a 19.8 ▲
aminopentyl 15.6 □ 20.3 h
aminodipropylamine 17.7 o 21.6 •
mg protein per gram of cellulose.
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Fig. 2.19 •
Dose response curves for a series of bromoacetamido derivatives 
of cellulose, (i) bromoacetyl; (ii) bromoacetamidoethyl; (iii) 
bromoacetamidopentyl and (iv) bromoacetamido-3-dipropylamine.
meq Br2 Protein mg/g.
(1) 0.43 48.2
(2 ) 0.17 12.5
c 3 3 0.18 49.5
( 4 ) 0.18 18.1
(a) Counts bound (B) vs. dose.
(b) B/g v s. . dose.
Fig. 2.20
Dose response curves, B vs. dose, illustrating the effect of 
coupling pH upon activity of the immobilised antibody.
Coupling • mg protein rr,. **Titre
pH per g. ■ V
1. Carboxyethyl cellulose 6.5 43.8 1 / 270
2. Carboxyethyl cellulose 8.75 55.1 1 / 950
3. Aminoethyl* 7.0 29.0 1 / 9 0 0
4. Aminoethyl 8.75 22.9 1 /1340
5. Aminodipropylamine* 7.0 28.7 1 /1110
6. Aminodipropylamine 8.75 14.8 1 /1910
* *
- activated with glutaraldehyde.
-  dqtq obtained from  titrq tio n  curves
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Influence of pH on the Coupling Reaction
The reaction of immunoglobulin with diazotised 4-aminobenzyl 
cellulose and N-(3-aminobenzyloxymethyl) cellulose was more satisfactory 
at pH 6.0 than at pH 8.75 in terms of the amount of protein immobilised 
(Table 2.5,p.5^ but coupling antibody at the higher pH produced immuno­
adsorbents of higher titreji.e. the molar ratio of antigen to immobilised 
antibody was increased (Table 2.11).
Glutaraldehyde aminoalkyl celluloses were reacted with immunoglobulin
at pH 7.0 and 8.75. Larger amounts of the added protein were immobilised
at the lower pH, but coupling at the higher pH produced an immunoadsorbent.
with greater capacity (Fig. 2,20ip.95).Dose response curves plotted in terms
of the B/g ratio showed that the avidities were not significantly 
o
different. Similar percentage amounts of antigen were recovered by elution 
from the two types of preparation.
Antibodies were coupled to carboxyethyl cellulose at either pH 6.5 
or 8.75 in 'the presence of the water-soluble carbodiimide EDC. At the 
lower pH the product was invariably obtained in an aggregated form, and 
if mixing was inadequate during the coupling procedure large gelatinous 
lumps were formed. The product of the reaction at pH 8.75 was homogenous, 
but its gelatinous nature, attributable to its ion exchange properties, 
made it difficult to handle in the assay. The titre of this preparation was 
greater than that of the immunoadsorbent prepared at the lower pH (Fig. 2.20^
p.95).
Similar results were obtained for the coupling of immunoglobulin to 
cyanogen bromide activated cellulose and bromoacetyl cellulose. Comparable 
percentages of adsorbed antigen were recovered by elution.
The advantage of coupling antibody to diazotised N- (3-aminobenzyl- 
oxymethyl) cellulose at pH 6.0 in terms of the amount of antibody coupled 
was outweighed by the loss of antibody activity. Coupling at pH 8.75 
was much more satisfactory in this respect. The higher pH favours 
reaction with the phenoxide ring of tyrosine, which at lower pH exists 
as the phenol which is much too unreactive to be attacked by the weakly 
electrophilic diazonium ion. The imidazole group of histidine is active 
at the lower pH.
Glutaraldehyde-activated aminocelluloses, bromoacetyl cellulose and 
cellulose imidocarbonate all react with amino groups in the protein. 
Alkaline conditions around pH 9.0 favour reaction with e-amino groups 
of lysine residues, whereas lower pH values favour reaction with N-terminal 
a-amino groups and histidine. The antigen-binding sites reside at the 
N-terminal ends of neighbouring heavy and light chains, and consequently 
any coupling reaction involving these groups will lead to blocking of the 
antigen binding site. ,
The Choice of Conditions for Protein Immobilisation
The methods of antibody immobilisation which produced immunoadsorbents 
conforming closely to the criteria for an ’ideal immunoadsorbent’ defined 
at the beginning of this chapter were selected for further studies.
Antibody activity has been considered in terms of equivalent amounts 
of immobilised protein. As. has been seen, the immobilisation of large 
amounts of antibody and the resultant, high ratio of antibody to carrier 
frequently results in the loss of antibody activity. Even if there is 
no loss the percentage of adsorbed antigen recoverable by elution may be 
less because of ’immunoadsorbent avidity'. In view of-these findings 
it has not been possible to satisfy all the criteria for an ’ideal immuno­
adsorbent ’.
Titration curves for a series of immunoadsorbents prepared under 
optimum conditions on the same occasion are shown in Fig. 2.21. The 
highest titre (1/1900) was obtained by coupling antibodies to diazotised 
N-(3-aminobenzyloxymethyl) cellulose at pH 8.75. Glutaraldehyde-activated 
aminodipropylamine cellulose reacted with antibody to produce an immuno­
adsorbent with a similar titre, 1/1860. Immunoadsorbents prepared from 
aminochlorotriazinyl cellulose, bromoacetyl cellulose and glutaraldehyde- 
activated aminoethyl cellulose had similar titres ranging from 1/1200 1 
down to 1/1070. The titres of preparations with diazotised 4-aminobenzyl 
cellulose and aminoethyl and carboxyethyl cellulose (carbodiimide) coupling 
method - (DCC) were considerably lower, that with carboxymethyl cellulose 
being so low that it could not be measured. The titre of the AS 51 immuno­
globulin preparation was estimated at 1/2800 by the double antibody method. 
A comparison of the relative immunoadsorbent activities can be drawn from 
the titres included in Table 2.11. The highest titres were obtained
100
a.
20
1/ 1/1 /100 10,0001,000
Immunoadsorbent dilution
Fig. 2.21
Titration curves of immunoadsorbents ' ^  prepared under previously 
determined optimum conditions. . -
In sequence from right to left the derivatives used to prepare the 
immunoadsorbents were:-
1. diazotised N-(3-aminobenzyloxymethyl)cellulose
2. aminodipropylamine cellulose(glutaraldehyde activated)
3. aminoethyl cellulose (glutaraldehyde activated)
4. aminochlorotriazinylcellulose
5. bromoacetylcellulose
6. aminoethyl cellulose (NjN’-dicyclohexylcarbodiimide)
7. diazotised 4-aminobenzyl cellulose
8. carboxymethyl cellulose (N,N’-dicyclohexylcarbodiimide)
(Series 1 in Table 2.11)
Table 2.11
Titres of different immunoadsorbent preparations determined from 
immunoadsorbent titration curves. Series 1,2,3 and 4 represent 
different groups of immunoadsorbent preparations. Titres in each 
series were determined on the same occasion with reference to the 
same standard and are directly comparable.
Table 2.11
Cellulose. 
derivative
Series 1 Series 2 Series 3 Series 4
■N- (3-j aminobenzyloxymethyl) 1/1900 - -■ - 1/1750 -
4-aminobenzyl 1/182 1/300 - - 1/300
Aminoethyl (i) 1/1070 1/1500 - ' 1/1340
Aminopentyl (i) - 1/860 - - -
Aminodipropylamine (i) 1/1860 1/1850 - 1/1910 -
3-amino-5-chlorotriazinyl 1/1200 1/1400 - . - -
Bromoacetyl 1/1150 1/1120 1/1105 1/1320 1/1250
Bromoacetamidoethyl - 1/1350 1/1300 - -
Bromoacetamidopentyl - - • 1/500 - -
Bromoacetamidodipropylamine - 1/1520 1/1550 - -
Aminoethyl (ii) - - - 1/670 -
Aminopentyl (ii) - very low - - -
Aminodipropylamine (ii) - - - 1/750 -
Carboxymethyl (iii) very low very low - -
N-hydroxysuccinimide 
ester (aminoethyl) - - 1/1200 -
N-hydroxysuccinimide ester 
(aminodipropylamine) - * \ - 1/750 -
Carboxymethyl hydrazide - - - 1/1040 -
Carboxyethyl (ii) - - - 1/950
Aminoethyl (iii) 1/320 1/300 - -
Aminodipropylamine (iii) - No binding - - -
Imidocarbonate (iv) - - - 1/1240 1/870
Oxirane • - - 1/920 -
Periodate oxidised (v) < 1/250 - 1/2200
(i) Activated with glutaraldehyde
(ii) Coupled with l-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 
(iii) Coupled with N,N’-dicyclohexylcarbodiimide 
(iv) Coupled at pH 8.9.
(v) Oxidised with 0.1 M periodate.
consistently with immunoadsorbents prepared from diazotised N- (3-amino- 
benzyloxymethyl) and glutaraldehyde-activated aminodipropylamine 
derivatives. A titre of 1/2200 achieved with antibody coupled to 
periodate-oxidised cellulose could not be reproduced.
The success of the method involving coupling to diazotised N-(3- 
aminobenzyloxymethyl) cellulose must lie with the involvement of tyrosine 
residues and the spacer arm furnished by the benzyloxylethyl group.
Coupling via tyrosine residues is not in itself responsible for the 
retention of a greater percentage of the antibody activity, as is evident 
from the relatively poor results with diazotised 4-aminobenzyl cellulose.
The majority of the other coupling procedures involved protein amino 
groups . The glutaraldehyde coupling method in conjunction with a dipropyl­
amine spacer arm provided the next most satisfactoiy immunoadsorbent, and 
the bromoacetamido derivative gave almost equally satisfactory results.
The carbodiimide method proved to be very effective as a means of immobilising 
protein, but the efficiency as regards retention of activity depended upon 
the carbodiimide and the carrier. The water-soluble carbodiimide (EDC) 
was much more satisfactoiy than DCC which had to be used in a water tetra- 
hydrofuran emulsion. Coupling via amino groups on the carrier and carboxyl 
groups on the protein was considerably less satisfactoiy than coupling the 
protein via its amino groups to a carboxylated carrier. This may point to 
the greater involvement of carboxyl groups in and around the antigen binding 
sites of the antibody. Loss of antibody activity in these preparations may be 
explained in part by cross-linking of the protein.
Elution of Antigen (IgG) from Specific Immunoadsorbents
The relative efficiencies of a variety of different eluting agents 
were determined, and the results are presented in Figs. 2.12(p.83), 2.16(p.88) 
and Tables 2.12 and 2.13. The findings clearly indicate that the relative 
efficacies of different eluting agents vary from one immunoadsorbent to 
another and depend upon the nature of the carrier, the method of coupling 
and the avidity of the antibody.
The largest recoveries of IgG were generally made under conditions 
of low pH with 50 mM glycine-HCl buffers or organic acids such as acetic 
and propionic. The percentage recovery of IgG was proportional to the 
pH of the eluting acid and, with the possible exception of citrate, was 
independent of the anionic species. On the other hand, the efficacies of 
electrolyte solutions are dependent upon the valency of the cation, the 
ionic species, the elctrolyte concentration and the immunoadsorbent. 
Furthermore, electrolyte solutions were found to be more efficient 
eluting agents when employed in batch-type purification procedures as 
opposed to column procedures.
The eluting power of ,tris-buffered 8 M urea was shown to be
comparable to that of 3 M sodium thiocyanate (Fig. 2.12, p.83) i. but -its use 
as an eluting agent was not entertained beyond a preliminary investigation 
because of its protein denaturing properties.
Table 2.12
Percentage recoveries of human IgG from sheep anti-human IgG(Fc) 
immunoadsorbents as measured by the recovery of 125I-IgG.
% recoveries of adsorbed IgG*
Cellulose derivative Eluting agents
Series 1. Table 2.11 Glycine-HClpH2.5
Acetic Acid 
1 M
NaSCN 
3 M
Diazotised N- (3-amino-
benzyloxymethyl) 53.1 69.0 77.0.
Bromoacetyl 46.6 69.0 61.0
Aminolchlorotriazinyl 59.0 81.0 67.0
Aminodipropylamine1 71.0 75.0 61.0
Carboxymethyl 20.2 - 59.0
Diazotised 4-aminobenzyl 52.0 72.0 66.0
Series 4. Table 2.11 pH 2.0 - -
Diazotised N- (3-amino- ,
benzy loxyme thyl) 58.7 41.7 66.0
Aminoethyl1 60.8 56.0 42.4
Aminodipropylamine1 67.0 59.7 48.0
Bromoacetyl 71.4 66.4 65.2
N-hydroxysuccinimide ester 
(aminoethyl) 65.0 71.0
t
* 59.2
N-hydroxysuccinimide ester 
(aminodipropylamine) 78.6 78.9 64.3
Carboxymethyl hydrazide 87.8 68.3 70.3
Carboxyethyl2 77.0 60.0 55.6
Aminoethyl2 82.7 - 73.9
Aminodipropylamine2 83.3 79.2 71.3
Imidocarbonate 3 77.9 74.4 61.0
Oxirane 69.1 63.5 54.8
Diazotised 4-aminobenzyl 82.5 78.5. 70.0
1 Activated with glutaraldehyde.
2 Coupled with l-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride. 
:3 Coupled at pH 8.9.
* Mean values of three determinations.
Table 2.13 
Comparisons of various eluting agents
% recoveries of adsorbed IgG 
Cellulose derivative________________  Eluting agents______
Glycine-HCl 
pH2.8 pH2.0
Acetic
Aa d
Propionic
Acid
1M
NaSCN
3M
MgCl 
3M z
MnSO. 
3M 4
Diazotised N-(3-amino- 
benzyloxymethyl) 60.8 68.8 62.3 62.7 59.5 66.1 17.4
Bromoacetyl 64.0 64.9 63.2 62.1 60.4 59.0 24.1
Imidocarbonate 69.8 - 68.7 - 56.6 60.5 27.1
Aminoethyl1 65.9 71.9 66.0 60.2 53.2 62.8 19.8
Aminodipropylamine1 65.6 73.2 66.6 60.0 60.0 55.5 16.0
Amino-chlorotriazinyl 78.7 75.7 42.7 44.7 53.2 56.6 6.2
Propionic 
Acid 
0.1 M 1.0 M
NaSCN
3M
pH6.0
MgCl 
. 3M z
Citric acid: 
NaCl: glycine 
pH2.8
Diazotised N- (3-amino- 
b enzyloxymethyl 60.1 65.4 74.7 60.2 63.9 **
Bromoacetyl 61.8 72.2 61.2 29.7 47.8
Amino dipropyl amine1 69.8 80.0 67.4 36.8 60.2
Aminodipropylamine2 65.3 78.7 69.9 37.5 56.5
1 Activated with glutaraldehyde
2 Coupled with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride - 
* Mean values of three determinations.
■** Mean values of six determinations.
Anti-bovine Insulin- Immunoadsorbents
Fig. 2.22 shows a series of log dose response curves obtained with 
bovine insulin and seven different immunoadsorbent preparations. The 
highest titres were obtained when the antibody was coupled to either 
diazotised N-(3-aminobenzyloxymethyl) cellulose or bromoacetamidodipropyl- 
amine cellulose. The bromoacetamidoethyl derivative was only slightly 
less efficient and the pentyl derivative considerably less efficient.
As has already been pointed out (Table 2.7,p.63)a pentyl derivative bound 
more of the available guinea pig immunoglobulin (46.51) than did the . 
ethyl (24.0%) and dipropylamine (30.0%) derivatives. This predisposition 
on the part of the pentyl derivative to react more readily, with the 
protein may point to a more effective immobilisation resulting in blocking 
of a higher proportion of antigen binding sites and a resultant loss of 
capacity. This order of effectiveness of the spacer arms is the same 
as that found for anti-IgG immunoadsorbents. Bromoacetyl- and aminochloro- 
triazinyl-cellulose based immunoadsorbents were less efficient, and the 
carbodiimide method of coupling to aminoethyl cellulose, employing N,N- 
dicyclohexylcarbodiimide, resulted in a gross loss of antibody activity. 
These results are of the same order as those obtained with anti-IgG 
immunoadsorbents. "When plotted as the B/Bo ratio, the dose response 
curves were comparable.
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Fig. 2.22 Log dose response curves obtained with .guinea-pig anti­
insulin immunoadsorbents prepared from the following cellulose 
d e r iv a ti v e s - diazotised N- (3-aminobenzyloxymethyl) , a - bromo- 
acetamidodipropylamine, □ - bromoacetamidoethyl, o - bromoacetamido- 
pentyl, > - aminochlorotriazinyl, b - bromoacetyl and © - amino- 
ethyl.
Stability of Immunoadsorbents bn Storage
Immunoadsorbents for protein purification were routinely stored 
in PBS, containing 0.11 sodium azide, at 4°C. Before use the preservative 
was removed by washing. For radioimmunoassay purposes freeze-dried 
material had its advantages in that it could be stored easily in small 
aliquots and reconstituted immediately before use.
In early freeze-drying experiments the cellulose-based immunoadsorbents 
were diluted to a concentration of 80 mg solid per ml PBS, quick frozen 
in a dry ice/cellosolve mixture and freeze dried. The products were 
invariably granular and attempts to reconstitute them failed to yield 
a uniform suspension even on sonication. The results were only slightly 
inproved by making the buffer 0.51 with respect to BSA. The suspensions 
were then diluted 20-fold before freezing and the end result was a fine 
powder. However, when reconstituted this did not regain the same small 
particle size and smooth suspension characteristic of the starting material. 
The procedure was again inproved, this time by adding sucrose (5%) to the 
buffer. After freeze-drying the material remained as a cake with a volume 
similar to that of the initial suspension. On adding water the immuno- 
adsorbent was reconstituted in a form indistinguishable from a fresh 
suspension.
The results of an assay conducted with aliquots of immunoadsorbents 
which had been freeze dried in a buffer containing 0.51 BSA,but no sucrose, 
or stored in suspension at 4°C,are shown in Fig. 2.23. The freeze-dried 
material was reconstituted with distilled water to its original volume. 
Freeze drying caused a 20% decrease in the number of available antibody 
sites but the avidity of the immobilised antibody was unchanged.
The effect of freeze-drying on the activity of anti-human IgG (Fc) 
immunoadsorbents prepared from bromoacetyl cellulose ( o and © ) and 
triazinyl cellulose ( o and 0 ). Preparations were stored at + 4°C 
for six weeks ( o and □ ) or freeze dried ( © and m ).
Fig. 2.24
Stability of sheep anti-human IgG (Fc) immunoadsorbents.
(i) Triazinyl cellulose based immunoadsorbents.
© Freeze-dried, neat 
© Freeze-dried, neat + 5% sucrose 
0 Freeze-dried, 1:12 dilution 
e Freeze-dried, 1:12 dilution + 5% sucrose 
v Stored at 4°C.
(ii) Bromoacetyl cellulose based immunoadsorbents.
a  Freeze-dried, neat • 
o Freeze-dried, neat + 5% sucrose
(iii)Diazotised N-(3-aminobenzyloxymethyl)cellulose based immunoadsorbents.
X
v Freeze-dried, neat + 5% sucrose.
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Antigen binding curves obtained with three different immunoadsorbents 
freeze dried under different conditions are shown in Fig. 2.24. The 
binding curves for sheep antihuman IgG(Fc) coupled to aminochlorotriazinyl 
cellulose did not differ appreciably for material kept at 4°C or freeze 
dried in the presence of sucrose. Freeze drying in the absence of sucrose 
resulted, in a loss in antibody activity which was more marked in the case 
of the neat suspension than in that of the 1:12 dilution. Sucrose was 
also shown to stabilise freeze-dried samples of immunoadsorbents prepared 
with bromoacetylcellulose and N-(3-aminobenzyloxymethyl)cellulose. Similar 
results were obtained with anti-insulin immunoadsorbents.
From these experiments it was concluded that immunoadsorbents for 
radioimmunoassay were best freeze-dried in buffer containing 0.5! BSA and 
5! sucrose. The immunoadsorbent concentration should not exceed 80 mg/ml.
If a stabilising agent such as sucrose cannot be used suspensions should 
be diluted, preferably to a concentration of less than 5 mg/ml, before 
freeze drying.
Standardisation of IgG Preparations and Sera (cf. p. 43, Purification of IgG)
Human IgG purified from pooled serum by ammonium sulphate precipitation, 
DEAE-cellulose chromatography and Sephadex G-200 chromatography was 
standardised on the basis of absorbance at 280 nm and single radial 
diffusion analysis (SRD). Serum IgG levels were also measured by SRD.
The results were expressed in a semi-logarithmic plot - (diameter of 
precipitin ring)2 vs. log antigen concentration. Fig. 2.25 shows a 
typical plot and the precipitin rings obtained in 1% agarose gel containing 
3! anti human IgG(Fc).
Fig. 2.25
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Conclusion
The results presented here clearly indicate that to believe in the 
existence of the ’ideal immunoadsorbent’ is sheer utopianism. Compromise 
is inevitable.
Of the seven criteria listed at the outset of this comparative study (p.27) 
it has been possible to achieve four with some degree of consistency.
These are: immobilisation by covalent coupling to a carrier; insolubility; 
stability with respect to time and eluting agent; and suitability of the 
physical form of the immunoadsorbent for a particular application. The 
accomplishment of two of the remaining three criteria, namely the specific 
binding of antigen to antibody without non-specific binding of other 
proteins, and the recovery of a large percentage of this specifically 
bound antigen by elution, depends veiy much on the compromise reached over 
the seventh and final criterion, which embodies all that goes to make for 
the efficient utilisation of the antibody. The conditions of the immobilisation 
process are likely to occasion the immunoadsorbent falling into one of two 
categories, and a choice has to be made between these. Importance is attached 
either to the immunoadsorbent having a high capacity for antigen, necessitating 
a high protein: carrier ratio, or to the antibody retaining a high percentage 
of its native activity, the amount of antibody coupled being a secondary 
consideration.
No v one of the methods of immunoadsorbent preparation investigated has 
resulted in retention of all the native antibody activity. The very nature 
of the immobilisation process makes it inevitable that activity will be 
lost due to chemical modification and steric hinderance of the antibody- 
antigen reaction. The carriers to which antibody could be coupled with the 
smallest loss in activity were diazotised N- (3-aminobenzyloxymethyl) cellulose 
and glutaraldehyde-activated aminodipropylamine cellulose. Slightly less 
satisfactory in this respect were bromoacetamidodipropylamine cellulose and
glutaraldehyde-activated aminoethyl cellulose, with bromoacet.' cellulose, 
3-amino-5-chlorotriazinzyl cellulose and bromoacetamidoethyl cellulose 
offering poorer alternatives.
High protein : carrier ratios were best achieved by coupling the 
antibody to diazotised N - (3-aminobenzyloxymethyl) cellulose, preferably 
the precipitated microcrystalline form, to bromoacetyl cellulose, or
to glutaraldehyde-activated aminocellulose. These three coupling methods 
also have the added advantage of giving retention of relatively high 
percentages of the native antibody activity . High levels of protein 
immobilisation were achieved by reaction with diazotised 4-aminobenzyl 
cellulose and with carbodiimide-mediated condensation reactions with 
amino or carboxyl celluloses, but both these methods led to gross losses 
of antibody activity. One problem of a high protein:carrier ratio is 
that of "immunoadsorbent avidity" referred to earlier. The high antibody 
density favours multiple reactions between one multi valent antigen and 
several antibodies. The energy of dissociation of such complexes is 
greater than that of a single antibody-antigen complex, and consequently 
elution of antigen from the antibody-immunoadsorbent is more difficult to 
achieve. This is also the case when there is a large number of covalent 
bonds between the antibody and the carrier. The three-dimensional structure 
of the protein is frozen. The advantages to be gained from incorporating 
spacer arms between antibody and carrier, in terms of reduced steric 
hindrance, are negated if large numbers of arms are involved.
On the basis of the findings reported here, coupling to diazotised 
N-(3-aminobenzyloxymethyl) cellulose ..at pH 8.75 and glutaraldehyde-activated 
aminodipropylamine cellulose are the methods of choice.
The ’off the shelf’ concept for activated carriers is particularly 
attractive to the laboratory involved in the routine preparation of immuno-
I
adsorbents. Of the immunoadsorbents investigated here only five can be
prepared directly without the need to activate the carrier. The cellulose 
derivatives involved are bromoacetyl, 3-amino-5-chlorotriazinyl, imido- 
carbonate, carboxy and amino. In the cases of the last two derivatives 
coupling is achieved in the present of a carbodiimide. The bromoacetyl 
and triazinyl derivatives are stored wet and the others diy. The bromoacetyl 
derivatives are to be recommended as 'off the shelf' reagents. Bromoacetyl 
cellulose itself may be preferred to the bromoacetamido derivatives, for 
although it causes greater losses in antibody activity these are more 
than outweighed by its larger capacity for coupling antibody. If a 
dried activated cellulose is more convenient the choice is limited to 
cellulose imidocarbonate.
The method most frequently reported in the literature is in fact that 
involving formation of an imidocarbonate by cyanogen bromide activation 
of the cellulose, followed immediately by reaction with the protein.
Few reports admit to diying the activated cellulose and coupling protein 
at a later date. The results presented here suggest that the method is by 
no means the most efficient for immobilising antibody. Its success may 
stem from the fact that it may be used equally well for the activation of 
cellulose, beaded agarose (Sepharose), or beaded dextran (Sephadex). The 
method of activation widely advocated in the past has been made hazardous 
because of the problems presented by the cyanogen bromide which is a 
dangerous poison. However, the introduction of an improved activation 
procedure by March, Parikh and Cuatrecasas (213) using acetonitrile as a 
solvent for the cyanogen bromide and dispensing with the need to run a 
continuous titration, augurs well for the continued popularity of this 
method. One wonders how many people would continue to use it if they 
realised how wasteful it is of antibody.
APPENDIX 1
The effect of immobilisation of an antibody may be judged by 
three properties relating to the activity of the antibody. These are 
capacity, affinity and avidity. The capacity is easily defined in ‘ 
terms of the number of antigen binding sites on the antibody. Hie terms 
affinity and avidity both relate to the.binding energy involved in a 
particular antibody-antigen reaction. Affinity describes the reaction 
between an antigenic determinant and the antibody-, and any measurement 
of this requires that either the antigen is univalent or the antibody 
is specific for a single antigenic determinant. Different, but related, 
antigenic determinants may show lesser affinities for the antibody species 
reflecting a lesser degree of recognition. Avidity is a particular 
property of the antibody and is a measure of the tightness of fit to the 
antigen. For the reaction -
Ab + Ag -------- ^  AbAgwxai - - - - L -
k2
- the avidity is defined as the equilibrium constant K, and
k* - | AbAg |
• k =  ------   = ----- ----------------------
k2 |Ab| |Ag|
ivhere |AbAg|, |Ag| and |Ab | are the molar Concentrations of antibody- 
antigen complex, free antigen and free antibody respectively, and kj and k 
are the association and dissociation rates.
The Interpretation of Radioimmunoassay Data
Standard dose response curves can be most enlightening with regard 
to the relative properties of different immunoadsorbents. However, the 
pitfalls to be encountered in the interpretation of these curves are 
numerous as revealed by Hkins (106), and in the past researchers have .been 
all too ready to draw unjustifiable conclusions. The mathematical theory
of radioimmunoassay has been examined by several workers, in particular 
Feldman and Rodbard (107), Berson and Yalow (108) and Ekins (109).
Hie data obtained from a radioimmunoassay may be expressed in a
variety of graphical forms. Plotting the data in terms of the number of
counts bound (B) or one of the ratios B/g , B/p or F/g against antigen
o
dose on either an arithmetic or a logarithmic scale yields standard dose- 
response curves. (B - counts bound; Bq - counts bound at zero dose;
T - total counts added; F - free or unbound counts).
i
Estimations of the equilibrium constant by application of the 
Michaelis-Menton equation have been made by Odell _et al. (110) and 
. (111) • A Michaelis-Menton hyperbola was constructed from data
obtained by incubating equal aliquots of antibody with increasing 
concentrations of antigen. The equilibrium constant was defined as the 
reciprocal of the free antigen concentration, expressed as a molar 
quantity, at 50% saturation, of the antibody binding sites. The constant 
is an average value for the whole antibody population, and is influenced most 
by the fraction with the highest K.Ab value.
An ’index of avidity' has been defined by Celada et al. (112) and 
Steward and Petty (113). The volume of antiserum necessary to bind 50% 
of available antigen at a range of antigen concentrations was determined.
A semilog plot of this value vs. antigen concentration gave a straight line 
with a gradient equal to the affinity index.
A standard dose response curve provides the necessary data for the 
construction of a Scatchard plot. This was first applied to radioimmuno­
assay by Berson and Yalow (114) and Ekins (115) and has since been described 
by several authors including Feldman and Rodbard (107). Hie plot is defined 
by the equation R = K (q - B), where R is the ratio of free to bound antigen,
K the equilibrium constant and q the concentration of antibody binding 
sites. A linear relationship is only found if there is a homogeneous 
antibody population.
The relative equilibrium constants of antisera containing 
heterogeneous antibody populations directed against several antigenic 
determinants of an antigen may be calculated by the method described by 
Steward and Petty (113, 116). A plot of 1/^ vs. 1/ from the equation 
1/^ = 1/k « 1/c• 1/Ab + ^Ab > derived from the Law of Mass Action and the 
Langmuir Isotherm, gives a measure of antibody concentration (Ab^). (b and 
c represent bound and free antigen respectively and K the equilibrium 
constant). The value of K was determined graphically by a logarithmic 
transformation of the Sips equation. Deviation from linearity of the plot 
Vjj ¥§. 1/ was explained in terms of disproportionate binding of antigen 
in conditions of relative antibody and antigen excess (91). Differences 
in relative equilibrium constants were reflected in a change of slope of 
the curve, this being greatest at low values of K. The intercept with the 
ordinate represented the reciprocal of antibody concentration.
Theoretical dose-response curves have been plotted by substituting 
values for the equilibrium constant (K), and concentrations of antibody 
(q) and labelled (p*) and unlabelled (p) antigen in the equation
(B/p)2 + B/p(i + Kp + Kp* - Kq) - Kq = 0 (117, 107).
The. equation satisfies all dose-response relationships for a single antibody- 
antigen system.
Berson and Yalow (114) considered the case of one antigen reacting with 
two antibody sites with different avidities and in different concentrations, 
but did not differentiate between labelled and unlabelled antigen;
R = Kjj i (qi ~ b-^ ) + (^2 " ^2^ *
(R = B/p ratio; K - equilibrium constant; q - concentration of antibody 
sites; b - amount of bound antigen). It is difficult to generate 
theoretical dose response curves because the quantities of antigen bound 
bp and b^, by the different antibody sites are not independent (119).
More recently Feldman et al. (120), Feldman and Rodbard (107) and Feldman 
(119) have examined the mathematical theoiy of the reaction of any number 
of antigens with any number of antibodies.
Figures Al, A2 and A3 illustrate the effects of varying the
concentration of antibody for a given value of K. The plot of counts
bound (B) vs. dose on an arithmetic scale leads to a raising and steepening
of the curve with increasing antibody concentration, characteristics which
also apply to the B vs. log dose curve. A plot of B/p scales the curves
o
to the same initial height and then they are virtually superimposable 
under the conditions chosen, i.e., 3 to 30-fold excess of label over 
antibody binding sites.
Figures A4, A5 and A6 show the effects of vaiying the equilibrium
constant (K). Again plots of B vs. dose on both arithmetic and logarithmic
scales are characterised by a raising and a steepening of the curve with
greater values of K. A set of parallel curves is obtained by plotting the
ratio B/p vs. log dose, 
o
Figures A7, A8 and A9 have been included for comparison, and show 
the effect of varying the amount of 'label* relative to the amount of 
uniabelled antigen.
Hie differences in saturation levels of the antibody have important 
indications for the dose response curves (118). There are essentially 
three types of competitive binding assay, distinguishable in terms of the 
relative concentrations of antibody and labelled antigen. The first type 
employs only a trace amount of label, and an antibody dilution is chosen 
such that 33%. o f the label is bound in the absence of unlabelled antigen:
Under these conditions the B/p ratio will always be equal to one at zero dose.
The third type of assay is typified by high antibody concentrations 
and excess labelled antigen. This method is particularly suitable when 
low specific activities are employed.
The effects of varying K and antibody concentration are also demonstrated 
by Scatchard plots. Increasing antibody concentration shifts the plot to 
the right,the equilibrium constant, and hence the slope of the curve, being 
unchanged. If on the other hand curves are constructed for equal concentrations 
of antibody with increasing values of the equilibrium constant, then a 
progressive steepening of the curve is observed. The intercept with the 
abscissa remains the same. In practice it is inconceivable that an anti­
serum will contain a single population of antibodies, and consequently 
Scatchard plots will not produce straight lines. The effective equilibrium 
constant is given by a tangent to the curve (95), and this changes with 
antigen dose. If only two distinct antigen populations are present, values 
of the equilibrium constants are obtained from asymptotes drawn to the curve 
close to the x and y intercepts. The positions of the asymptotes are shifted, 
without altering the gradient, such that the sums of the intercepts with one 
axis are equal to the intercept of the curve with that axis. Hie slope of
p *  > o and q 0.5
K
The second type of assay conforms to Ekins* Rule (117)
A
K
the asynptote equals - K, and its intercept with the abscissa, 
(concentration of antibody sites).
F ig s ,  A l -  A 9 (o n  th e  f o l lo w in g  p a g e s ) .
T h e o r e t i c a l  dose re s p o n s e  c u rv e s  d e m o n s tr a t in g  th e  e f f e c t s  o f  
v a r y in g  c o n c e n t r a t io n  o f  a n t ib o d y , e q u i l ib r iu m  c o n s ta n t  and  
c o n c e n t r a t io n  o f  la b e l l e d  a n t ig e n .  See t e x t ,  p .  1 2 0 .
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CHAPTER THREE 
Solid-Phase Radioimmunoassay
RADI 0IMCINOAS SAY 
Introduction
Radioimmunoassay combines a high degree of sensitivity with 
specificity and precision for the microdetermination of proteins, 
peptides, steroids and other substances in unfractionated mixtures 
such as serum and urine. The assay originally conceived by Yalow 
and Berson (122) for the measurement of insulin levels in plasma 
depends upon competition between labelled and unlabelled antigen 
(insulin) for antigen binding sites on specific antibodies. The 
separation of antibody-bound antigen and free antigen permits the 
determination of the amounts of labelled antigen in the two fractions.
The ratio of antibody-bound labelled antigen to free labelled antigen 
(B/p) is a function of the concentration of the specific antibody, the 
kinetics of the antibody-antigen reaction and, most importantly, the 
concentrations of labelled and unlabelled antigen. The B/p ratio 
decreases progressively with increasing concentrations of unlabelled 
material. Standard curves are constructed for a known range of antigen 
concentrations with constant amounts of antibody and labelled antigen, 
and the concentrations of unknowns are determined by interpolation.
One of the many problems associated with the development of radio­
immunoassays has been that of separating bound from free antigen.
Methods making use of antibodies in an insoluble form offer the advantages 
of simplicity and completeness of separation.
Some techniques for the separation of bound and free antigen employ 
specific physico-chemical properties of the antigen. For example, insulin 
is adsorbed on to cellulose paper, and so when the assay mixture is electro- 
phoresed on this medium the free antigen remains adsorbed to the paper at 
the origin whilst antibody-bound insulin migrates towards the anode (122).
The method is of limited practical value because of the difficulties 
involved in processing large numbers of paper strips and in handling 
large volumes. Electrophoresis on cellulose acetate exploits the 
different mobilities of the antigen and antigen-antibody complex, but 
has similar disadvantages to electrophoresis on paper (123). Solvent 
extraction techniques employing ammonium sulphate (124) or ethanol: 
sodium chloride (125, 126) do not place any restriction on the assay 
volume but tend to be very exacting. The ethanol: sodium chloride 
extraction in particular is very sensitive to temperature. The immuno­
assay of insulin using dextran-coated charcoal to separate free and bound 
labelled hormone, was reported by Herbert et al (127) . The technique 
has since been applied to the assay of several hormones and digoxin (128). 
The value of the dextran coating has been questioned (129) in the light 
of evidence presented suggesting that the dextran does not exhibit a 
molecular sieving action, which would exclude antibody-antigen complexes 
from the charcoal, but simply reduces the number of sites available for 
adsorption. Both free and bound antigen were shown to be adsorbed by the 
charcoal, the former to a far greater extent. Dextran coating was found 
only to be effective at low protein concentrations. These conclusions 
were reached using a human thyrotropin assay system. Other adsorption 
methods involve the use of talc (130) or ion-exchange resins (131). 
Adsorption methods are particularly sensitive to variations in total 
protein concentration and non-specific effects encountered when measuring 
antigen levels in plasma (132).
Probably the most widely used radioimmunoassay procedure is the 
double antibody method first employed for the determination of insulin 
levels (133). The primary reaction is between antibody and labelled and 
unlabelled antigen. A second antiserum raised against immunoglobulin of
the species employed to raise the first antibody is then added to 
precipitate the bound antigen. The technique gives a complete separation 
of bound and free antigen (134), but the need for a second incubation 
prolongs the assay by one to two days.
The first report of a radioimmunoassay employing an insoluble 
antibody derivative was that of Hales and Randle (135). Guinea pig 
.antiserum was precipitated with rabbit anti guinea pig y-globulin, and 
the precipitate was used as the solid phase in a radioimmunoassay.
Gurvich and Drizlikh (136) developed a method of detecting radioactively 
labelled antigen with antigen covalently linked, to cellulose. The 
principle of the method lay with the fact that bivalent antibody reacted 
with the immobilized antigen through one combining site leaving the second 
site free to react with soluble homologous antigen. Catt et al. (137) 
and Wide and Porath (138) coupled antibody to the solid-phase, the former 
by physical adsoiption to polystyrene tubes and the latter by covalent 
bonding to isothiocyantophenoxyhydroxypropyl-Sephadex. Specific antibodies 
to insulin, growth hormone (GH), human chorionic gonadotrophin (HCG), 
luteinising hormone (LH) and IgG were successfully coupled to Sephadex 
and used for the assay of the appropriate antigens. Solid phase radio­
immunoassays for numerous other antigens have since been developed with 
the solid phase variously taking the form of polymerised antibodies (139) , 
antibodies physically adsorbed on to polystyrene tubes (140) or thin discs 
(14i) and antibody covalently coupled to cellulose particles (142), paper 
discs (143) ,Sephadex (138) and Sepharose (80).
The solid phase radioimmunoassay systems mentioned so far have all 
been indirect techniques employing competition between antigen and 
radioactively labelled antigen for binding sites on an immobilised antibody. 
The uptake of labelled antigen varies inversely with the concentration of
unlabelled antigen in the assay mixture. Such assays do not achieve 
maximum sensitivity for four reasons. Firstly, only a fraction of 
the unknown reacts with the antibody as a result of competition with 
the radioactively labelled derivative. Secondly, the iodination 
procedure may affect the antigen in such a way that its reaction with 
antibody shows a different equilibrium constant. Thirdly, the equilibrium 
of the antibody antigen reaction may be affected by the low antibody 
concentration so that the amount of complex formed is limited. Finally, 
the indirect systems do not make allowance for possible cycling steps 
which would increase the yield of complex from the unknown (144). The 
sandwich and immunoradiometric techniques are both direct methods of 
assay and come close to overcoming these problems. However, the foimer 
may be affected by iodination damage to antigen employed in the measurement 
of antibody.
The 1 sandwich technique1 requires that the antigen has at least two 
antigenic sites. An excess of the immunoadsorbent is incubated with 
the antigen, and then washed. Immunoadsorbent purified antibodies 
labelled with a radioactive isotope are added to the immunoadsorbent.
These antibodies react with the bound antigen; the amount of activity 
bound is directly proportional to the amount of antigen present. This 
direct technique is particularly sensitive since binding of a small amount 
of radioactivity is indicative of the presence of antigen. HCG, LH and 
immunoglobulin E (IgE) have been measured using this technique. The 
method proved to be ten times more sensitive than the competitive inhibition 
system for the detection of IgE (145) . A similar sandwich technique is 
used for the assay of antibodies. The antibodies are incubated with 
insolubilised antigen. The immunoadsorbent is then washed prior to the 
addition of radioactively labelled antigen. The uptake of antigen gives 
a direct measure of the antibodies present.
A specialised radioimmunoassay employing the sandwich technique 
was used for the detection and assay of reaginic antibodies (146).
The antigens which elicit production of reaginic antibodies and which 
cause an allergic response are known as allergens. In the radioallergo- 
sorbent technique allergen is coupled to an insoluble support and reacted 
with reaginic antibody (IgE). The immunoadsorbent is washed and then 
incubated with radioactively labelled anti-IgE antibody. After a further 
wash, the radioactivity bound to the immunoadsorbent is counted and gives 
a direct measure of the reaginic antibody concentration.
The immunoradiometric technique introduced by Miles and Hales (4) 
for the assay of insulin has the advantage of being a "direct" method. 
Antibodies are isolated by immunadsorption on to an insolubilised antigen 
immunoadsorbent, and are radioactively labelled in situ in order to 
protect at least one antigen binding site. Hie labelled antibodies are 
eluted and an excess of these incubated with the antigen. "Free" antibody 
is removed by the addition of an antigen-immunoadsorbent. After 
centrifugation of the assay mixture to sediment the immunoadsorbent the 
remaining radioactivity in the supernatant is directly proportional to 
the amount of antigen present. Ideally univalent antibodies or antibody 
fragments should be used in order to avoid binding to free hormone and 
immunoadsorbent occurring simultaneously (147). The method is highly 
sensitive and should find general application.
' The double antibody radioimmunoassay has been simplified by introducing 
the second antibody in the form of an immunoadsorbent (148). The conventional 
technique requires the introduction of two variables, namely carrier 
Y-globulin and the antiserum to y-globulin (second antibody) after the 
initial incubation. Consequently it is necessary to optimise the assay 
conditions regularly. If the second antibody is introduced in an immobilised 
form there is no need for carrier y-globulin and the amount of second
antibody required is consequently much less. Furthermore, provided 
the immobilised second antibody is in excess, the optimum assay 
conditions are less critical. In theory the antibody can be regenerated 
by treatment with a suitable eluent such as glycine-HCl buffer pH 2.0 
and reused.
The first radioimmunoassay was developed for the measurement of 
insulin (122), and the assay of this hormone has since attracted more 
attention than that of any other protein. The first solid-phase assay 
was performed by Hales and Randle (135) using a precipitated antibody 
to human insulin. The quantitative determination of small amounts of 
immunoglobulin was undertaken by Mann jet al. (149) who employed anti human 
immunoglobulin antibodies covalently linked to cellulose in radioimmunoassay 
systems. IgG, IgA, IgM, and k  and A-light chains were measured using 
appropriate immunoadsorbents prepared with bromoacetylcellulose. The 
sensitivity of this test ranged from 1 yg for IgM to 10 ng for IgG and 
the k light chain. Prior to this Gurvich and Drizlikh (136) reported 
the use of a sandwich technique employing anti-human IgG immunologically 
bound to human IgG, which in turn was coupled to cellulose. The uptake of 
I131 labelled IgG was measured by a rather laborious technique, which was 
improved upon by Salmon et al. (150) using polystyrene isocyanate discs in 
preference to cellulose. Wide and Porath (138) mentioned the use of 
Sephadex-coupled antibodies for the measurement of IgG, and their method 
was subsequently used to assay IgND (now known to be IgE) (151, 152, 153,
154). McLaughlan et al. (154) advocated the use of cellulose carbonate (43). 
Carrel et al. (19 ) and Polmar et al. (121) assayed IgE after the method of 
Mann et al. (149), and both groups were' able to detect the immunoglobulin 
at a level of 30 ng/ml. Polmar et al. (121) compared three radioimmunoassay 
techniques, double antibody, Sepharose-bound antibody and bromoacetylcellulose 
bound antibody, for the measurement of serum IgE. Using these methods it
was possible to detect 2-4 ng/ml, 18 ng/ml and 30 ng IgE/ml respectively.
Comparable results were obtained when measuring elevated levels of IgE, 
but the immunoadsorbent methods were inaccurate insofar as they indicated 
the presence of higher levels of IgE than was actually the case at low 
concentrations of IgE. • Consequently the double-antibody method was 
considered to be the superior technique.
Comparative assessments of double-antibody and solid-phase radio- . 
immunoassays have also been made by Wide et al. (155), Bolton and Hunter 
(80) and Gardner jet al. (156). In each of these cases the antiserum
was immobilised by covalent coupling to a carrier by the cyanogen bromide 
method. In the assays of LH and FSH (155) the antibody-antigen reaction 
required longer to attain equilibrium when the antibody was immobilised.
In order to keep the incubation time to a minimum without too great a 
loss in sensitivity the level of labelled hormone was increased so that 
the Bq value was of the order of 10-15%. Non-specific binding of labelled 
material was reduced to approximately 0.1% by the use of 0.5% Tween 20 in 
the assay and wash buffers. Antibodies to steroids and small peptide 
hormones retained up to 90% of their activity when coupled to carriers (80), 
but those directed against larger peptide hormones retained only 10-15%'and 
gave assay curves with reduced sensitivity. Losses in activity were put down 
to steric hindrance.. Microcrystalline cellulose and Sephadex G25 Superfine 
were considered easier to handle than Sepharose because they packed down 
better on centrifugation'. Furthermore, cellulose-and Sephadex-coupled 
antibodies yielded standard curves of higher precision than.did Sepharose 
preparations.
N '
Gardner et al. ( 156) considered that the main disadvantages of the 
solid-phase method were the large loss of antibody due to coupling, the 
need to mix tubes throughout the assay and a decreased apparent avidity 
leading to a reduced sensitivity. These conclusions were drawn from ■
experiments with a solid-phase assay system for human placental 
lactogen (HPL). Between 70 and 80% of the original antibody activity 
was lost and cellulose was found to couple less antibody than Sepharose 
4B. The latter observation was thought to be because of there being 
fewer accessible activated sites and a smaller particle size. A diminished 
apparent equilibrium constant for the antibody-antigen reaction when the 
antibody was immobilised was explained in terms of the antibody being in 
discrete packets occupying a small volume rather than being freely available 
throughout the system. It was concluded that the solid-phase assay was 
to be preferred when antiserum was abundant and high sensitivity was not 
essential.
In the present study indirect solid-phase radioimmunoassays have been 
developed for the measurement of insulin, human placental lactogen (HPL), 
IgG and IgD. Double antibody assays were run in parallel except in the 
case of HPL.
Materials and Methods 
Iodination of Insulin
Recrystallised porcine insulin was labelled with carrier-free
125
Na I by the chloramine T method of Greenwood, Hunter and Glover 
(104). The iodination of 5 yg of insulin was achieved at pH 7.5 
with ImC 125I. Purification of the iodinated protein was achieved 
by adsorption chromatography on Whatman CF11 cellulose powder. After 
washing unadsorbed material from the column with phosphate buffer 
(0.05M) the iodinated insulin was eluted with phosphate buffered 5.0%. 
BSA. The fraction was diluted to 25 ml with buffered 0.5% BSA and 
stored in 1 ml aliquots at -20°C.
Iodination of IgG and IgD
This was achieved by the method described for IgG in Chapter 
2 (Method i). Iodinated human placental lactogen was supplied by 
Wellcome Reagents Ltd., Beckenham, Kent.
Preparation of Immunoadsorbents
Methods previously described in Chapter 2 were employed to couple 
antibodies to cellulose. For the measurement of insulin and HPL 7 
'whole* antisera were coupled to the support. The purified globulin 
fractions of antisera were used to prepare immunoadsorbents for the 
assay of IgG and IgD. The cellulose derivatives employed were bromo­
acetylcellulose, bromoacetamidoalkylcellulose, aminochlorotriazinyl- 
cellulose, diazotised benzyloxymethyl cellulose and aminoalkylcellulose, 
coupling to amino alkyl cel lulose being effected by the glutaraldehyde 
method.
Whatman CC31 microcrystalline cellulose was- used in the preparation 
of all the immunoadsorbents used in solid-phase radioimmunoassay.
Assay Buffers: AB1 - boric acid 5.5 g
sodium tetraborate 4.5 g
sodium chloride 8.5 g
ethylene diamine tetra- 
acetic acid (sodium salt) 3.7 g
sodium azide ' 1.0 g
BSA 5.0 g
to 1 litre with distilled water pH 7.4 0.05M with respect to borate.
ABIT - as above plus 0.5% Tween 20.
AB2 - NaH2P04.2H20 2.34 g
Na2HP04.2H20 10.68 g
sodium chloride 8.5 g
ethylene diamine tetra- 
acetic acid (sodium salt) 3.7 g
sodium azide 1.0 g
BSA 5.0 g
to 1 litre with distilled water pH 7.4 0.05M with respect to phosphate.
AB2T - as above plus 0.5% Tween 20.
Performance of the Assay and Calculation of Results
Non-specifically bound radioactivity was estimated with assay 
tubes in which the specific antibodies were replaced by normal 
immunoglobulin. Appropriate controls were included in each assay.
All samples were run in triplicate and results were expressed as 
the means of triplicates. Where the coefficient of variation between 
triplicates exceeded 5% the result was discarded in order to exclude 
accidental drop-outs due to broken tubes, omission of label etc. This- 
level was lifted to 8% for the HPL solid-phase radioimmunoassay.
The sensitivity of an assay system has been defined as the least 
amount of unlabelled antigen that can be detected with confidence, 
and precision the ability to achieve good replication both within and 
between assays.
Insulin Radioimmunoassays 
Double antibody method
Titration of the second antibody and determination of the most 
satisfactory anti-insulin serum dilution were achieved in the same 
experiment. Dilutions of the guinea pig anti-bovine insulin serum 
(243/1) were incubated at 4°C for 72 hr with a dilution of normal 
guinea pig serum and a fixed amount of iodinated insulin. Dilutions 
of rabbit anti-guinea pig immunoglobulin were then added and the assay 
tubes incubated for a further 24 hr at 4°C. Details of the assay 
protocol were as follows:-
Guinea pig anti-insulin sepum dilution 100 yl
Assay buffer AB1 200 yl
1:100 dilution of normal guinea pig serum 100 yl
125
I-insulin (2 ng/ml). 100 yl
These four constituents were mixed and incubated at 4°C for 72 hr.
The mixture was then incubated for a further 24 hrs following the 
addition of 200 yl of rabbit anti-guinea pig immunoglobulin (AS 180)
The precipitate was collected by centrifugation at 2000 g for 
30 min. and washed once by resuspension in fresh assay buffers (AB1)
The same protocol was adopted for the insulin assay with the 
exception that lOOyl of the assay buffer was replaced by 100 pi of 
the insulin standard or unknown.
Typical second antibody titration curves are shown in Fig. 3.1.
The rabbit anti-guinea pig immunoglobulin serum gave rise to significant 
pro and post-zones with maximum precipitation being achieved with a 
1:8 dilution of the antiserum. Precipitation was shown to be unaffected 
by antigen free plasma when EDTA containing assay buffers were employed. 
The 1/40,000 dilution of the anti-insulin serum bound 50% of the added 
label and the 1/80,000 dilution 36%. The 1/80,000 dilution was used 
in the insulin assay to achieve maximum sensitivity. Insulin standards 
.ranged from 62.5 pg/ml to 100 ng/ml (1.5* to 2500 yU/ml), the approximate 
working range of the resulting standard curve (Fig. 3.2) being from 0.2 
to 10 ng (5 to 250 yU).
Solid-Phase Method
. Immunoadsorbents were prepared by reacting 0.5 ml of whole guinea 
pig anti-insulin serum with the cellulose derivative. Iondiated guinea 
pig IgG was added to each reaction mixture to give a measure of the
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Fig. 3.1 Optimisation of conditions for the assay of insulin by 
the double antibody method employing guinea pig anti-insulin 
(dilutions of 1/10000 to 1/80000) and rabbit anti-guinea pig 
globulin serum.
extent of coupling of the antibody. Results of some of the preparations 
have been summarised in Table 2.7. Preparations were diluted to the 
equivalent of an antiserum dilution of 1:10000.
Assay protocol: immunoadsorbent dilution 200 yl
assay buffer AB1 100 pi
insulin standard or unknown 100 yl
125Ir1insulin 100 yl
500 yl*
Incubation 16 hr at room temperature with tumble mixing.
Immunoadsorbent was collected by centrifugation at 2000 g for 5 min. 
and washed twice by resuspension in fresh assay buffer (AB1).
* NB Volume was equal to that of the first incubation in the double 
antibody assay to permit a direct comparison to be made.
Standard curves obtained with various immunoadsorbent dilutions 
are shorn in Fig. 3.3. The coefficient of variation between triplicates 
was less than 31.
Covalent coupling of the insulin antibodies to bromoacetyl cellulose 
resulted in a considerable loss in antibody activity. Whereas a 1/80000 
dilution of the uncoupled antiserum in the double antibody assay bound 
361 of the 125I-insulin added, a dilution of between only 1/10000 and 
1/20000 of the immobilised antibody was required to bind a comparable 
percentage of counts. Furthermore, immobilisation resulted in a 
considerable loss in sensitivity (Fig. 3.2 and 3.3) which reflects a 
loss in avidity. The method of antibody immobilisation has been bettered 
in terms of retention of antibody activity by introducing spacer arms 
between the carrier and the antibody (Fig; 2.22,p.io8).
Fig. 3.2 Standard curve for the radioimmunoassay of bovine 
insulin using the double antibody method. A 1/80000 dilution 
of guinea pig antiserum 243/1 was used. This bound 36% of the 
labelled insulin in the absence of unlabelled insulin.
Fig. 3.3 Standard curves for the radioimmunoassay of bovine 
insulin using the indirect solid-phase method. Dilutions of 
the immunoadsorbent were calculated on the basis of 85.1% 
immobilisation of the antiserum. The antibody was coupled to 
bromoacetyl cellulose (Table 2.7). The results are directly 
comparable with those in Fig. 3.2. .
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The need for mixing the insulin assay incubation mixture was 
investigated by the same method as for the HPL assay described later. 
The results obtained with the two systems are presented together in 
Table 3.1.
Human Placental Lactogen Radioimmunoassay 
Solid-Phase Method
Immunoadsorbents were prepared by racting 1 ml of whole rabbit 
antiserum with 1 g of bromoacetyl cellulose.
A suitable working dilution of the immunoadsorbent was established 
by performing a titration with dilutions ranging from 1/100 to 1/3200 
(Fig. 3.4).
Assay protocol: Assay buffer AB2 or standard 500 p 1
I25j-HPL (10 ng/ml) 100 pi
Immunoadsorbent dilution 100 pi
incubated at 37°C on a tumble mixer for 2 or 4 hr. Tmnunoadsorbent 
collected by centrifugation at 2000 g for 5 min. and washed twice by 
resuspension in fresh assay buffer AB2T.
The 1/800 dilution of the immunoadsorbent, which bound 50% of the 
added counts, was selected for subsequent assays.
•. The assay for HPL was set up as follows, each sanple or standard 
being assayed in triplicate.
Assay protocol: Assay buffer AB2 400 pi
Standard or unknown 20 pi
125i_hpl (10 ng/ml) 100 pi
Anti-HPL immunoadsorbent 1/800 100 pi
70
60
50
20
10
0
1/100 1/200 1/2*00 1/800 1/1600 1/3200
Dilution of anti HPL immunoadsorbent
Fig. 3.4 Titration of immobilised anti HPL. O and n - 2 hr 
incubation with label alone and label plus 500 ng of standard 
respectively. X  and © - 4 hr incubation with label alone and
label plus 500 mg standard respectively.
Tubes were incubated at 37°C on a tumble-mixer for 4 hr. and then 
centrifuged at 2000 g for 10 min. The immunoadsorbent was washed 
twice by resuspension in 1.0 mL and AB2T. Standard curves obtained in 
two separate experiments are shown in Figs. 3.5 and 3.6. The results 
obtained with three dilutions of each of seven plasma samples are 
included in the legend to Fig. 3.6. The correlation shown between 
HPL concentrations measured in various plasma dilutions testifies 
for the validity of the assay. The coefficient of variation between 
triplicates was less than 61.
Mixing During the Incubation
The need for mixing during the assay was investigated by comparing 
the results of 0.5 and 4 hr. incubations, both with and without mixing. 
The experiment was conducted for both HPL and insulin.
Mixing the tubes was found to have no significant effect upon the 
amount of hormone bound after 0.5 or 4 hr. incubations (Table 3.1).
The very small particle size of the immunoadsorbents enabled them to 
stay in suspension long enough for binding of the hormones to occur. 
Earlier experiments (Fig.2.8p.^ ) showed that binding of the hormone was 
essentially complete within X\ hr. (insulin) and- 2\ to 3 hr. (HPL).
For routine clinical applications the tumble mixing of tubes was not 
essential. However, for the purposes of the present study mixing was 
routinely employed to overcome problems presented by the variation in 
particle size between the different immunoadsorbents.
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Figs. 3.5 and 3,6 Standard curves for solid-phase radioimmunoassay 
of HPL with anti HPL immobilised on bromoacetylcellulose. The 
’'unknownsn are taken from standard curve 3.6.
’’Unknowns” Dilutions of "Unknowns"
1/1 1/4 1/16
a - -
b 6.00 6.00 5.76
c 1.05 0.92 -
d 4.35 .4.12 4.32
e - 12.40 12.48
f 7.5 8.00 6.40
g 7.5 6.8 6.5
Values represent yg/ml of HPL corrected for the dilution factors.
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o f  s o l id -p h a s e  rad io im m u n o assays  f o r  i n s u l i n  and HPL
(a)
Guinea pig anti-insulin serum (243/1) immobilised by reaction with 
bromoacetyl cellulose. Immunoadsorbent dilution equivalent to a 
1/10,000 dilution of the antiserum.
Incubation time ■125I-insulin
hr. Alone Plus 2 ng standard
Counts bound (cpm) , (n = 3)
StoOd 0.5 4236 + 104 2994+ 56
Mixed 0.5 4370 + 157 2986 + 102
Stood ' 4.0 6495 + 221 4500 +_ 111
Mixed 4.0 6599 + 187 4540 + 92
( b )
Rabbit anti-HPL serum (HS 241 ) immobilised by reaction with bromoacetyl
cellulose
Incubation time 125i-hpl
hr. Alone Plus 100 ng standard
Counts bound (cpm) , (n = 3)
Stood 0.5 3162 + 115 1659 + 104
Mixed 0.5 3110 + 212 1619 + 112
Stood 4.0 4162+137 2220 + 135
Mixed 4.0 4199 + 225 2207 + 81
Radioimmunoassay of Human IgG
Double Antibody Method
Sheep anti-human IgG(Fc) was employed as first antibody, its
precipitation, after incubation with the antigen, being effected with
rabbit anti-sheep y-globulin. A preliminary investigation revealed
cross-reacting antibodies in the rabbit antisera. This activity was
removed by adsorption with a glutaraldehyde polymerised human serum
pool (Table 3.2).
Assay protocol: Assay buffer AB1 200 yl
Dilution of sheep serum (1/400) 100 yl
Standard or unknown 100 yl
125I-IgG 50 yl
Dilution of sheep anti IgG(Fc)
incubated at 4°C for 48 hr. 50 yl
Dilution of rabbit anti-sheep
Y-globulin incubated at 4°C 100 yl
for 24 hr.
Precipitate collected by centrifugation at 2000 g for 30 min. and washed 
once by resuspension in 500yl AB1.
The standard curve obtained with a 1/2000 dilution of sheep anti­
human IgG(Fc) (AS 57) is shown in Fig. 3.7. The sensitivity of the 
.assay extended down to 10 ng/ml.
Solid-Phase Method
Cellulose based immunoadsorbents prepared by any of the methods 
described in Chapter 2 could be used for the radioimmunoassay of human 
IgG. Those prepared from bromoacetylcellulose, diazotised benzyloxymethyl 
cellulose and glutaraldehyde activated aminocellulose were used routinely.
Table 3.2
The removal of cross reacting antibodies with human IgG from rabbit 
anti-sheep y-globulin by immunoadsorption.
Dilution of rabbit 
anti-sheep y-globulin 
(AS 322)
% counts precipitated 
Pre-adsorption Postadsorption
1/2 89.0 -
1/4 85.7 55.5
1/8 85.5 56.4 -
1/12 85.9 -
1/16 85.1 47.3
1/24 81.6 -
1/32 77.6 36.4
1/48 63.1 29.1
1/64 48.0 23.3
0 2.7 1.3
1/12 (anti IgG(Fc) omitted) 61.0 4.5
A double antibody radioimmunoassay for IgG was necessary to enable 
a comparison to be made between antibody activity in the free and 
immobilised states.
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Fig. 3.7 Standard curve for double antibody radio­
immunoassay of human IgG employing sheep antihuman IgG 
(Fc) at a dilution of 1/2000.
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Fig. 3.8 Standard curve for the solid-phase radioimmunoassay 
of human IgG employing sheep anti human IgG (Fc) immobilised on 
diazotised aminobenzyloxymethyl cellulose ( • ) and bromoacetyl 
cellulose ( O ).
Assay protocol:- Assay buffer AB1
Standard or unknown
100m 1
IOOmI
125I-IgG
Immunoadsorbent suspension
lOOpl
lOOyl
Tubes were capped, mixed on a vortex mixer and then tumble-mixed for 
16 hr at room temperature. The immunoadsorbent was collected by 
centrifugation at 2000 g for 5 min and washed thrice by resuspension in 
1 ml ABIT. The sensitivity of the routine assay was 100 ng/ml, and it 
was possible to improve this to 10 ng/ml. However, such sensitivity was 
deemed unnecessary, and furthermore impractical, as it was achieved with 
a standard curve below the convenient working range of IgG concentrations. 
The coefficient of variation of triplicates was less than 3%.
Radioimmunoassay of IgD 
Double-Antibody Method
The assay system employed rabbit anti-human IgD as the first antibody 
and goat anti-rabbit y-globulin as the second antibody. The IgD antisera 
were raised according to the protocol outlined in Chapter 5, a primary 
immunisation being followed by three intramuscular booster injections.
Anti light chain activity was removed by adsorbing the antisera with 
glutaraldehyde-polymerised F ab. Other cross-reacting antibodies were 
absorbed out with a pooled ’normal’ human serum polymer. Controls were 
run with each assay and contained either pure IgG instead of IgD or 
125I-IgG instead of 125I-IgD.
The working dilution of the second antibody was determined by titration 
with the following protocol:-
Assay buffer AB1 100 yl
Rabbit anti IgD (6) 1/1000 (GD21) 100 yl
Rabbit serum 1/100 100 yl
125I-IgD 100 yl
Tubes were incubated at 4°C for 72 hr and then for a further 16 hr 
after addition of 100 yl of a dilution of goat anti-rabbit globulin (AS 357). 
The precipitate was collected by centrifugation at 2000 g for 30 min and washed 
once by resuspension in 700 yl AB1.
Maximum precipitation of the anti IgD/IgD complex was achieved with 
a 1/8 dilution of AS 357. The antiserum was judged to be specific for 
the rabbit protein in the assay system by its inability to precipitate 
125I-IgD in the absence of anti-IgD. When 125I-IgG replaced the iodinated 
IgD in the assay system, less than 1.5% of the added counts (370 ex 25,000) 
were detected in the precipitate.
The protocol which was adopted for the assay of IgD, and which gave 
maximum sensitivity, was as follows:-
Standard or unknown 200 yl
v ,
Rabbit anti-human IgD (<5) 1/3000
(GD 21) 100 yl
125I-IgD 100 yl
Rabbit serum 1/100 100 yl
* Tubes were incubated at room temperature for 24 hr and for a further
24 hr following the addition of 100 yl of a 1/8 dilution of AS 357. The
precipitate was collected by centrifugation at 2000 g for 30 min, and 
washed once by resuspension in 700 yl AB1.
A typical standard curve obtained with this protocol is included in 
Fig. 3.10.
Solid-Phase Method
Immunoadsorbents were prepared by reacting 1.0 ml of rabbit anti­
human IgD (6) with 1.0 g of bromoacetyl cellulose, diazotised benzyloxy- 
methyl cellulose or glutaraldehyde-activated amino cellulose. The 
relevant methods have been described in Chapter 2. The immunoadsorbenta 
were suspended in buffer AB1, made up to 25 ml, and stored at 4°C.
The same protocol as was adopted for the first step of the double 
antibody technique was followed with the exception that the antiserum 
dilution was replaced by a dilution of the immunoadsorbent. Tubes were 
capped and tumble-mixed at room temperature for 24 hr, or 72 hr to 
achieve equilibrium. The solid phase was collected by centrifugation 
(2000 g, 5 minj and washed three times with ABIT. A fourth wash led to a 
further slight reduction in the number of background counts, but did not 
effect the sensitivity of the assay.
A 1/100 dilution of a bromoacetyl cellulose based immunoadsorbent 
bound 501 of the added 125I-IgD when the former was titrated. This was 
equivalent to between a 1/2500 and 1/3000 dilution of the original anti­
serum. A 1/4000 dilution of that antiserum bound an equal percentage of 
counts.
Standard curves obtained with 1/100 and 1/200 dilutions of the 
immunoadsorbent are shown in Fig. 3.9, and with both the solid-phase and 
double antibody techniques at equivalent antiserum concentrations in 
Fig.3.10. The smaller binding capacity of the immobilised antibody reflects 
the 1 loss' of antigen binding sites by steric hindrance and blocking. The 
coefficient of variation of triplicates . was of the same order as in 
the IgG assay, less than 31.
The solid-phase assay was used routinely to assess the effectiveness 
of IgD purification procedures and for measuring the IgD levels in serum 
samples. The results of such measurements are included in Chapter 5.
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Fig. 3.9 Standard curves for the solid-phase radioimmunoassay
of IgD. Dilutions of the immunoadsorbent - ©- 1/100; o- 1/200.
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Fig. 3«10 'Comparison of the standard curves obtained by the
solid-phase ( © ) and double antibody ( O ) methods.
Conclusions
The majority of techniques for the quantitation of immunoglobulins 
are based on precipitation reactions. For most purposes the sensitivities 
of such methods are adequate, but with the discoveries of IgE and IgD, 
which occur in concentrations of 1 and 30 yg/ml or less in normal subjects, 
the advent of tissue culture studies with lymphocytes and an increasing 
interest in immunoglobulin sub-classes, the need for a more sensitive 
assay became acute. The double-antibody technique provides such an assay, 
but the problems associated with optimisation of this system and the length 
of time required to complete the assay leave room for improvement. 
Immobilisation of the antibody on a carrier such as cellulose leads to 
a reduction in the amount of work and time required to perform the assay. 
Furthermore, the solid-phase method is more economical than the double­
antibody method insofar as there is no need for a ’second' antibody.
The one drawback with the indirect solid-phase method is the loss of 
antibody activity because of covalent coupling to the support. When 
antibodies to insulin were coupled to bromoacetylcellulose the activity 
was reduced by approximately 801. Other coupling procedures, including 
those with cyanogen bromide activated cellulose and those involving the 
use of carbodiimide mediated condensation reactions, were even more 
detrimental to antibody activity. On the other hand a higher percentage 
of the original titre (up to 45%) was retained when coupling methods 
involving spacer arms between the carrier and insulin antibody were used. 
The results obtained with antibodies to human IgG were of a similar order, 
but the anti-IgD immunoadsorbents prepared with bromoacetyl cellulose and 
diazotised benzyloxymethyl cellulose retained relatively high percentages 
(up to 75%) of the original antibody titre. The insulin assay showed a
reduced sensitivity when compared with the double antibody method, but 
reductions were not so apparent in the cases of the immunoglobulin 
assays. Loss of actual avidity due to chemical modification of the 
antibody and/or loss of apparent avidity due to steric hindrance of the 
antibody-antigen reaction account for the loss in sensitivity. It is 
not possible to deduce which of these factors is the more important 
on the strength of results in the present study. However, it is 
interesting to note that the activities of the anti-immunoglobulin sera 
were less affected by- coupling than was the insulin antiserum and the 
activity of anti-IgD less than that of anti-IgG. An explanation may be 
in the way the different sera were treated before coupling of the 
antibodies to the carrier rather than with the method of coupling.
The insulin antiserum was not adsorbed and consequently contained 
antibodies with different specificities and a full spectrum of avidities. 
The anti-IgG serum was rendered specific for the Fc fragment by immuno- 
adsorption with immunoglobulin-deficient polymerised serum, appropriate 
immunoglobulin immunoadsorbents and an Fab immunoadsorbent. The anti-IgD 
serum was adsorbed with glutaraldehyde-polymerised "normal" human serum. 
The anti-IgG (Fc) serum is therefore specific for only a fragment of the 
whole IgG molecule, and contains a representative antibody population as 
regards affinities. The anti-IgD serum on the other hand is specific 
for the £ heavy chain and devoid of the high avidity antibodies present 
in the original serum. The immunoadsorbent prepared from 'normal* human 
serum, which contains some IgD, will have removed the highest avidity 
antibodies. It was suggested earlier that immobilisation by covalent 
coupling to a carrier was more likely to affect high avidity antibodies, 
which are involved in a close fit with the antigen, than low avidity 
antibodies. The hypothesis was based on the argument that immobilisation
reduces the flexibility of the three dimensional structure of the 
antibody. Consequently‘the conformational changes required to achieve 
a close fit between antibody and antigen are denied. If the hypothesis 
is applied in this case, the anti-IgD, which has a lowered avidity, 
has less to lose by immobilisation than do the insulin and IgG antisera.
The sensitivity of the solid-phase radioimmunoassay for IgG 
was extended down to 10 ng but with some sacrifice of precision and 
of the working range of the assay. These results compared favourably with 
that of Mann et al . (149). With the solid-phase radioimmunoassay for IgD 
it was possible to detect the immunoglobulin at concentrations of
0.05 IU/ml (70 ng/ml) or 0.01 IU/assay tube (15 ng/assay tube). The 
sensitivity is dictated by the avidity of the antiserum and the 
availability of more avid antisera may make improvements in sensitivity 
possible. A similar assay technique applied to the measurement of IgE 
levels has achieved a sensitivity of 100 pg, a value which was improved 
upon with a solid phase sandwich technique using 125I-labelled antibodies 
to IgE (166, 167).
The coefficients of variation between triplicates obtained for the 
insulin and immunoglobulin assays were less than 3% and 4% respectively. 
Comparable figures could be achieved for the HPL assay but occasionally 
the coefficient of variation was as high as 8%. Had this high figure 
been obtained consistently the fault could have been attributed to a low 
avidity antiserum. The inclusion of 0.5% Tween 20 in the incubation buffer 
might have resulted in improved reproducibility and reduced non-specific 
adsorption, but because of the possibility of this detergent interfering 
with the antibody-antigen reaction it was considered advantageous to omit 
it until the final washing steps. The good precision obtained with the 
solid-phase radioimmunoassay method stems from its ability to achieve 
complete separation of bound and free antigen.
No evidence was found to suggest plasma concentrations were 
influencing the results as has been shown to be the case with other 
techniques for separation of free and bound antigen (168). Possible 
incubation damage caused by the action of plasma proteins on the 
label was not investigated, but the solid-phase assay lends itself 
to the avoidance of such a problem as has been suggested by Hunter 
(169) . The plasma and immunoadsorbent are incubated together and 
the latter is then separated out and washed. The label is then added 
and the system left to equilibrate before washing and counting of 
the immunoadsorbent. In this way the plasma and label never come into 
contact and the possibility of plasma proteins damaging the label is 
avoided.
The solid-phase radioimmunoassay is particularly attractive because 
of both its practicality and economics. Possibly the most important 
consideration in most laboratories will be that of time. The double 
antibody method, which is the most widely used and the only one offering 
anything like the same degree of completeness of separation of free and bound 
antigen as with the solid-phase method, takes from 3 to 5 days to complete. 
The solid-phase assays for insulin and HPL reported here have been 
executed satisfactorily in one working day. Extra time is required for 
counting and processing of results, but when automatic counting and data 
processing facilities are available this can be achieve outside working 
hours.
One disadvantage of the solid-phase method is that of having to 
cap and tumble-mix the tubes. This is essential when maximum sensitivity 
is required, but for routine clinical applications it may be possible to omit 
these steps. Satisfactory results have been obtained in the insulin and 
HPL assays by mixing the assay mixture at the beginning of the incubation
period and then leaving it to stand. Providing that the particle size 
is small enough, and that the antibodies have a high avidity, the 
antibody-antigen will be essentially complete before sedimentation of 
the particles is sufficiently far advanced to influence the results.
If the tumble-mixing procedure is to be omitted cellulose is the . ideal 
carrier in preference to Sephadex, Sepiiarose or Biogel, all of which 
have a relatively large mass and separate out from suspension rapidly.
Good assay results have been obtained with anti-immunoglobulin 
immunoadsorbents prepared up to two years previously, after having been 
stbred either in buffered 0.5% bovine serum albumin (AB1) at 4°C or 
freeze dried at 4°C. Anti-insulin immunoadsorbents were stored freeze- 
dried at 4°C and they too gave good results. This storage capability puts 
the immobilised antibody into the category of a "off the shelf reagent" 
which, for many laboratories, will be another point in its favour.
In conclusion, it must be stressed that the immobilisation of 
antibody invariably leads to a reduction in activity and that the 
assay in which it is used is usually less sensitive than the double 
. antibody procedure for example. Good antisera for radioimmunoassay 
are particularly difficult to raise and it may be very difficult to justify 
wasting them in solid-phase radioimmunoassays. Certainly a large proportion 
of any development work should be carried out with model systems which 
employ less valuable antisera and antigens. Only when a system has 
been proven can one justify adopting it to save time and any other 
savings such as that of a 'second' antibody, and can only be regarded as 
offsetting the loss of antiserum activity.
CHAPTER FOUR
Protein Purification by Immunoadsorption 
The Purification of Human IgG.
Protein Purification by Immunoadsorption
The purification of proteins by immunoadsorption involves the 
adsorption of the protein by specific antibodies immobilised on a 
solid support. The immunoadsorbent may be used in either a column 
or batch procedure.
Sepharose, Sephadex and beaded polyacrylamide based immuno­
adsorbents are ideal for use in columns which are prepared directly 
by pouring a slurry of the immunoadsorbent. Cellulose will form 
satisfactory columns, but it has been found necessary to mix '
reprecipitated microcrystalline cellulose with a solid diluent in 
order to improve its flow properties (157, 28). A coarse grade of 
cellulose may be used for this purpose (157), or better still 
Sephadex which has the added advantage of acting as a molecular 
sieve. Sephadex has been employed in conjunction with antibody immuno­
adsorbents prepared after the method of Gurvich (38) for the purification 
of serum immunoglobulins (28, 158), and also with disulphide linked 
antibodies (22, 23). Antibody polymers prepared with glutaraldehyde 
(2) and ethylene maleic anhydride (74) have been used alone in column 
procedures. Most reports advocate the use of a slow flow rate in order 
to expose the antibody for a maximum period of time. Alternatively, 
the antigen solution can be recycled through the column or the flow 
arrested once the antigen has entered the column (2). The last method 
has the disadvantage of exposing only a small part of the immunoadsorbent 
to the antigen,unless the antigen can be dispersed throughout the column.
Following the immunoadsorption step unbound protein is washed from 
the adsorbent, usually with phosphate or tris buffered saline. In the 
batch procedure this is achieved by centrifugation followed by resuspension
of the immunoadsorbent pellet in fresh buffer. The process is repeated 
until no protein can be detected in the supernatant. Columns are 
washed through.with buffer until the absorbance of the effluent at 
280 nm is zero.
Elution of specifically adsorbed protein presents the greatest 
problem. The ideal eluting fluid alters the confonnation of the proteins 
sufficiently to decrease the affinity of the antibody for.its antigen thus 
allowing dissociation of the complex,but does not cause denaturation 
of the proteins.
Temynck and Avrameas (159) showed that a precipitate obtained with 
albumin and anti-albumin antibodies from hyperimmunised rabbits was not 
soluble in distilled water. However, if the same antibodies were , ■
adsorbed on to glutaraldehyde-polymerised albumin, 50% were recovered 
by washing with distilled water. They proposed that insolubilisation of 
the antigen decreased its affinity for the antibody, and consequently 
decreased the.antigen-antibody association constant.
The integrity of the antigen-antibody complex is maintained by 
relatively weak bonds in the form of electrostatic interactions, 
hydrogen bonds, hydrophobic bonds and van der Waals forces. These may 
be broken by reagents such as urea, guanidine-HCl and chaotropic ions 
(thiocyanate, perchlorate and iodide) (160,61). Where complete
dissociation proves difficult disulphide bonds may be involved.
\
Dandliker et al. (160, 61) recovered active antibody from a BSA 
immunoadsorbent with chaotropic ions. A 65% recovery of precipitable 
antibody was achieved with 2M thiocyanate, but similar concentrations of 
perchlorate and iodide were less effective. It was suggested that
several factors could contribute to the success of the ions as eluting 
agents including electrostatic shielding, salting out, binding to 
the protein and influence on hydrophobic bond formation. Edgington 
(161) extended this work when investigating the dissociation and 
elution of fluoresceinated anti-human IgG from an IgG-BSA. copolymer 
prepared by the ethyl chloroformate method (20). Thiocyanate proved 
to be a more efficient eluting agent than iodide. However, whereas 
the antibody recovered after thiocyanate elution retained only 40% 
of its precipitating capacity, that recovered after elution with 
iodide retained 89.3% of its original activity. The eluting powers 
of sodium chloride were particularly poor, causing dissociation of only 
15% of the amount of protein released by thiocyanate and iodide with 
no apparent antibody activity. The dissolving power of bivalent cations
was found to be considerably greater than that of monovalent cations
2+ 2+ ?+ 2+
in the order of Mg > Ba > Ca > Sn . The halides were most
effective in the order iodide>bromide> chloride. However, at high
concentrations of the eluting electrolyte the yield of antibody from the
antigen immunoadsorbent was independent of both the type of ion employed
and the pH of that solution. Stepwise increases in the electrolyte
concentration permitted fractionation of the antibodies into various
populations. Too low a pH or too high an ionic strength had irreversible
effects on the antibody (160). The removal of chaotropic ions from
the eluate can be achieved only by dialysis or desalting on a suitable
grade of gel filtration medium.
Elution may be effected with a low pH achieved with hydrochloric 
acid or suitable organic acids. Antibodies to BSA, for example, were 
eluted from an antigen immunoadsorbent with 1% sodium chloride adjusted 
to pH 3.2 with hydrochloric acid (1), and human IgG has been eluted
from a specific rabbit antibody-immunoadsorbent by a similar solution at 
pH 2.3 (50). The hydrochloric acid is frequently used in a glycine 
buffer between pH 2.0 and 2.8. Such a buffer containing 0.2 M glycine 
was employed by Avrameas and Ternynck (63) to recover antibodies to 
human and rabbit IgG in yields of 91% from antigen immunoadsorbents 
prepared with beaded polyacrylamide. Complete recovery of homologous- 
antigens was achieved with the same eluting fluid from anti-rabbit 
IgG and anti-rat IgG immunoadsorbents. The elutions were effected at 
4°C. The same authors had previously reported (159) that elution of 
antibody was achieved sooner at 20°C than at 4°C. whether glycine- 
hydrochloric acid buffers or an electrolyte solution was used. Maximum 
elution of BSA antibodies was achieved within 15 min. at 20°C with the 
acid buffer, whereas it took 90 min. at 4°C. The time taken to complete 
elution of specific antigen from an immunoadsorbent will depend upon antibody 
avidity and the equilibrium constant of the reactions, factors which 
will also dictate the severity of'the elution conditions. Purification 
of antibodies to BSA, for example, was achieved using an ethylene 
maleic anhydride copolymer (74). Sequential treatment of the immuno­
adsorbent with glycine buffers of decreasing pH resulted in the elution 
of three distinct fractions. Antisera from animals that had received 
only two or three injections over a short period yielded the highest 
proportion of antibody at pH 3.0, with lesser amounts being eluted at 
pH 2.5 and 2.0. The first peak represented the antibodies of lowest 
ayidity. In hyperimmune animals high affinity antibodies will predominate 
and consequently a lower pH will be required to elute them.
As has already been mentioned, Sephadex can be mixed with immuno­
adsorbents to improve the flow rates of columns. Sephadex G-200 was 
used in this manner in a human serum albumin (HSA)system (22, 162) and
the exclusion properties also gave partial resolution of the HSA and 
the acid eluent. Forty percent of the protein was recovered above 
pH 6.0 with 0.2 M glycine-^HCl pH 2.2. The bed volume of the column 
was found to be critical with this grade of Sephadex since it influenced 
the pH profile and both the total amount of protein recovered and the 
amount recovered above pH 6.0. Subsequently (162) Sephadex G-15 was 
found to be better than the G-200 in that it packed easily into uniform 
columns with the immunoadsorbent and gave faster flow rates. Furthermore, 
the pH front was more sharply defined and a higher recovery of protein was 
achieved above pH 6.0, and in a smaller volume. The authors suggested 
that a shallow pH profile leads to a gradual protonation of the proteins, 
which causes partial dissociation of the antibody-antigen complex. Non­
specific antigen-immunoadsorbent complexes are then formed which 
cannot be dissociated at low pH. On the other hand rapid protonation 
associated with a sharp pH profile produces complete dissociation of the 
antigen-antibody complex. Fluorescent-labelled human IgG was recovered 
in yields 70-90% at neutral pH after elution with 0.2 M glycine-HCl 
pH 2.2.
The relative abilities of 2 M potassium iodide, 8 M urea,. I'M 
propionic acid and 20 mM hydrochloric acid pH 1.8 to elute myoglobin 
antibodies from several different myoglobulin-immunoadsorbents were 
studied by Boegman and Crumpton (27). Propionic acid and hydrochloric 
acid gave the highest protein recoveries, the former giving the higher 
recovery of precipitatable antibody.
Hill (81), bearing in mind the importance of hydrophobic bonding 
in the antibody-antigen reaction, investigated the effect of dioxan 
dissolved in weak organic acids on elution. The inclusion of 10%
dioxane in 0.1 and 0.5 M solutions of acetic and propionic acids 
increased the effectiveness of the acids as eluents of antibody 
from bromoacetyl cellulose-HSA and Sepharose-HSA. Higher yields 
of pig lactate dehydrogenase antibodies were obtained by adding 
dioxane to citric acid used as eluent. Batch elution of most of the 
antibody was achieved in 10-15 min. at room temperature with 10% 
dioxane in 0.1 M acetic acid. Antibodies eluted in the presence of 
dioxane after 2 hr. at room temperature were of high avidity than those 
recovered in the absence of the dioxane. Hie organic solvent did not 
appear to have an adverse effect on the antibodies. It was suggested 
that the success of dioxane was due to its randomising the water 
structure in the hydrophobic regions of the antibody since it had been 
shown to reduce dipole-dipole interactions and hydrogen bonding in 
water (163). Hydrophobic bonds contribute considerably to the maintenance 
of antibody-antigen complexes, and disruption of these would therefore 
favour dissociation of the complex.
Antibody immunoadsorbents specific for IgG, IgA, IgM and K and L 
chains have been prepared by coupling the antibody to cyanogen bromide 
activated Sepharose 4B and used to remove immunoglobulins from serum 
(164). The adsorbed immunoglobulin was eluted with either 3 M thiocyanate 
or 0.01 M hydrochloric acid - 0.15 M sodium chloride. Sequential use 
of -the immunoadsorbents allowed complete removal of the immunoglobulins 
from serum, and columns were used as many as 20 times over a period of 
12 months.. The authors suggested the possible application of the
"technique to the removal of IgD and IgE and possibly to the removal and
isolation of IgG subgroups. Bennich and Johannson (165), Carrel et al. 
(19) and Aalberse et al. (158) applied the technique to the purification
of human polyclonal IgE. Immunoadsorbents were prepared with Sepharose 
4B, cross-linked polyacrylamide and diazotised benzyloxymethyl cellulose 
respectively, and elution was effected with acid or 3.0-3.5 M thiocyanate 
(19, 165) and glycine-citrate buffer pH 2.8 (158). The cellulose based 
immunoadsorbent (158) was used in conjunction with Sephadex G25 in a 
manner similar to that described by Crooke et al.(162) for their Mk 3 
column. Sephadex G25 was mixed with the immunoadsorbent, the former 
being in a 20 to 80-fold excess, in order to improve the flow rate of 
the column and resolve the protein and acid peaks emerging from the 
column. A batch procedure gave higher yields of IgE than did the column 
procedure, but the degree of contamination was greater. Glutaraldehyde- 
polymerised antibodies to IgE were also tested but were found to have a 
lower antigen binding capacity than the cellulose coupled antibodies, 
and the purity was even lower than that obtained with the batch procedure 
The preparation obtained with the cellulose-based immunoadsorbent was 
found to have both a modified antigenic composition and a modified electro 
phoretic mobility, possibly due to denaturation, fragmentation or 
aggregation.
In the present study the purification of IgG by immunoadsorption has 
been used as a model for the purification of IgD from myeloma and 'normal 
human sera. Cellulose-based immunoadsorbents were used and these were 
prepared by methods described in Chapter 2. Six possible purification
procedures were investigated: -
1. Column (Immunoadsorbent alone)
2. Column (Immunoadsorbent mixed with Sephadex or Biogel)
3. Column (Immunoadsorbent packed on top of Sephadex or Biogel)
4. Batch.
5. Batch combined with use of Amicon filtration tubes.
6. A combination of both batch and column procedures.
Materials and Methods
All immunoadsorbents were prepared according to methods described in 
Chapter 2, the only variation being in the grade of cellulose used.
. Phosphate-buffered saline (P.B.S.) pH 7.66 was prepared by dissolving 
12.8gNa2HPC>4, 1.56 g Na^PO ^ ^ ^ O  and 85.00 g NaCl in 10 litres of distilled 
water. Borate buffered saline (B.B.S.) pH 8.4 contained 4.50 g H^BO^,
5.50 g Na2B^0  ^and 8.5 g NaCl in 1 litre. Phosphate buffer pH 7.66,
100 mM, contained 12.80 g Na2HP0^ and 1.56 g Na^PO ^ ^ ^ O  in 1 litre. 
Glycine-HCl buffers for elution were prepared by titrating 50 mM glycine 
to the desired pH with hydrochloric acid.
Antigen Purification Procedures
Method 1
The immunoadsorbent was packed into a glass column fitted with 
a teflon plunger supporting a plastic sinker, and equilibrated with 
B.B.S. The effluent buffer was monitored at 280 nm by a U.V. spectro­
photometer fitted with a flow cell. An aliquot of serum was applied to 
the top of the column and washed through with B.B.S. In some experiments 
the serum was recycled through the column for a given time, or the flow 
was arrested before washing. Washing was judged to be complete when 
the adsorbance at 280 nm was zero. The B.B.S. was replaced by the 
eluting fluid, and fractions emerging from the column were collected 
into equal volumes of 100 mM phosphate buffer pH 7.66.
Method 2
The same protocol as in Method 1 was followed, with the exception that 
the immunoadsorbent was first mixed with preswollen Sephadex G-25.
Method 3
The immunoadsorbent was packed on top of a column of Sephadex G-25 
or Biogel P. 10. The bed volume of the gel-filtration medium was three 
times that of the immunoadsorbent.
Method 4
Batch Procedure.
A suitable amount of the immunoadsorbent was mixed with serum in a 
25 ml screw-top universal bottle. The bottle was rotated on a Luckhams 
rocker-roller mixer for 30 min or more before the immunoadsorbent was 
collected by centrifugation in a bench centrifuge at 4°C.- The immuno­
adsorbent was washed repeatedly by resuspension in fresh B.B.S. followed 
by centrifugation. Washings were checked for protein by absorbance at 
280 nm, and once a steady state had been attained (usually 8 to 10 washes) 
the immunoadsorbent was mixed with the eluting fluid. The bottle was rotated 
on the Luckhams mixer for 5 min. or more before separation of the immuno­
adsorbent and eluate by centrifugation. The eluate was neutralised with 
alkali and dialysed against 1 litre of P.B.S. for 16 hr. before analysis.
Method 5
Modified Batch Procedure.
Method 4 was followed through to the immunoadsorption step. The 
suspension of the immunoadsorbent in serum was transferred to the upper 
chamber of an Amicon filtration tube fitted with a glass-fibre disc on top 
of a cellulose acetate membrane with an 8y exclusion limit. Matched tubes 
were centrifuged at 1000 g for 3 min. The adsorbed serum passed through 
to the lower chamber leaving the immunoadsorbent on the filter in the 
upper chamber.
Non-specifically adsorbed protein was washed from the immunoadsorbent 
by introducing B.B.S. into the upper chamber and centrifuging. The
process was repeated until protein was absent from the washings.
Elution was effected either by introducing the eluting fluid into the 
upper chamber with the immunoadsorbent and leaving it to filter through 
into an equal volume of 0.1 M phosphate buffer pH 7.66, or by suspending 
the immunoadsorbent in the eluting fluid.
Method 6
Combined Batch and Column Procedure.
Methods 4 and 3 were combined. The batch procedure was followed 
to the completion of the immunoadsorption step at which point the 
suspension was transferred on to the top of a column of Sephadex G-25 
or Biogel P. 10. The washing and elution procedures were carried out in 
the column.
Measurement of IgG and Total Protein
Protein^containing fractions of the eluate were pooled and dialysed 
against P.B.S. The dialysates were concentrated by pressure dialysis 
and the volume adjusted to equal that of the original serum volume used. 
The protein content was measured by the adsorbance at 280 nm and IgG by 
radial immunodiffusion as described in Chapter 2. The purity was checked 
by immunodiffusion and immunoelectrophoresis and, when the results of 
these tests justified it, by disc gel electrophoresis and ultra­
centrifugation.
Results and Discussion
Whatman CC31 microcrystalline cellulose, which had proved to be 
very suitable for use in radioimmunoassay procedures, was found to be 
unsuitable for use alone in columns because of its very small particle 
size. Either flow rates were very slow or the columns clogged. More 
satisfactory results were obtained by preparing the immunoadsorbents 
with Whatman'CF11 fibrous cellulose. The immunoadsorption step was
conducted in one of three ways: (i) the serum was loaded on to the 
column and run straight through; (ii) the flow was arrested once 
the serum had entered the immunoadsorbent and restored after a given 
time; (iii) the serum was recycled through the column. The highest 
recovery of IgG was obtained with the recycling procedure, but this 
preparation also contained considerable protein impurity (Table 4.1).
The recovery of IgG after arresting the flow was slightly less and 
again there were considerable levels of protein impurity. After 
running the serum straight through the column the amounts of IgG 
recovered was even less, but this proved to be the cleanest of the 
three preparations (Table 4.1). From these results it was concluded 
that the shorter the time of exposure of the serum to the immuno- 
adsorbent the smaller the amount of non-specific protein adsorption.
In an attempt to improve column flow rates and the efficiency 
of the washing procedure, columns were prepared from mixed slurries of 
the immunoadsorbent and Sephadex G-25 (Method 2). Differences between 
the densities of the immunoadsorbent particles and those of the gel 
made the packing of uniform columns difficult. The best results were 
obtained when thick slurries were poured with Sephadex in a three to 
four-fold excess. It was possible to use the Whatman CC31 based 
immunoadsorbents because the Sephadex prevented clogging and allowed 
the maintenance of satisfactory flow rates. Only partial resolution 
of the protein and acid front was achieved (Fig. 4.1). Two factors 
may contribute to this. Firstly, antigen is specifically adsorbed 
throughout the length of the column, and consequently antigen dissociated 
towards the end of the column will not be resolved from the acid front.
The second- possibility,which must be borne in mind, is that of 
readsoiption of the antigen. Antigen dissociated from the immunoadsorbent 
at the top of the column passes ahead of the acid front as a result of
gel filtration. Once free of the acid conditions the antigen may 
be readsorbed by antibody further down the column. The protein front 
is therefore retarded by readsorption and fails to resolve fully 
from the acid front. Furthermore, if readsorption of the antigen 
occurs there is always the possibility that it will become involved 
in a reaction with antibody which shows a greater avidity for the 
antigen. Then, dissociation of the resulting antibody-antigen complex 
may require a ’stronger’ eluting agent.
These problems were overcome by adopting the procedure described 
in Method 3. The results of a typical separation are presented in 
Fig. 4.2. Two protein peaks were eluted from the column, the first, 
and major peak, ahead of the acid front and the second peak with the 
acid front. The first peak contained 10.1 mg of IgG, and this was 
shown to be homogenous by ultracentrifugation (Fig.4.3). Radioactivity 
was divided between the first and second peaks in the ratio 85:15. 
Similar results were obtained when 1M propionic acid was used as the 
eluting agent.
In the immunoadsorbent section of the column. (Method 3) the eluted 
protein moves with or behind the acid front, and is only resolved from 
this on passing into the Sephadex G-25. There is therefore no danger 
of readsorption of the antigen. This may explain why the yield of IgG 
was greater than that achieved with the mixed bed column (Fig. 4.1).
Although column procedures gave satisfactory purification of IgG, 
batch procedures were also tested to ascertain the relative merits of 
the two approaches. Method 4 had one obvious disadvantage from the 
outset. After centrifuging and decanting the supernatant a considerable
amount of liquid remained trapped in the immunoadsorbent. This failure 
to separate the two phases completely prolonged the washing procedure 
required before specifically adsorbed protein could be eluted. The 
problem was easily overcome by the use of Amicon filtering centrifuge 
tubes (Method 5 and Fig. 4.4) which gave almost complete separation of 
the two phases and greatly facilitated the collection of washings and 
eluates. The eluates were collected directly into 0.1 M phosphate buffer, 
pH 7.66, in the lower chamber.
The results of some typical batchwise purifications are shown 
in Table 4 .2 . Immunoelectrophoresis revealed that IgG isolated : 
from whole serum by Method 4 was heavily contaminated, a result 
corroborated by the discrepancy between theoretical and actual O.D^gQ 
values. Albumin appeared to be the major contaminant. Similar 
results were obtained with Method 5, although the amount of contamination 
was less. Ammonium sulphate precipitation of the immunoglobulin 
fraction of serum prior to immunoadsorption overcame the problem of 
albumin contamination, but, although immunoelectrophoresis with anti­
whole human serum failed to show any obvious contamination of the IgG 
fraction, a discrepancy between theoretical and actual 0-D.^gQ values 
remained.
A reduction in the level of contamination, with a sacrifice in 
yield, was achieved by adopting a stepwise elution protocol (Table 4.2). 
After adsoiption of IgG from unfractionated serum and washing of the 
immunoadsorbent at pH 7.66, the fraction eluted at pH 4.0 contained 
relatively more contaminating protein than that eluted at pH 2.0.
Methods 4 and 5 were used routinely for absorbing antisera to render 
them mono-specific. ( \
The combination of batch and column procedures (Method 6) was 
used in the purification of IgD (Chapter 5). A comparison of 
column Method 3, batch/column Method 6 and batch Method 5 confirmed 
the findings for IgG.
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Fig. 4.1
Purification of human IgG by Method 2.
Antibody coupled to glutaraldehyde activated aminodipriopylamine cellulose. 
Total protein coupled:- 86 mg
Antibody coupled:- 17 mg (AS 57)
Sephadex G.25: Immunoabsorbent:- 3:1.
Column dimensions:- 20 x 1.5 cm.
’ Human Immunoglobulin added:- 35 mg.
Eluting agent:- 50 mM glycine - HC1, pH 2.0.
Yield:- 7.1 mg (Determined by radial immunodiffusion).
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Fig. 4.2
Purification of human IgG by Method 3.
Antibody coupled to glutaraldehyde activated aminodipropylamine cellulose 
Total protein coupled:- 86 mg.
Antibody coupled:- 17 mg (AS 57).
Bed volume Sephadex G 25:- 30 ml.
. Bed volume immunoadsorbant:- 6 ml.-
Column dimensions:- 21 x 1.5 cm.
125
Human immunoglobulin added:- 35 mg + trace labelled I”IgG.
Eluting agent:- 50 mM glycine - HC1, pH 2.0.
Yield:- 10.1 mg. (Determined by radial immunodiffusion).
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Fig. 4.4
Diagrammatic representation of filtering centrifuge tube.
1. Cap
2. Plastic tube
3. Upper chamber/filter holder
4. O-ring
5. Glass fibre or cellulose acetate filter
6. Filter support screen
7. - Wire-mesh under-support.
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Conclusion
The five protocols applied here to the purification of IgG have 
proved successful to various degrees, column procedures on the whole 
giving the best results. The two methods of antibody immobilisation 
giving retention of the highest percentages of antigen-binding capacity 
(as reported in Chapter 2), namely covalent coupling to diazotised 
N- (3-aminobenzyloxymethyl) cellulos e and glutaraldehyde-activated amino- 
dipropylamine cellulose, provided immunoadsorbents which performed 
admirably on a preparative scale. As mentioned previously the diazotised 
derivative has the apparent advantage of coupling via tyrosine residues 
and a spacer arm, whilst the glutaraldehyde activation of aminodipropyl- 
amine cellulose owes its success to the 14-atom spacer arm which results.
The most efficient conditions for immunoadsorption in columns were 
achieved by recycling the antigen solution. The method was only really 
satisfactory when the immunoadsorbent was used without a gel filtration 
column. Immunoadsorption of maximum amounts of antigen was achieved- 
in batch procedures, but these methods also appeared to attract higher 
levels of non-specific protein binding. However, this may reflect less 
adequate washing of the immunoadsorbent than can be achieved in columns, 
and accentuates the importance of efficient washing prior to elution. The 
problem was resolved in part by using a stepwise wash/elution protocol 
wifh buffers of decreasing pH. Ideally the immunoadsorbent should be 
prepared from moderately high avidity antibodies so that washing with low 
acidity buffers does not result in loss of specifically adsorbed antigen 
prior to elution with a buffer of higher acidity. Ternynckand Avrameas 
(63) claimed that non-specific adsorption onto an immunoadsorbent prepared
from glutaraldehyde-activated Biogel was almost non-existent, and more 
recently (216) excellent results have been obtained with glutaraldehyde- 
activated aminohexyl-Sepharose-4-B, non-specific protein adsorption 
accounting for less than 0.2! in the case of IgA and even less for IgG.
In the present study appreciable levels of non-specific adsorption were 
encountered with glutaraldehyde-activated aminodipropylamine cellulose. 
Cellulose may therefore be a less satisfactory carrier than are Biogel 
and Sepharose from this point of view.
Elution was effected with acid pH, glycine-HCl and propionic acid 
being the eluting agents employed routinely. Sodium thiocyanate (3M) 
was found to be a satisfactory eluting agent when employed in batch 
procedures, but did not come up to expectation when used in columns. This 
also was found to be the case in the purification of rabbit antibodies 
specific for HCG (I. Cayzer, personal communication). Antibodies were 
recoveredfrom Sepharose-4-B-HCG with glycine-HCl pH 2.0, but not with 
sodium thiocyanate (3M) as judged by latex agglutination (Prepurex) and 
Ouchterlony immuno-diffusion.
Rapid removal or neutralisation of the eluting agent after 
dissociation of the immunoadsorbent-antigen complex is desirable 
in order that the chances of protein denaturation are minimised. The 
acid eluting agents used in columns were successfully resolved from the 
dissociated protein by gel filtration on Sephadex G-25. Resolution was 
achieved in the minimum time with the immunoadsorbent and gel filtration 
medium in series in the same column. This approach also circumvented 
the problem of readsorption of the antigen which apparently was encountered 
when the immunoadsorbent was mixed with the Sephadex. In the case of 
batch procedures, neutralisation and subsequent dialysis provided the
only effective means of removing the eluting agent.
*
Column techniques were generally superior to batch techniques 
in as far as post-immunoadsorption washing and elution were concerned. 
However, the efficiency of batchwise handling has been improved 
considerably by the use of Amicon filtration tubes.
Subject to the availability of pure antigen it may prove 
advantageous to prepare a pure antibody fraction from a suitable 
antiserum. If prepared by immunoadsorption the antibody'will • . -
be pure with respect to both specificity and avidity. Immunoadsorbents 
with a high antibody:carrier ratio and medium to low avidity may then 
be prepared. The resultant need for smaller amounts of carrier and 
the presence of little or no non-antibody protein will reduce the 
potential risk of non-specific adsorption. These improvements have 
been implemented for the purification of IgD (Chapter 5)^  together 
with the use of a batch/column protocol (Method 6, Chapter 4).
{
CHAPTER FIVE
The Purification of IgD and anti-IgD, and 
the Partial Characterisation of an IgD Myeloma
IMMUNOGLOBULIN D (IgD)
Introduction
Immunoglobulin D (IgD) was first discovered in the serum of a 
patient with multiple myeloma by Rowe and Fahey (170, 171). It 
constitutes a class of immunoglobulins distinct from immunoglobulins 
G, M, A and E.
The mean concentration of IgD in ’normal1 human serum is 
generally accepted to be 30 yg/ml (171, 172), and it is this low 
concentration, together with a lack of physicochemical properties 
distinguishing it from other immunoglobulins, that have led to failures 
in attempts to purify it from serum. Consequently, the majority of 
studies have been carried out on myeloma IgD, with the exception of 
those reported by Bratcher et al. (173) for IgD from dysgammaglobulinaemic 
serum.
Rowe et al. (174) employed ion-exchange chromatography on DEAE- 
cellulose in conjunction with Sephadex G-200 gel filtration to effect 
purification of myeloma IgD. The serum was dialysed against 0.01 M 
phosphate buffer pH 8.0 and chromatographed on a DEAE-cellulose column 
with an eluting buffer gradient from 0.01 to 0.30 M. The IgD was eluted 
after transferrin and before a2-macroglobulin. Sephadex G-200 
chromatography was performed in 0.05 M tris pH 8.0, 0.2 M with respect 
to sodium chloride. One of the myeloma sera had very low levels of IgG 
and IgA, but even so the IgD preparation contained trace amounts of the 
other immunoglobulins. Initial attempts at purification yielded.Fc-like 
fragments which were eluted from the Sephadex column immediately after 
the IgD. It was established that the protein underwent proteolysis, and 
the problem was partly .resolved by working at 4°C and including the enzyme 
inhibitor E-amino caproic acid at a concentration of 0.001 M. The ..
concentration of the inhibitor was increased to 0.01 M on completion 
of the purification. Griffiths and Gleich (175) noted that 5 mM e-amino 
caproic acid inhibited the activation of plasminogen but did not effect 
plasmin activity. Leslie et al. (176) and Spiegelberg et al. (177) used 
similar procedures, but again the preparations contained small amounts 
(< 1!) of other immunoglobulins. Griffiths and Gleich (175) modified 
the procedure by introducing an initial dialysis against 0.02 M phosphate 
pH 5.4 containing 0.02 M EDTA. The resulting euglobulin precipitate was 
shown to contain the fifth component of complement which, if the dialysis 
step was omitted, contaminated the IgD preparations. Precipitation of 
the immunoglobulins was effected with 50! ammonium sulphate, and after 
desalting the purification was completed with DEAE-cellulose and 
Sephadex G-200 chromatography. Several of the preparations, although 
apparently.homogeneous by physical techniques, were shorn to contain 
trace amounts of IgG and a2-macroglobulin by Ouchterlony analysis.
Bratcher et al.(173) took advantage of the solubility of IgD in 0.05 M 
zinc acetate at pH 6.5 and the absence of IgA from a dysgammaglobulinaemic 
serum. The purification also involved DEAE-cellulose and Sephadex 
chromatography and immunoadsorption. Any trace amounts of IgG and IgM 
were removed in a final purification step by immunoadsoiption employing the 
appropriate antibodies covalently linked to p-aminobenzylcellulose. Saha 
et al.(178) also used immunoadsorbents prepared from bromoacetylcellulose 
to ..render their preparations homogenous. (See page 194).
Like IgG, IgD is composed of two heavy and two light chains linked 
together by disulphide bridges, one between the neighbouring heavy chains 
and one between each heavy chain and a light chain (1.77, 179) . In the 
IgD myelomas studiedx light chains have predominated. The immunoglobulin 
differs markedly from IgG in that it contains 11-14! carbohydrate as
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opposed to '3%, a figure more in keeping with the levels found in IgE 
and IgM. Hydration of the carbohydrate moieties of these glycoproteins 
is reflected in increased values of the frictional coefficient ratios, 
and consequently values obtained for IgE and IgD "
j • “ could be expected to be similar. Reported values of the
frictional coefficient ratios are 1.80 (IgD), 1.60 (IgE) and 1.47 (IgG) 
(175). The molecular weight of the intact molecule has been reported 
variously between 166,000 and 200,000 daltons (174, 177, 178) , and those 
of heavy and light chains as 60,000 and 23,000 daltons respectively - (177). 
The sedimentation coefficients of various IgD myeloma proteins measured by 
different research groups vary considerably. Two IgD samples purified 
by Rowe et al (174) had values of 6.14 and 6.19 S^q w  as compared with 
6.64 S?n for IgG, while values as high as 6.92 (173), 7.0 (177) and
ZU jW
7.2 S?n (180) have been measured. The partial specific volume of IgD
ZU jW
is 0.717 ml/g (173, 177) which is somewhat lower than that if IgG at 
0.738 ml/g, and is indicative of a higher density. On chromatographing 
the immunoglobulins on Sephadex G-200, IgM is eluted first followed by 
IgD, IgE, IgA monomer and IgG (173), a sequence in keeping with their 
Stokes radii (175) . The physical parameters of IgD together with its 
susceptibility to digestion by proteolytic enzymes (175) suggest that 
its structure is in some way unique amongst the immunoglobulins. The 
molecule is considered to be hydrated, elongated and flexible.
Myeloma IgD has been reported to migrate in the slow ^-globulin 
region on zone electrophoresis (170) and was found by Bratcher et al (173) 
to have an isoelectric point of 5.85 and electrophoretic mobility of 
2.52 x 10 ^cm^volt ^sec
Amino acid analysis of IgD myeloma proteins has shown: that one IgD 
differs considerably from another (178). The proline level was low
compared with other immunoglobulins, and the Bence-Jones protein 
excreted by one of the patients was unusual in that it contained three 
methionine residues as opposed to none in other Bence-Jones proteins.
The biological function of IgD is still a mystery, but antibody 
activity has been ascribed to the class ill a few instances. Ritchie
(181) demonstrated IgD antinuclear antibodies in a number of patients 
with rheumatic disorders, and these were also found by Watson et al.
(182) in 12 out of 25 patients with systemic lupus erythematosus and 
Kantor et al. (183). IgD anti thyroid antibody was also found in 1 out 
of 26 patients tested (183). A fluorescent labelled anti-rabbit 
globulin was used in conjunction with class specific anti Fc serum
to detect the antibodies in the patients serum (182, 183). This technique 
was employed by Schmidt and Mueller-Eckhardt (184, 185) in a study of 
82 patients with demonstrable antinuclear factor (ANF). Of these 32 
were found to have IgD-ANF, cases with systemic lupus erythematosus, 
rheumatoid arthritis and chronic liver diseases being the most frequently 
involved.
Anti penicilloyl activity was found associated with IgD by Gleich 
et al. (186). The antibodies were detected in an antiglobulin test on benzyl 
penicillin coated eiythrocytes. The antiglobulin reagent was blocked by 
pure IgD but not by other immunoglobulins. Heiner and Rose (187) 
conducted a study of antibody responses by radio immunodiffusion and 
demonstrated antigen binding activity in the IgD fraction of four sera.
Three of the patients were sensitive to cow’s milk and had antibodies 
to bovine IgG while two of them also had antibodies to BSA. The fourth 
patient produced antibodies in response to a booster injection of 
diphtheria toxoid.
Devey et al. (188) found what appeared to be IgD antibody to insulin 
in three out of six diabetic patients investigated using a red blood cell
linked antigen-antiglobulin reaction.
Klapper and Mendenhall (189) investigated the concentration of IgD 
in pregnant women and found that 41% of the women screened at the time 
of delivery had high levels of circulating IgD. Other pregnant women 
and those using oral contraceptives showed lesser elevations in their 
IgD levels. IgD was not. detected in 30 cord sera. However, the immuno­
globulin was demonstrated in the sera of 7 out of 84 neonates tested by 
Evans et al. (190) and 4.5% of those screened by Leslie and Swate (191). 
Variations in the permeability of placentae could have accounted for IgD 
being present in the neonates.
A study of sarcoidosis and tuberculosis patients (192) led to the 
detection of IgD in the sera of 20% more tuberculosis patients and 
20.7% fewer sarcoidosis patients than in the respective controls. Also 
the serum IgD concentration was found to be age dependent, high levels occurring 
predominantly in tuberculosis patients and low levels in middle-age sarcoidosis 
patients.
Pemis, Chiappino and Rowe (193) employed rhodamine-labelled anti 
IgG and fluorescein-labelled anti IgD to demonstrate separate populations 
of IgG and IgD secreting cells. - Furthermore, the numbers of s,uch cells were 
shown to be proportional to the circulating levels of the immunoglobulins.
van Boxel et al. (194) found that a high percentage (2.7%) of peripheral 
blood lymphocytes bear surface IgD. This figure represents 18% of lymph­
ocytes with surface immunoglobulins. They suggested that either IgD or its 
Fc fragment is cytophilic for a subset of lymphocytes or that the lymph­
ocytes are ones which d^ ail to mature into immunoglobulin secreting cells. 
Piessens et al. (195) and Knapp et al. (196) obtained similar results, the 
latter demonstrating both IgD and IgM on the same lymphocyte surface, and 
Rowe et al. (197) demonstrated that c. 15% of peripheral lymphocytes in the
new-born contain IgD, the level of circulatory IgD being virtually 
undetectable. Rowe et al. (204) also reported that membrane-bound IgM 
and IgD with the same light-chain subtypes were demonstrable on the 
same peripheral lymphocytes in both neonates and adults. The same two 
immunoglobulins were found together on the cells of patients with chronic 
lymphocytic leukaemia (207), and on the surfaces of monoclonal B 
lymphocytes from the bone marrows of seven cases of Waldenstrom’s macro- 
globulinaemia (199). van Boxel et al. (205) have shown that IgD is present 
in the membranes of lymphocytes grown in continuous culture jm vitro, 
along with IgG, IgA and IgM, supporting the view that the immunoglobulins 
are produced in the cells on whose surfaces they occur. It has been 
suggested (204) that a switch from the synthesis of 6. to y chains 
accompanies maturation of the B lymphocytes.— The-more-mature members 
of each lymphocyte clone, the plasma cells, rarely carry IgD, even when the 
majority of lymphocytes in the bone marrow bear IgD on their surfaces. 
Further evidence for a switch from 6 to y chain synthesis during B 
lymphocyte differentiation came from studies on patients with immuno­
deficiency disorders (215). The immunodeficiency stemed from a block 
in the B cell differentiation at a level between lymphocyte's carrying ^ oth 
y and <5 chains and those carryingy chains alone. It appears that B cells 
carrying both IgD and IgM have first to lose their surface IgD and become 
IgM producers before differentiating further into IgG and IgA bearing 
lymphocytes. The possibility of a switch from 6 to y chain production 
was not endorsed by Fu et al. (200). IgM and IgD occurring together on . 
the leukaemic lymphocytes of one particular patient were found to have the 
same idiotypic specificity, a phenomenon observed over several months 
and therefore regarded as being a stable one. The concept of separate 
m-RNA specie's for 6 and y chains with identical regions was inferred.
Onfyone light-chain sub-type has been found on any one cell (205). 
In the case of IgD, X light-chain producing cells predominate over 
k  producers in the spleen in the ratio of 5:1 (206), figures reflected 
in the serum levels in normal individuals and in the relative numbers 
among IgD myelomas. In 45 reported IgD myelomas (206), paraproteins 
with X-chains outnumbered those with K-chains by 37 to 8. In the cases 
of the other immunoglobulins the position is reversed, the ratio of 
k to X being close on 2:1.
The biological function of IgD may be related to its presence on 
cell surf aces, and the high proportion of IgD bearing lymphocytes could 
point to the involvement of the immunoglobulin in the induction of 
immunotolerance. The IgD molecules may function essentially as antigen 
receptors. y
Kohler and Farr (208) have reported the occurrence of higher IgD 
levels in atopic (reaginic) sera than in non-atopic (non-reaginic) sera, 
and work by Hsieh and Chen (201) has shown that serum IgD is elevated 
in. asthmatic children, suggesting a role in human atopy. However, 
there have been no reports so far of allergen-specific IgD class 
antibodies.
This summary of the work contributed thus fof on IgD shows that 
the immunoglobulin may play an important role in the human immune 
system. The development of simple methods of purification of the 
immunoglobulin from both myeloma and normal sera together with sensitive 
assays for measurement of the protein and specific antibodies of the 
IgD class may help to solve part of the problem.
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Re: page 188.
The applications of isotachophoresis (217) and isoelectric 
focusing (214) to the purification of human IgD myeloma proteins 
have recently been described in the literature. In both instances 
the success of the purification was judged by immunoelectrophoresis. 
After purification by isotachophoresis the electrophoresis mobility 
of the IgD was more cathodal, a fact attributed to loss of sialic 
acid residues.
Materials arid Methods
(i) Cellulose Acetate Electrophoresis
Cellogram strips were floated in sodium barbitone buffer I- 
0.05 for 30 min. and then totally immersed in the buffer. The strips 
were then blotted lightly before use. Samples were applied to the 
strips with a Shandon ’comb type’ applicator delivering 2 yl. The 
electrophoresis was run for 30 min. at 250 volts.
Proteins were stained by immersing the strips in either 0.2% 
ponceau S in 51 acetic acid or 0.11 coomassie brilliant blue R made 
up in 80 ml ethanol; 180 ml water: 30 g trichloracetic acid; 9 g 
sulphosalicylic acid (202). De-staining was effected with S% acetic 
acid or a mixture of methanol, water and acetic acid in the proportions 
250:650:80.
(ii) Isoelectric Focusing
Polyaciylamide was used to stabilise the ampholyte pH gradient 
and the gels were made up incorporating the protein sample and the 
ampholyte. A standard Shandon disc gel electrophoresis apparatus was 
used with glass tubes 75 mm long and 5 mm internal diameter. The 
electrofocus ing was performed at 4°C. Gels were prepared by the 
method of Wrigley (203) with acrylamide and ampholyte concentrations 
of 5 and 2% respectively. Chemical polymerisation was achieved with 
ammonium persulphate. A maximum current of 1.5 mA per tube was 
maintained for 90 min. by increasing the voltage, and the voltage was 
then maintained for a further 3 hr. Protein bands were stained with 
coomassie briliant blue R as described under ’cellulose acetate 
electrophoresis’.
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(iii) ^radipore* Electrophoresis
The apparatus was kindly loaned by Mr. Graham of Universal 
Scientific who also supplied the preformed polyacrylamide gel 
gradients.
The gel slabs were supplied containing borate-buffered saline, 
and these ions were removed by pre-running the gels in 0.05 M tris- 
glycine pH 8.3 for 2 hr. Samples were applied to the top of the 
gel through a comb template, and electrophoresis was commenced at 3 mA/cm 
with the template in place. After 30 min. the template was removed and 
electrophoresis continued for 24 hr. at constant current. Protein was 
stained with coomassie brilliant blue R or 0.7$ tAmido Black.
(iv) Analytical Ultraceritrifugation
Ultracentrifugation studies were conducted in Spinco Model E 
centrifuges fitted with Schlieren and interference optics. An An-D 
rotor was used in conjunction with a 12 mm 2° sector cell at rotor 
speeds of 44,000 r.p.m. (electronic speed control) and 50,740 r.p.m. 
(mechanical speed control). Samples were made up in 50 mM phosphate 
buffer pH 8.0, 150 mM with respect to sodium chloride and containing 
.10 mM e-amino caproic acid Q^HPOi* 13.65g, Na^PO^l^O 0.65 g, NaCl 
8.775 g and e-aminocaproic acid 0.656 g to 1 litre with distilled water).
• Sedimentation coefficients were determined for a number of serial 
dilutions of the protein and values extrapolated to infinite dilution.
The viscosity of the buffer relative to distilled water was measured 
with a.No. 0 Ostwald viscometer equilibrated in a water bath at 20°C. 
Fluid densities were measured with a 25 ml pycnometer. Values for ■ 
partial specific volumes were taken from the literature.
Sedimentation coefficients were corrected to standard conditions 
using the following equation:-
S°6>w = Sobs . . J W  . 1 -v C20,W
n20 %  1 -v Ct sol
where ri = viscosity, C = density and v = partial specific volume.
(v) Reduction of Interchain Disulphide Bonds
A II solution of the immunoglobulin was mixed with an equal 
volume of 0.15 M tris-HCl pH 8.0 made 0.15 M with respect to sodium 
chloride and 0.002 M with respect to ethylene diamine tetraacetic 
acid. Dithiothreitrol (DTT) was added to give a final concentration 
of 0.01 M, equivalent to a 150 molar excess, (assuming a molecular 
weight of 150,000 for immunoglobulins). The mixture was incubated 
for 2 hr. at 25°C. Solid iodoacetamide was added to a final concentration 
of 0.04 M, and the reaction vessel was wrapped in foil and placed in the 
dark for 15 min. The reaction mixtures were then dialysed overnight 
against 0.01 M phosphate buffer pH 7.1, again in the dark. The dialysates 
were concentrated to II protein in Amicon B15 concentrator cells. This 
solution was made II with respect to DTT and sodium dodecyl' sulphate 
(SDS), and 51 with respect to sucrose, and heated at 100°C for 2 min.
A sample containing the equivalent of 100 yg of the original protein 
was examined by electrophoresis.
(vi) Electrophoresis in Sodium Dodecyl Sulphate
Bromophenol blue was included as a marker in all samples, and 
these were run in a 51 polyacrylamide gel containing 0.11 SDS and 
buffered, with 0.1M phosphate pH 7.1. The electrophoresis was run for 
2 hr. at .90 volts.
51 Acrylamide gel:-
1.67 ml Acrylamide 30 g, N,N’-methylene bisacrylamide 0.8 g
to 100 ml with distilled water.
2.00 ml 0.5 M phosphate buffer. Na2H:P0i+ 40.50 g, NaH2P0i* .H20
29.65 g to 1 litre.
1.00 ml II SDS.
0.005 ml N,N,Nf jN’-tetramethylethylenediamine.
5.20 ml Distilled water.
0.10 ml 101 ammonium persulphate. '
Electrode Buffer:- 200 ml phosphate buffer
100 ml II SDS
700 ml Distilled water.
The mobilities . of proteins and peptides were determined by the 
method described by Weber and Osborne (218):-
_ Distance protein migrates . w ' length of gel before destaining
"  - ■ ■ T ■ . r r y*" , ■ ■■ • u ' I •- 1 I ■ - '  n * - - 'w  ' » T _ ' — -  . W r •T't
Length of gel after destaining Distance dye migrates.
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(vii) IgD Myeloma Sera
Two myeloma sera were available in sufficient quantities to make 
purification of the immunoglobulin a viable proposition. A small amount 
of an IgD myeloma pool was also available, and this was used in the first 
instance for raising antisera in rabbits.
A preliminary study of the sera involved cellulose acetate and 
IGradipore’ electrophoresis. The electrophoretic mobilities of the 
two myeloma proteins were different, that of S.T. being greater than that 
of M.V. (Fig. 5.1 (a)). A coup ar is on with two other known myeloma sera 
designated ’red’ and Tblue! showed that the IgD band in myeloma serum
S.T. had a similar mobility (Fig. 5.1(b)). The different mobility of 
the IgD in serum M.V. may be explained by the fact that the serum had 
been kept at room temperature for several days during transit.
!Gradipore’ electrophoresis clearly demonstrated the presence of 
the myeloma protein in the four sera tested (Fig. 5.1(c)).
(viii) Antisera to IgD
Two groups of three rabbits were immunized with 1 yl and 0.5 yl 
respectively of an IgD myeloma pool in 1 ml of saline/Freunds complete 
adjuvant in the proportion 1:2 by volume. Booster injections of the 
same amount of material were given at 4 week intervals for 12 weeks.
Test bleeds were made 2 weeks after the final booster injection. The 
antisera were tested by immunoelectrophoresis with the IgD myeloma 
pool and were found to contain antibodies to the whole spectrum of 
serum proteins (Fig, 5.2). Adsoiption of the antiserum with an immuno­
adsorbent prepared by glutaraldehyde polymerisation of a human serum 
pool rendered the antiserum specific for protein migrating to the
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F ig .  5 .1  (a )
M yelom a s e r a  S . T .  ( to p )  and  M .V . (b o tto m ) ru n  on c e l l u l o s e  a c e ta te  
and s ta in e d  w i t h  c o o m ass ie  b r i l l i a n t  b lu e  R.
F ig .  5 .1  (b )
M yelom a s e ra  'b lu e '  ( to p )a n d  S . T .  (b o tto m ) w i t h  a sam ple  fro m  a  
hum an serum  p o o l ru n  i n  b e tw e e n . E le c t r o p h o r e s is  on c e l lu l o s e  
a c e t a t e  fo l lo w e d  b y  s t a in in g  w i t h  P o n ceau  S .
F ig .  5 .1  (c )
’ G r a d ip o r e ’ e le c t r o p h o r e s is  o f  ( fro m  l e f t  to  r i g h t )  m yelom a serum
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’ b l u e ’ , m yelom a serum  ’ r e d ' ,  hum an serum  G . C . ,  m yelom a serum  S . T . , 
m yelom a serum  M .V . and human serum  p o o l .
F ig .  5 .2  (a )
Im m u n o e le c tro p h o re s is  o f  p o o le d  hum an serum  (W e lls  1 - 3 )  and p o o le d  
m yelom a s e r a  ( Ig D )  (W e lls  4 - 6 )  a g a in s t  (a )  sheep a n ti-h u m a n  seru m ,
(b ) (c )  (d )  (e )  r a b b i t  a n t is e r a  r a is e d  to  a myeloma ( Ig D )  p o o l and  ( f )  
r a b b i t  a n ti - Ig G .
F ig .  5 .2  (b )
Im m u n o e le c tro p h o re s is  o f  p o o le d  m yelom a s e r a  ( Ig D )  ( w e l ls )  a g a in s t  
s i x  r a b b i t  a n t is e r a  ( tro u g h s )  r a is e d  to  a p o o l o f  p u r i f i e d  Ig D  
p a r a p r o te in s  and a d s o rb e d  w i t h  g lu ta r a ld e h y d e -p o ly m e r is e d  Ig D .
ct2/$ region. The antibody was of very low titre and was demonstrated 
in the antisera from five of the six rabbits.
Injections were resumed after three months using purified IgD from a 
myeloma pool.Each rabbit received 100 yg of protein in 1 ml of saline/ 
Freunds complete adjuvant. A booster injection of the same dose was given 
four weeks later amd the rabbits were bled after a further ten days.
All animals produced antisera with a high titre of antibodies to IgD 
- '.1:16/1:32 by Ouchterlony gel diffusion test. These were rendered 
specific by adsorptions with a human serum pool polymer.
Two further groups of rabbits were injected with 50 and 100 yg 
doses of purified myeloma IgD (S.T.). Two booster injections were given 
at four week intervals, and the animals were bled ten days after each 
of the three injections. Twenty ml of blood was collected on the first 
two occasions. The resulting antisera were adsorbed with polymerised 
IgG, prepared from a human serum pool, to remove any anti-light chain 
activity (Fig. 5.2).
All injections were given intramuscularly, primary injections 
into the four limbs and boosters into the hind limbs only.
Cix) Purification of Myeloma IgD by Physicochemical Techniques
The procedure adopted was essentially that of Griffiths and 
Gleich (175) with minor modifications.
(1) Five ml of myeloma serum was dialysed for 18 hr. at 4°C 
against 1 litre of 0.G1 M phosphate buffer pH 5.4 containing EDTA 
and e-amino caproic acid at concentrations of 0.01 M and 0.005 M 
respectively. (KH2P04 1.36 g, EDTA 3.72 g and e-amino caproic acid 
0.656 g made up to 1 litre with distilled water.
(2) Centrifuged 15 min. at 12,000 g. This resulted in 
pelleting of the pH 5.4 precipitate and flotation of a lipid
fraction. The latter proved to be quite considerable in the two myeloma 
sera studied.
(3) The clear serum fraction was stirred continuously at 4°C during 
the dropwise addition of an equal volume of saturated ammonium sulphate 
over 15 min. The serum was left overnight at 4°C.
(4) The precipitate resulting from the previous step was collected 
by centrifugation at 2,500 g for 15 min. at 4°C. and washed twice by 
resuspension in fresh 501 saturated ammonium sulphate. The precipitate 
was dissolved in the minimum volume of 0.15 M saline and chromatographed 
on a 75 x 1 cm column of Sephadex G-25 (fine) equilibrated with 0.01 M 
sodium phosphate - 0.005 M e-amino caproic acid pH 7.66. (Na^PO^^O 
1.56 g, Na2HP0^ 12.8 g and e-amino caproic acid 6.56 g to 10 litres with 
distilled water).
(5) The protein was loaded onto a column of DE 32 cellulose 20 x
1.5 cm equilibrated with the same phosphate buffer. Ten 6 ml fractions 
were collected and protein was eluted from the column by phosphate buffer 
(300 ml gradient from 0.01 M to 0.1 M) (Fig. 5.3). Samples were 
concentrated by ultrafiltration using a diaflo PM 30 membrane and examined 
by immunoelectrophoresis. Stepwise elution with phosphate buffer in 0.005 M 
increments of concentration was also performed.
(6) Fractions containing IgD were pooled, concentrated to approximately 
3 ml and dialysed against 0.05 M phosphate biffer pH 8.0, 0.15.M with 
respect to sodium chloride and 0.005 M with respect to -amino caproic acid 
at 4°C for 16 hr.
(7) The IgD fraction was loaded onto a Sephadex G-200 column (120 x
2.5 cm) equilibrated in the same phosphate buffer. Fractions from the 
column were analysed by immunoelectrophoresis and polyacrylamide disc gel 
electrophoresis.
(8) When necessary trace amounts of IgG contaminating the 
preparation were removed by immunoadsorption. Sheep antibodies 
specific for the Fc region of human IgG were coupled to diazotised 
N- (3-aminobenzyl) cellulose, and the resulting immunoadsorbent 
was used in a ’batch’procedure. Aliquots of the immunoadsorbent 
were stirred with IgD preparation at room temperature for 1 hr, and 
then recovered by centrifugal filtration.
Samples of IgD were stored deep frozen at -40°C.
(x) Rabbit anti-human IgD (6)
Aliquots (10 ml) of rabbit antiserum raised .to human myeloma IgD 
were centrifuged at 12,000 g for 20 min. at 4°C to separate any precipitated 
material by pelleting and fat by flotation... An equal volume of saturated 
ammonium sulphate was added dropwise to the clear serum fraction with 
continuous stirring, thus rendering the solution 50% saturated with respect 
to ammonium sulphate. The mixture was kept at 4°C for 18 hr. before 
collecting the precipitate by centrifugation at 2,500 g for 15 min. at 
4°C and washing it twice with 50% saturated ammonium sulphate. The 
precipitate was dissolved in 5 ml PBS and dialysed against five changes 
of 1 litre of PBS over 2 days. The antiserum fraction was rendered 
6-chain specific by immunoadsorption with glutaraldehyde polymerised pooled 
human serum. . The success of the immunoadsorption was judged initially by 
immunoelectrophoresis and immunodiffusion, and then by radioimmunoassay.
The antiserum was tested for residual anti-IgG and anti-light chain 
activity by determining whether or not IgG inhibited the binding of 
125I-IgG and 125I-IgD respectively.
(xi) Purification of Myeloma IgD by Immunoadsorption
Method 3 (Chapter 4) was used to purify myeloma IgD (S.T.). The 
immunoglobulin fraction of rabbit anti-human IgD (6) jBR2| was coupled 
to either diazotised N- (3-aminobenzyloxymethyl) cellulose or glutaraldehyde­
activated amino dipropyl amine cellulose. Hie immunoadsorbent was packed 
on top of a column of G25 Sephadex. Elution was effected with either 
50 mM glycine-HC1 or 1 M propionic acid.
Purification was also achieved by the batch procedure (Method 5,
Giapter 4) .-
(xii) Purification of "Normal11 IgD by Immunoadsorption
(a) (Method 6, Chapter 4). A 200 ml sample of fresh serum (spiked
with 125I-IgD (S.T.)) was mixed with c. 10 ml packed volume of rabbit 
anti-IgD (6) BR2 immunoadsorbent in a 500 ml screw-top bottle. The 
bottle was rotated about its long axis on a rocking-roller mixer (Luckhams) 
for 2 hr. at room temperature. The mixture was centrifuged at 1500 g 
for 2 min., and the immunoadsorbent was resuspended in PBS and mixed 
with an equal volume of Sephadex G-25. The mixture was packed into a 
column on top of a column of Sephadex G-25 (35 x 1.5 cm). Elution was 
effected with either 50 niM glycine-HCl or 1 M propionic acid. The IgD was 
located by monitoring the radioactivity emerging from the column, and 
by measuring the ability of fractions to inhibit the binding of 125I-IgD 
in a solid-phase radioimmunoassay (Chapter 3).
(b) (Method 3, Chapter 4). Serum was fractionated by 501 ammonium 
sulphate precipitation and IgD was purified from the immunoglobulin 
fraction.
In both cases, column fractions were concentrated in Amicon B15 cells.
(xii| Purification of Rabbit Anti-Human IgD (6) Antibodies
Immunoadsorbents were prepared by coupling pure myeloma IgD (S.T.) 
to cellulose and used according to Method 3 (Chapter 4) to purify anti­
human IgD (6) antibodies from the immunoglobulin fractions of rabbit 
antisera.
(xiv) Radioimmunoassay of IgD
This was performed according to the protocol for IgD solid-phase 
radioimmunoassay (Chapter 3).
(XV) Neuraminidase Treatment of Purified Myeloma IgD
IgD (S.T.) (2 mg in 0.5 ml PBS) was dialysed against two
changes of 0.1M acetate buffer pH 5.0. A 100 yl aliquot of a
*
solution of neuraminidase, at a concentration of 2 Units/ml 
acetate buffer, was added to the dialysis sac. The sac was put 
into a universal bottle containing 10 ml 0.1 M acetate buffer 
at 37°C. The temperature was maintained for 1 hr before 
transferring’the dialysis sac into fresh PBS at 4°C. Dialysis 
was against two changes of PBS overnight. Samples were examined 
by electrophoresis and isoelectric focusing in polyacrylamide' 
gels.
*
( Neuraminidase from Clostridium perfringens - Type VI (Sigma), 
Lot 92C -8090, containing 0.78 Units of neuraminidase activity 
per mg of protein — bovine submaxillary mucin as substrate).
Results and Discussion
Characterisation of IgD Myeloma Sera
A preliminary study involving acetate and ’Gradipore’ electro­
phoreses has been described in Methods, section (vii). Further 
electrophoretic studies were conducted with sera S.T. and M.V. 
Immunoelectrophoretic analysis of the whole myeloma sera with light 
chain specific antisera (Mercia) revealed free A-type light chains 
in serum S.T. as well as identifying A-type light chains in the 
myeloma protein. Serum M.V. failed to react with either A or k light 
chain specific antisera, and light chains were identified as being 
of the A-type only after D.T.T. reduction of the purified immunoglobulin
When examined immunoelectrophoretically with 6-chain specific 
antisera raised to the myeloma pool both myeloma proteins were found to 
migrate to the $1 region. As the plates were developed transient 
secondary arcs were observed which could have been due to myeloma 
protein polymers. This possibility was also raised by the results 
of the ’Gradipore1 electrophoresis which indicated a molecular weight 
of the order of 360,000 daltons in keeping with a dimeric form of IgD.
Isoelectric focusing of the myeloma serum (S.T.) and pooled ’normal 
human serum revealed a complex pattern of lines perculiar to the former 
and presumably attributable to the myeloma protein (Fig. 5.3). This 
was confirmed by P.M. Johnson (214 and personal communication) who 
compared the isoelectric focusing pattern with those obtained for 
several IgG myeloma. On the basis of circular dichroism studies, which 
revealed that K-chains absorbed far more strongly at 294 nm than did 
A-chains, Johnson et al.(209) suggested that the isoelectric focusing 
patterns of IgG myeloma proteins are influenced by molecular constraints 
dependent upon the light chain type. A more complex isoelectric
209
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focusing pattern could therefore be attributed to a K-type light 
chain. Such an explanation cannot be proposed in the case of IgD 
(S.T.) because this protein has a A-type light chain. The complexity 
of the IgD pattern is comparable to those obtained for IgA myeloma 
proteins. The high carbohydrate content which the two immunoglobulins 
have in common may be implicated, and in particular the high sialic acid 
contents of the two proteins which contribute to their low isoelectric 
points.
The possibility that the complexity of the IgD isoelectric 
focusing pattern was due to partial loss of sialic acid residues was 
considered. Preparations of IgD (S.T.) were treated with neuraminidase 
to remove exposed sialic acid residues. Unfortunately the enzyme 
treatment appeared to have no effect on the protein.
Purification of Monoclonal IgD
Dialysis against buffer at pH 5.4 resulted in the precipitation 
of a euglobulin fraction which contained at least one protein which 
otherwise contaminated subsequent fractions of the preparation. Immuno­
electrophoresis patterns obtained for the sera after removal of copious 
amounts of lipid by centrifugation and flotation no longer showed diffuse 
anodal tailing from the origin (Fig. 5.5).
DEAE-cellulose chromatography failed to resolve IgG and IgD.
The protein trace from a cblumn eluted with a 0.01 to 0.10 phosphate 
buffer gradient is shown in Fig.5.4(a). Fractions were examined by 
immunoelectrophoresis, and IgG was found in fractions 18 to 28 with 
peak concentrations in fractions 19 and 23. IgD was first detected in 
fraction 21 and its concentration reached a peak in fractions 25 and 
26. The more anodal component of the IgD fraction (Fig. 5.5) was eluted 
from the column in fractions 49 et seq. Stepwise elution of protein
% 
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Column fractions
Fig 5.-^  (a).
Elution profile for myeloma serum S.T. from- a DE-32 cellulose 
column.. Protein was eluted in phosphate buffer, pH 7.66, in 
a gradient from 0.01 to 0.1M.
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Column fractions
1 IgG  f
I----Transferrin— f
Fig 5.If ("b)
Gel filtration.of.an IgD containing fraction on Sephadex 
G-200. 'Fraction' contained fractions 23 to 29 from DE-32 
column (Fig 5.3)*
LX.L
Fig. 5.5 (a)
Fractions 16-33 from DEAE-cellulose column (20 x 1.5 cm).
IgG is present in fractions 16-26. The first and last wells 
contained whole myeloma serum and sheep anti whole human 
serum was placed in all the troughs.
Fig. 5.5 (b)
Fractions 18-33 from DEAE-cellulose column (20 x 1.5 cm). 
IgD is present in fractions 21-33 with a peak concentration 
in fractions 25 and 26 - demonstrated by single radial 
diffusion technique. The first and last wells contained 
whole IgD myeloma serum and rabbit anti human IgD (Fc) was 
placed in all the troughs.
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from the ion-exchange column was also investigated, but again fractions 
containing IgD were heavily contaminated with IgG. Similar elution 
profiles were obtained for both myeloma sera (S.T. and M.V.).
A 120 x 2.5 cm column of Sephadex G-200 was found to be adequate 
for the resolution of IgD and IgG (Fig. 5.4 (b))% The purity of the IgD 
fraction was ascertained by polyacrylamide disc gel electrophoresis 
and solid-phase radioimmunoassays for IgG and IgD. IgG contamination 
in later fractions of the IgD peak were removed by batch immunoadsoiption 
with anti-IgG antibodies coupled to bromoacetyl cellulose.
Monoclonal IgD (S.T.) was successfully purified from the immuno­
globulin fraction (50% ammonium sulphate) of the serum according to the 
procedure described in Methods, section (xi). The Sephadex effectively 
retarded the acid front so that the bulk of the protein was eluted from 
the column before the pH dropped (Fig.5.6). The first peak represented 
IgD as did the fourth- (Table 5.1). The second and third peaks of radio­
activity contained relatively little protein, and these were shown to 
represent iodinated IgD fragments which resulted from degradation of the 
purified iodinated protein on storage. The fractions were adsorbed 
with anti-IgG antibodies coupled to bromoacetyl cellulose to remove trace 
amounts of IgG (Table 5.1), and then examined by disc gel electrophoresis, 
immunoelectrophoresis and isoelectric focusing (Fig. 5.7), and ultra-- 
centrifugation (Fig. 5.8). The preparation was judged to be homogenous 
by the electrophoretic techniques, but the ultracentrifugation analysis 
revealed a high molecular weight component. This may well have been an 
IgD aggregate, the existence of which has been postulated earlier on the 
strength of observations in immunoelectrophoresis and TGradipore! 
electrophoresis.
The amount of IgD recovered by elution when the column was used 
for a second time was less, but so also was the amount adsorbed as 
indicated by the amount recovered in the wash peak. Losses due to
irreversible adsorption and the prolonged washing prior to elution
\
were less on the second run, presumably because of the blocking of 
high avidity antibody.
The combination of batch immunoadsorption and column washing and 
elution gave a good yield of IgD (Table 5.1) with only a marginal 
increase in the amount of IgG contamination. The immunoadsorbent was 
not mixed with Sephadex G-25 prior to packing in the column and 
consequently IgD dissociated by.the eluting agent was carried with the 
acid front until it passed into the Sephadex portion of the column where 
the two were resolved. Readsorption of IgD was thus prevented, and 
a single protein peak emerged from the column ahead of the acid front 
(Fig. 5.9). Elution of readsorbed IgD may have accounted for the late 
protein peak observed in Fig. 5.6.
The batch procedure using Ami con filtration tubes was combined with 
stepwise elution of the protein in an attempt to reduce the amount of 
IgG contamination. Hie overall yield of IgD was slightly less than that 
obtained by combining batch immunoadsorption with column elution, but 
the larger part of the contaminating IgG’was removed in the pH 4.0 and 
3.0 fractions (Table 5.1 and Fig. 5.10). These results may be explained 
in one of two ways. Firstly, the IgG contamination may arise as the 
result of non-specific physical adsorption to the carrier which is 
reversible at pH 4.0. Secondly, the possibility still remains that the 
immunoadsorbent employed to render the anti-IgD serum specific failed to 
remove some low avidity antibody directed against IgG.
A direct quantitative comparison of the column and batch techniques 
is difficult because of the need to either dilute or use larger quantities 
of the IgD containing immunoglobulin fraction in the batch procedures in 
order to achieve suspension of the immunoadsorbent.
Counts per
125-r T ~ m m  I-IgD
r4000
CM
•H
rH
.3000 •H
O
2000
1000
Column fractions
' Fig. 5.6
Elution profiles from G25 Sephadex/G25 Sephadex - anti IgD (6) 
immunoadsorbent column. (Methods, section (xi)). Elution was 
achieved with 50 niM glycine-HCl pH 2.5 and protein concentration,
radioactivity and pH were monitored. ( -----  - radioactivity
[125I-IgD], ........ - optical density 280 nm, a n d    - pH }.
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M yelom a Ig D  ( S .T . )  p u r i f i e d  b y  im m u n o a d s o rp tio n  -
(a )  fro m  l e f t  to  r i g h t : -  i s o e l e c t r i c  fo c u s in g  p a t t e r n  i n  p o ly a c r y la m id e  g e l ,  
pH ra n g e  3 -1 0 ;  i s o e l e c t r i c  fo c u s in g  p a t t e r n  i n  p o ly a c r y la m id e  g e l ,  pH ra n g e  
4 - 9 ;  a c r y la m id e  g e l  e le c t r o p h o r e s is  p a t t e r n .
(b ) Im m u n o e le c tro p h o re s is  o f  Ig D  ( S . T . )  a g a in s t  r a b b i t  a n t i  Ig D  ( 6 ) .  U p p e r  
w e l l ,  Ig D  p u r i f i e d  b y  im m u n o a d s o rp tio n . Low er w e l l ,  Ig D  p u r i f i e d  b y  immuno­
a d s o r p t io n  and Sephadex G200 g e l  f i l t r a t i o n .
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Column fractions
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5 PH
6
Fig 5.9
Elution of IgD (S.T.) from anti IgD immunoadsorbent. 
Eluting agent - glycine-HCl pH 2.0. Antibody coupled 
to glutaraldehyde-activated aminodipropylamine cellul­
ose, (Method 6, Chapter 4)o
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nH 50e
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o
-rH 10
'7.66/ 4.0/7.66/3.0/7.66/2.0/ 7.66/7.66
pH of eluting agent or wash buffer 
-Fig 5,10
Elution of IgD (S.T.) from anti IgD immunoadsorbent. 
Eluting agents - glycine-HCl buffers. Antibody coupled 
to glutaraldehyde-activated aminodipropylamine cellulose' 
(Method 5, Chapter 4).
Stability of IgD on Storage and on Heating
Immunoelectrophoresis of heated (56°C) and unheated myeloma serum 
(Fig.5.11) revealed little or no change in the IgD pattern. Heating at 
56°C for 30 min caused precipitation of the lipid fraction of the serum 
which characteristically gave anodal tailing from the well. Hie protein 
was not stable when stored in solution, at a concentration of 3 mg/ml, 
at 4°C for 2 weeks. The immunoelectrophoresis pattern was considerably 
modified by the extension of the IgD line in the anodal direction. When 
examined by ultracentrifugation the solution was found to contain a 
major component of approximately 3.5 S and a minor 7 S component. The 
nature of the former, a degradation product of the 7 S IgD, is uncertain.
Sedimentation Velocity
The sedimentation constant S°q w  of myeloma IgD (S.T.) was 6.84, 
determined by extrapolating values to infinite dilution. . The correlation 
coefficient, r, was 0.96, and a value of 0.77 was assumed for the partial 
specific volume (197) (Fig. 5.12). The protein was purified by ammonium 
sulphate precipitation followed by immunoadsorption and Sephadex G200 
chromatography.
Molecular Weights of IgD (S.T.) Heavy and Light Chains
The conditions of dithiothreitrol (DTT) reduction chosen were such as 
to result in only partial reduction of the IgG and consequently reduction 
intermediates were present in. the final mixture. IgD (S.T.) proved to be 
more susceptible to reduction and, except for a small amount of a heavy- 
light chain (HL) intermediate, was degraded completely to heavy (H) and 
light (L) chains. Hie results of SDS electrophoresis of reduced IgG 
and IgD are shown in Fig. 5.13. Hie identification of HHL, HH and HL
+F ig .  5 .1 1
S t a b i l i t y  o f  Ig D .
A l l  t ro u g h s  c o n ta in e d  r a b b i t  a n t i - I g D  ( i5 ) .
W e fls  c o n ta in e d  ( to p  to  b o tto m )
( i )  F r e s h ly  th a w e d  m yelom a serum  (S .T )
( i i )  M yelom a serum  s to r e d  a t  4°C  f o r  3 days (0 .1%  sod ium  a z id e  a d d e d ) .
( i i i ) M y e lo m a  serum  h e a te d  a t  37°C  30  m in .
( i v )  M yelom a serum  h e a te d  a t  56°C  30  m in .
(v )  F r e s h ly  p re p a re d  Ig D  ( S .T . )
( v i )  P u r i f i e d  Ig D  s to r e d  a t  4°C  in  p re s e n c e  o f  0 .1%  sod iu m  a z id e  f o r  2 w e e k s .
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Fig. 5.13
SDS electrophoresis of reduced and alkylated IgG and IgD (S.T.) 
in 5% polyacrylamide gels. (Left - IgG and right IgD).
Standard curve constructed from the mobilities of IgG reduction 
products assuming molecular weights of 22,500 and 53,000 for light 
and heavy chains. (Confirmed by reference to external standards -
see text).
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IgG reduction intermediates and H and L chains was made by reference 
to external standards. (Chymotrypsinogen A, 25,700; egg albumin, 46,000 
and human serum albumin, 66,000). A semilog plot of molecular weight and 
mobility revealed a linear relationship (Fig. 5.13). By reference to 
this standard curve the molecular weights of IgD (S.T.) H and L chains 
were found to be 70,500 and 26,000 dal tons respectively. Assuming two 
H and two L chains per molecule of IgD, the molecular weight of the whole 
molecule would be 193,000 daltons.
The IgG used in this study was purified from pooled human serum 
which presumably contained both k and A light chains. The poorly defined band 
immediately behind the band with fastest mobility (Fig.5.13) respresents 
the Alight chain.
The value of 70,500 dal tons for the H chain is in good agreement 
with values obtained by electrophoresis and gel filtration by Perry 
and Milstein (179) and Leslie, et aL. (176) within the accuracies of the 
methods. The value of 26,000 dal tons for the L chain reported here is 
higher than that of other IgD myeloma proteins at 22,500 dal tons (176).
This value of 22,500 dal tons hs been widely reported as the molecular 
weight of immunoglobulin light chains. It is possible that the difference 
is due to an artefact attributable to the SDS technique. Higher values 
have been obtained using this technique as reported by Ahmad-Zadeh et al.
(210) and Virella and Coelho (211). In the first case values of 25,170, 
26,407, 25,589 and 26,351 dal tons were estimated for human IgM, IgA and 
IgG light chains and Bence-Jones protein respectively. These values are 
in good agreement with that found for IgD (S.T.) light chains in the present 
study, the only difference being that 5% gels were used as opposed to 
10% gels. Virella and Coelho (211) reported a difference between the
mobilities of A and k light chains as deteimined by SDS electrophoresis.
In 51 gels the molecular weights of k and A chains were estimated as 
22,845 and 28,395 dal tons respectively. IgD (S.T.) light chains are 
6f the A type.
Carbohydrate has been shown to reduce the mobilities of proteins
in SDS gel electrophoresis (212), a factor attributable to increased molecular
weight and possible hydration of the carbohydrate moiety. Carbohydrate 
would account for the reduced mobility of IgD (S.T.) light chain.
Assuming a mean residue weight of 109, the molecular weight of IgD (H), 
as deteimined by SDS electrophoresis, is consistent with an immuno­
globulin chain with five domains as is the case with both y and e chains. 
Taking the values of 70,500 and 52,500 dal tons for the molecular weights 
of IgD (H) and IgG (H) and carbohydrate contents of 121 and 31 respectively, 
the chains would contain 468 and 567 amino acid residues. These figures 
compare with values of 570 (y), 550 (e) and 45 (v).
Amino Acid Analysis
Amino acid analyses were performed on the purified IgD paraproteins from
sera S.T. and M.V. (1 and 2 respectively, Table 5.2). The results represent
the means of two separate analyses. Purification was achieved by ammonium 
sulphate precipitation and immunoadsorption. IgG, purified from serum S.T. 
was analysed for comparison. Levels of lysine, aspartate and tyrosine were 
lower in IgD than IgG while levels of threonine, serine, glutamate and 
alanine were higher. The . relatively low levels of proline in IgD para­
proteins noted by Saha et al. (178) -were not found in the proteins studied 
here.
r
Table 5.2
Amino Acid Analysis of Immunoglobulins
IgG IgD (1) IgD (2)
Lysine . 90 66 71
Histidine 26 36 39
Arginine 44 68 72
Aspartate 112 105 98
Threonine 114 159 185
Serine - 166 196 197
Glutamate 147 173 180
Proline 108 128 128
Glycine 97 118 111
Alanine 66 140 127
Valine 122 140 134
Methionine 11 13 15
Isoleucine 29 28 28
Leucine 109 138 128
Tyrosine 57 42 42
Phenylalanine 45 53 52
Tiyptophan 22 21 22
I Cystine 25 .22 24
Ammonia 94 74 117
•moles of amino acid per mole of
immunoglobulin *
Norleucine was included as an internal standard.
*
Assuming molecular weights of 193,000 and 153,000 and carbohydrate 
contents of 12 and 3 percent for IgD and IgG respectively.
*
Immunoglobulin D (IgD) Levels in Myeloma Sera and ’Normal* Sera
IgD levels were measured by solid-phase radioimmunoassay as described 
in Chapter 3, and expressed in terms of either International Units (MRC/WHO 
standard 67/37) or mass. The immunoadsorbent was prepared from immuno­
adsorbent purified rabbit anti-human IgD (6) antibodies raised to an IgD 
paraprotein pool. Competitive-binding assays were set up with labelled 
IgD (purified from paraprotein pool) and dilutions of standard 67/37, and 
the resulting standard curves were used to determine the concentrations 
of IgD in dilutions of sera S.T. and M.V. and in a fraction of purified 
paraprotein S.T. (Table 5.3). The concentrations of IgD in the two myeloma 
.sera studied in detail were 4,226 _+ 152 I.U. (S.T.) and 1,373 + 74 I.U. (M.V.).
Assuming a molar extinction coefficient at 280 ran E ^ m = 14.5,a S.T. prepar­
ation contained 1.027 mg/ml, one I.U. was equivalent to 1.67 + 0.03 yg of 
paraprotein S.T., The assays were repeated with purified paraprotein S.T. 
as a standard and then 1 I.U. was equivalent to 1.55 _+ 0.03 yg.
The mean IgD concentration in a group of 30 subjects was found to be
26.8 _+ 17.2 I.U./ml. (arithmetic mean) within the range 5.4 to 75.4 I.U./ml. 
(MRC/WHO standard 67/37). Values were determined using 20, 50 and 200 fold 
dilutions of ’normal' serum. Assuming a value of 1.67 yg IgD per I.U., the 
mean IgD concentration was 44.8 yg/ml.
Purification of ’Normal’ IgD •
The batch/column method described in Methods (xii) was adopted for 
the purification of IgD from normal serum B.C., which contained 4550 I.U. 
or 7.6 mg of IgD per 100 ml.
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The immunoglobulin fraction of antiserum.BR2 raised to an IgD pool 
was coupled to glutaraldehyde-activated aminodipropylamine cellulose.
Two grams of the immunoadsorbent contained of the order of 28 mg of 
antibody. A total of 1250 I.U. of IgD was recovered from the immuno­
adsorbent by elution with 50 mM glycine-HCl pH 2.0, representing 141 
of the total IgD. Assay of the serum after adsorption revealed 2100 I.U. 
remaining unadsorbed. Therefore, 51% (1250 ex 2450 I.U.) of the adsorbed 
IgD was recovered by elution, the remainder either having been lost in the 
washings after physical adsorption or retained by the immunoadsorbent.
The eluate was contaminated with IgG (c.60%) and some albumin (not 
quantitated). -
The method left some room for improvement in terms of the efficiency 
of the immunoadsorption. This could have been improved by the use of more 
avid antibodies with the accompanying risk of losing antigen in undissociable 
antibody-antigen complexes. In the absence of such antibodies, it was 
sought to improve the immunoadsorption by reducing the reaction volume,, 
excluding certain serum proteins from the system and using partially 
purified anti-IgD antibodies. The antibodies were purified by adsorption 
on to and-subsequent elution from IgD (S.T. and M.V. together) coupled to 
glutaraldehyde activated aminodipropylamine cellulose, and themselves 
immobilised on the same carrier. The immunoglobulin fraction of serum B.C.
■was precipitated by 45% saturation with ammonium sulphate. The fraction 
was exhaustively dialysed against five changes of PBS over 2 days and made 
up to 25 ml of solution. The total IgD concentration was 4100 I.U., and 
3700 I.U. were adsorbed. After washing at pH 7.66 and pH 5.0, 2900' I.U. 
were recovered by elution with 50 mM glycine - HC1 pH 2.0. Disc gel 
electrophoresis of the concentrated eluate revealed that the preparation was
homogenous (Fig. 5.14). However, IgG contamination was detectable 
by radioimmunoassay and accounted for approximately 2% of the total 
protein. Immunoelectrophoresis gave no evidence of IgD degradation 
products. Ultracentrifugation analysis revealed a single peak of 
approximately 7S (Fig. 5.15). Insufficient data was available to 
enable an accurate determination of the sedimentation coefficient 
to be made.
J -
Fig. 5.14
Polyacrylamide disc gel electrophoresis.
From left to right: ’normal’ IgD (B.C.) purified by ammonium sulphate 
precipitation and immunoadsorption; myeloma IgD (S.T.) and whole serum 
(S.T.).

Conclusion
The physical and immunochemical data amassed here confiim that the 
protein purified from normal senmi was in fact IgD as judged by its 
similarity to the IgD paraproteins S.T. and M.V. These in turn had 
been shown to identify with IgD paraproteins described in the literature.
Immunoelectrophoresis showed both the myeloma and normal IgDs1 as 
having comparable 3 mobilities. A degradation product with greater mobility 
was detected in the myeloma serum and in the pure IgD fractions upon storage 
at 4°C. This was identified with the ’Fc-like’ piece reported elsewhere 
(174, 175).
A value of 6.84 S^q w  for the sedimentation coefficient of para­
protein S.T. compared favourably with values of 6.92, 7.0 and 7.2 S^q w  
reported for other paraproteins (1973, 177, 180). Ultracentrifugation 
also revealed a high molecular weight component in some preparations which, 
in the absence of any other positive identification, was assumed to be 
an IgD dimer. This conclusion was supported by the result of ’Gradipore’ 
gradient polyacrylamide gel electrophoresis, which showed the IgD in whole 
myeloma serum as having a molecular weight of 360,000 dal tons. The value 
of 193,000 dal tons determined by summing the molecular weights of heavy 
and light chains, as determined by SDS gel electrophoresis, may be on the 
high side. This is because of the high value attributed to X chains with 
this technique. If a value of 22,500 dal tons is assumed for light-chains 
a molecular weight of 186,000 is obtained. The molecular weight of H 
chains, 70,500 dal tons, is consistent with the existence of a fifth domain, 
in common with e and y chains.
The isoelectric focusing pattern of the myeloma protein S.T. differed 
from that reported by Johnson et al. (214) in that the purified IgD 
appeared to be considerably less heterogeneous. The difference may have
its origin in the method of purification employed. The possibility 
that the immunoadsorbents showed a specificity for a particular IgD 
(S.T.) sub-population has to be considered.
The concentration of IgD in the myeloma sera S.T. and M.V. were 
4226 and 1373 I.U./ml respectively, while the mean concentration in 
a group of normal subjects was 26.8 I.U./ml. The determinations of 
these values by solid-phase radioimmunoassay, using antisera raised 
to an IgD paraprotein pool and either paraprotein or IgD reference serum 
as standard, highlighted the pitfalls likely to be encountered when 
measuring levels of normal protein in terms of paraprotein standards 
and vice versa. The problem hinges around the antibody population of the 
antiserum. By raising antisera to a single IgD protein one is ignoring 
the possibility of isotypic sub-class variants and allotypic variants.
The resulting antiserum will contain antibodies specific for a restricted 
population of IgD variants. The antisera used here for radioimmunoassay 
and purification of formal' IgD were raised against an IgD pool to 
minimise the chances of this occurrence.
Very encouraging results were obtained with the immunoadsorption 
purification procedures. The relatively high levels of IgD in the 
myeloma sera facilitated purification, but IgD fractions were always 
contaminated with IgG. Further adsorption of anti-IgD sera prior to 
immobilisation failed to reduce the eventual level of IgG contamination 
confirming that the contamination arose from non-specific adsorption to the 
immunoadsorbent. Similar contamination was encountered when purifying 
IgD from normal serum, but in this case the level was significantly 
reduced by using immunoadsorbent purified antibodies which allowed the 
attainment of higher specific antibody:carrier ratios. The higher degree 
of purification achieved was attributed to the use of smaller amounts of
carrier and the presence of.very little non-antibody protein. Ninety 
percent of the IgD in an immunoglobulin fraction from 'normal' serum 
was adsorbed onto the solid-phase, and 78% was recovered on elution, the 
level of IgG contamination being 1.4%. IgG was most easily removed from the 
fractions by immunoadsorption with immobilised anti-IgG.
Using the whole immunoglobulin fraction of IgD anti-serum coupled 
to cellulose, the highest degree of purification of IgD from myeloma 
serum was achieved with the two tier immunoadsorbent :Sephadex G 25 
column. . Contamination with IgG was 4.1%, and this fell to 2.8% when 
the immunoadsorbent was reused.
Purified antibodies specific for IgD may find an application in the 
development of a solid-phase radioimmunoassay for specific IgD class 
antibodies along the lines of the radioallergosorbent technique (RAST).
CHAPTER SIX
In Conclusion
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The most efficient immunoadsorbents are prepared by coupling 
antibody to diazotised N-(3-aminobenzyloxymethyl) cellulose, via 
tyrosine residues, and to glutaraldehyde-activated aminoalkylcellulose, 
via amino groups. Both activated carriers incorporate spacer arms, 
that in the case of glutaraldehyde activated aminodipropylaminecellulose 
being 14-C*long. The lengths of the spacer-arms and the degree of 
activation of the carrier have both been shown to influence the activity 
of the immobilised antibody. The longer the spacer arm the greater the 
distance between the carrier and the antibody and the less the steric 
effects of the carrier on the antibody. The more efficient the 
immobilisation, in terms of the number of covalent bonds, the greater 
the overall constraint placed upon the antibody structure and the 
greater the chance of bonding occurring via amino acid residues in 
the antigen-binding site. Both will result in loss of overall binding 
capacity, and the former may influence the avidity of the antibody.
The phenomenon of ’immunoadsorbent avidity’, attributable to high antibody 
packing density on the carrier, has been discussed, and it is thought 
that this may influence the yields of antigen recoverable by elution.
Coupling to glutaraldehyde-activated aminoalkylcellulose is 
recommended. The coupling conditions are not hazardous, as for 
example with cyanogen bromide, and were found to be more reproducible 
than those involving diazotisations. Of the methods tested this gave 
retention of the highest percentage of original antibody activity.
However, the amount of antibody protein immobilised using the amino- 
alkylcelluloses described here was considerably less than was possible 
with diazotised N-(3-aminobenzyloxymethyl)cellulose preparations, and
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the use of this derivative is to be preferred if a high protein:carrier 
ratio is required Alternatively, the use of cellulose derivatives with 
larger numbers of amino groups, or carriers with primary amino groups as 
inherent parts of the chemical structure, such as beaded polyacrylamide 
(Biogel), may be used.
Sepharose has come to the fore due to the commercial enterprise of 
Pharmacia Ltd., who now market a range of Sepharose derivatives to 
which protein and carbohydrate may be coupled. These include cyanogen 
bromide activated Sepharose, carboxyl and amino derivatives, and the 
oxirane derivative which is suitable for the immobilisation of carbo­
hydrates. The biggest attractions of these derivatives are their good 
column flow characteristics and their gel filtration properties.
Although cellulose cannot match these particular properties it does 
have the advantage of being considerably cheaper, lyophilizable and 
chemically more robust. Column characteristics may be improved by mixing' 
the cellulose-based immunoadsorbents with gel filtration media. However, 
the resulting separation of the eluted protein from the eluting-agent-front 
may not be in the best interests of the method. The possible readsorption 
of eluted antigen once it has passed ahead of the eluting-agent-front 
may result in a reduced yield. A two-tier column system, with the immuno­
adsorbent packed on top of a column of gel filtration material, has been 
shown to give the best results.
Column procedures are far less demanding than batch procedures on the 
time of their users and are therefore more attractive from the routine 
production point of view. Furthermore, column techniques have been shown
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to be superior to batch techniques in tems of the purity and recovery 
of antigen. In use under these conditions acid eluting agents were 
more efficient than high ionic strength electrolytes such as sodium 
thiocyanate.
Cellulose-based immunoadsorbents are suitable for lyophilisation 
provided suspensions are first made 5% with respect to sucrose. 
Immunoadsorbent preparations kept in this way provide a very suitable 
"off the shelf" reagent" for standardising radioimmunoassays, as well 
as being convenient to use*.
The solid-phase competitive binding assays have been found to be 
less sensitive than the double-antibody assays in the systems tested, 
but sensitivity was still more than adequate for routine applications.
A big advantage of certain immunoadsorbent preparations, those with 
bromoacetyl cellulose and reprecipitated N- (3-aminobenzyloxylmethyl) 
cellulose in particular, is their small particle size, and resulting slow 
rate of settling, which makes tumble-mixing of the assay tubes during the 
incubation unnecessary.
Immunoadsorption has been used successfully to purify IgG from 
"normal" serum and IgD from both myeloma and "normal" sera. All the 
IgD preparations were contaminated with IgG and this was removed by 
immunoadsorption. The level of contamination in preparations from 
"normal" serum was reduced by using immunoadsorbent purified immobilised 
antibodies.
*lnsulin, IgG and IgD have been assayed routinely using such reagents.
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